Sentence,class,file
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir Year: 2015, Volume: 7, Issue: 1, Pages: 969-970,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/53/92/969-970.PMC4455296.pdf
http://www.ephysician.ir Page970advise those involved with the healthcare system to make them more aware of the significant influence of Health 2.0.,Non-OADS,/arxiv_data1/oa_pdf/53/92/969-970.PMC4455296.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir Year: 2015, Volume: 7, Issue: 1, Pages: 971-976,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/b2/6e/971-976.PMC4455297.pdf
http://www.ephysician.ir Page972high levels of polyphenols and polysaccharide swereidentified in lemon balm.,Non-OADS,/arxiv_data1/oa_pdf/b2/6e/971-976.PMC4455297.pdf
"Electronphysician , Vol.7, No.1, March 2015 http://www.ephysician.ir Page973 Figure 1 .Comparison ofthe heartratesof thedifferent groups [Control group and extract groups (100 and 200 mg/kg)].",OADS,/arxiv_data1/oa_pdf/b2/6e/971-976.PMC4455297.pdf
"http://www.ephysician.ir Page974increased intracellular calcium during arrhythmia, thereby causing delay and early after depolarization (15).",Non-OADS,/arxiv_data1/oa_pdf/b2/6e/971-976.PMC4455297.pdf
"Electronphysician , Vol.7, No.1, March 2015 http://www.ephysician.ir Page9753)Ghaffatiyan S, Mohammadi SA, Aharizad S. DNA isolation protocol for the medicinal plant lemon balm (Melissa officinalis, lamiaceae).",Non-OADS,/arxiv_data1/oa_pdf/b2/6e/971-976.PMC4455297.pdf
http://dx.doi.org/10.1590/S1415 -47572011000200021.,Non-OADS,/arxiv_data1/oa_pdf/b2/6e/971-976.PMC4455297.pdf
http://dx.doi.org/10.1155/2012/539475.,Non-OADS,/arxiv_data1/oa_pdf/b2/6e/971-976.PMC4455297.pdf
"http://www.ephysician.ir Page97622)Fang, M. C., Stafford , R. S., Ruskin, J. N., & Singer, D. E. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.",Non-OADS,/arxiv_data1/oa_pdf/b2/6e/971-976.PMC4455297.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir Year: 2015, Volume: 7, Issue: 1, Pages: 977-984,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"http://www.ephysician.ir Page978nerve blocks, and beam radiation) (3).",OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"Electronphysician , Vol.7, No.1, March2015 http://www.ephysician.ir Page9790.1M heated until all the powder was completely dissolved.",Non-OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
http://www.ephysician.ir Page980The radioisotope was dissolved in acidic media as a starting sample and was further diluted and evaporated for obtaining the desired pH and volume followed by sterile filtering.,Non-OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"Electronphysician , Vol.7, No.1, March2015 http://www.ephysician.ir Page981concentration and reached to ~ 100% at a ratio of [ligand]/[metal] ~ 15:1.",OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"http://www.ephysician.ir Page9823.3 Biodistribution studies in rats The animals were sacrificed by CO 2asphyxiation at selected times after injection (2 h, 4 h, 6 h, 20 h and 40h).",Non-OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"Electronphysician , Vol.7, No.1, March2015 http://www.ephysician.ir Page983Conflict of Interest: There is no conflict of interest to be declared.",Non-OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"55:61-6. http://dx.doi.org/10.1038/bjc.1987.13, PMid:3814476 PMCid:PMC2001575 2)Mundy GR.",OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"2:584-93, http://dx.doi.org/10.1038/nrc867, PMID: 12154351.",OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"22, 41 -45, http://dx.doi.org/10.1016/S0001 -2998(05)80156 -4,  PMID: 1589805.",OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"20, 189 -196, http://dx.doi.org/10.1 200/JCO.20.1.189, PMid: 11773169.",Non-OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"88, 157 -161,  http://dx.doi.org/10.1524/ract.2000.88.3 -4.157.",Non-OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"23, 67 -74, http://dx.doi.org/10.1097/00006231 -200201000 -00011, PMid: 11748440.",Non-OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"57, 177, http://dx.doi.org/10.1016/S0969 -8043(02)00104 -5, PMID: 12150276 17)Das, T., Chakraborty, S., Sarma, H. D., Banerjee, S.:177Lu-DOTMP: a viab le agent for palliative radiotherapy of painful bone metastasis.",Non-OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"96, 55. http://dx.doi.org/10.1524/ract.2008.1464.",Non-OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"23(2): 202 -213, http://dx.doi.org/10.1089/cbr.2007.374.",Non-OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"Appl Rad Isot 46:133 –138, http://dx.doi.org/10.1016/0969 -8043(94)00101 -5.",OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"266:377 –384, http://dx.doi.org/10.1007/s10967 -005-0920-5.",Non-OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"http://www.ephysician.ir Page98421)Goorley T, Nikjoo H (2000) Electron and photon spectra for three gadolinium -based cancer therapy approaches.",OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"Radiat Res 154:556 –563, http://dx.doi.org/10.1667/0033 -7587(2000)154[0556:EAPSFT]2.0.CO;2, PMID: 1025652.",OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"284:315 –320, http://dx.doi.org/10.1007/s10967 -010-0486-8.",Non-OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"Jul ;24 (5):367 -72,http://dx.doi.org/10.1016/S0969 -8051(97)80001 -7, PMID:9290069.",OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"31, 1603 -1607. http://dx.doi.org/10.1021/jo01343a067.",Non-OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"101, 37 –43, http://dx.doi.org/10.1524/ract.2013.1999.",OADS,/arxiv_data1/oa_pdf/82/d1/977-984.PMC4455298.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir Year: 2015, Volume: 7, Issue: 1, Pages: 985-989,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/d6/e8/985-989.PMC4455299.pdf
"http://www.ephysician.ir Page986East, e.g., Turkey (4.1%), Kuwait (24.6%), Jordan (9.8%), and Saudi Arabia (2%) (7-10).",Non-OADS,/arxiv_data1/oa_pdf/d6/e8/985-989.PMC4455299.pdf
"Electronphysician , Vol.7, No.1, March2015 http://www.ephysician.ir Page987Among all of the people in the cas e group and the control group, there was just one person who tested HGV anti -E2 positive in the case group (2.9%); all of the people in the control group tested negative.",Non-OADS,/arxiv_data1/oa_pdf/d6/e8/985-989.PMC4455299.pdf
"http://www.ephysician.ir Page988Acknowledgments We thank the Day Private Laboratory in Hamadan, Iran, for collecting and analyzing the serum samples for HGV antibodies.",Non-OADS,/arxiv_data1/oa_pdf/d6/e8/985-989.PMC4455299.pdf
"Electronphysician , Vol.7, No.1, March2015 http://www.ephysician.ir Page98918)Grassi M, Raffa S, Traditi F, Ferrazzi M, Cioschi S, Fontana M, et al.",OADS,/arxiv_data1/oa_pdf/d6/e8/985-989.PMC4455299.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir Year: 2015, Volume: 7, Issue: 1, Pages: 990-997,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/4a/e2/990-997.PMC4455300.pdf
"Electronphysician , Vol.7, No.1, March2015 http://www.ephysician.ir Page991achieve the Millennium Development Goal 4( MDG 4)target of reducing the mortality rate of children by 67% by 2015(6).",Non-OADS,/arxiv_data1/oa_pdf/4a/e2/990-997.PMC4455300.pdf
http://www.ephysician.ir Page992perceived that her child was ill. A recall period of one month was used to avoid any recall bias.,Non-OADS,/arxiv_data1/oa_pdf/4a/e2/990-997.PMC4455300.pdf
"Electronphysician , Vol.7, No.1, March2015 http://www.ephysician.ir Page993The mothers were categorized again as ‘Below Poverty Line (BPL) card holders’ and ‘non -holders.’ Among 307 (75.8%) B PL card holder mothers, 239 (77.9%) displayed healthcare -seeking behavior, whereas, among 98 non - BPL mothers (24.2% cases), 25 (25.5%) sought healthcare services.",Non-OADS,/arxiv_data1/oa_pdf/4a/e2/990-997.PMC4455300.pdf
http://www.ephysician.ir Page994noted.,Non-OADS,/arxiv_data1/oa_pdf/4a/e2/990-997.PMC4455300.pdf
"Electronphysician , Vol.7, No.1, March2015 http://www.ephysician.ir Page995Community -based studies conducted in rural and tribal India have documented significant gender bias in the utilization of healthcare, where in 52.8 % of sick male newborns and 24.3% of sick female newborns receive treatment (17, 18).",Non-OADS,/arxiv_data1/oa_pdf/4a/e2/990-997.PMC4455300.pdf
References 1)UNICEF: The state of the world's children 2010 2010 [http://www.unicef.org/rightsite/sowc/pdfs/statistics/SOWC_Spec_Ed_CRC_TABLE%201.%20B ASIC%20IN DICATORS_EN_111309.pdf].,Non-OADS,/arxiv_data1/oa_pdf/4a/e2/990-997.PMC4455300.pdf
"http://www.ephysician.ir Page9963)Sreeramareddy CT, Shankar RP, Sreekumaran BV, Subba SH, Joshi HS, Ramachandran U: Care seeking behaviour for childhood illness —a questionnaire survey in western Nepal.",Non-OADS,/arxiv_data1/oa_pdf/4a/e2/990-997.PMC4455300.pdf
"Electronphysician , Vol.7, No.1, March2015 http://www.ephysician.ir Page99726)D'Souza RM: Role of health -seeking behaviour in child mortality in the slums of Karachi, Pakistan.",Non-OADS,/arxiv_data1/oa_pdf/4a/e2/990-997.PMC4455300.pdf
Available from http://jpma.org.pk/ful l_ article_text.php?article_id=3188 .,Non-OADS,/arxiv_data1/oa_pdf/4a/e2/990-997.PMC4455300.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir Year: 2015, Volume: 7, Issue: 1, Pages: 998-1004,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/5f/bf/998-1004.PMC4455301.pdf
"Electronphysician , Vol.7, No.1, March2015 http://www.ephysician.ir Page9991.2.",Non-OADS,/arxiv_data1/oa_pdf/5f/bf/998-1004.PMC4455301.pdf
http://www.ephysician.ir Page10002.4.,Non-OADS,/arxiv_data1/oa_pdf/5f/bf/998-1004.PMC4455301.pdf
"Electronphysician , Vol.7, No.1, March2015 http://www.ephysician.ir Page1001those who had normal glucose tolerance (NGT) (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/5f/bf/998-1004.PMC4455301.pdf
http://www.ephysician.ir Page1002has been projected to be 9.8% in 2025.,Non-OADS,/arxiv_data1/oa_pdf/5f/bf/998-1004.PMC4455301.pdf
"Electronphysician , Vol.7, No.1, March2015 http://www.ephysician.ir Page1003Acknowledgments The authors are since rely grateful for all participants in the study.",Non-OADS,/arxiv_data1/oa_pdf/5f/bf/998-1004.PMC4455301.pdf
"http://www.ephysician.ir Page100420)Al-Lawati JA, Al Riyami AM, Mohammed AJ, J ousilahti P. Increasing prevalence of diabetes mellitus in Oman.",Non-OADS,/arxiv_data1/oa_pdf/5f/bf/998-1004.PMC4455301.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/57/omv042.PMC4455787.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/86/omv040.PMC4455788.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/48/omv039.PMC4455789.pdf
2011. http://www.anzca.edu.au /fellows/sig/obstetric- anaesthesia-sig/obstetric-anaesthesia-scientiﬁc-evidence/management-of-pre-eclampsia-and-eclampsia.html 114.,Non-OADS,/arxiv_data1/oa_pdf/29/24/sfr163.PMC4455825.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2a/66/omv041.PMC4455829.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/17/d5/tcrm-11-885.PMC4455842.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pTherapeutics and Clinical Risk Management 2015:11 885–887Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  885Case seRiesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S8043 1T wo cases of Paget’s disease of scrotum   in biological brothers Dapang Rao1 Haibo Zhu2 Kaiyuan Yu2 Haifeng Yu2 Liping Xie1 1Department of Urology, First  affiliated Hospital, Medical  College,Zhejiang University,   Hangzhou, People’s Republic of China;   2Department of Urology, second  affiliated Hospital of Wenzhou  Medical University, Wenzhou, People’s  Republic of ChinaAbstract:  This article reports two cases of scrotum Paget’s disease in two biological brothers  who were admitted and treated in our hospital in 2013.",Non-OADS,/arxiv_data1/oa_pdf/17/d5/tcrm-11-885.PMC4455842.pdf
"Case 2 The 68-year-old elder brother was admitted on January 25, 2013 with history of  symptoms similar to those of his younger brother for a year, including pruritus of the Correspondence: Liping Xie Department of Urology, First Affiliated  Hospital of Zhejiang University,  Hangzhou 310003, People’s Republic of China email xielp@zju.edu.c n Journal name: Therapeutics and Clinical Risk Management Article Designation: Case Series Y ear: 2015 Volume: 11 Running head verso: Rao et al Running head recto: Paget’s disease of scrotum in biological brothers DOI: http://dx.doi.org/10.2147/TCRM.S80431",Non-OADS,/arxiv_data1/oa_pdf/17/d5/tcrm-11-885.PMC4455842.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/17/d5/tcrm-11-885.PMC4455842.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/d5/tcrm-11-885.PMC4455842.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1e/fa/dhps-7-087.PMC4455843.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug, Healthcare and Patient Safety 2015:7 87–95Drug, Healthcare and Patient Safety Dove press submit your manuscript | www.dovepress.co m Dove press  87Original reSearcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DHPS.S8207 0environmental and host-related determinants  of tuberculosis in Metema district, north-west  ethiopia cheru T esema1 Takele Tadesse2 Mulat gebrehiwot2 azanaw Tsegaw3 Fitsum Weldegebreal4 1college of Medical and Health  Science, Debre Markos University,  Debremarkos, 2institute of Public  Health, college of Medical and Health  Sciences, University of gondar,  3college of Health and Medical  Sciences, University of gondar,  gondar, 4Haramaya University,  college of Health and Medical  Sciences, Department of Medical  laboratory Science, Harar, ethiopia correspondence: cheru Tesema   college of Medicine and Health Science,  Debre Markos University, PO Box 269,  Debre Markos, ethiopia   email thesistubercu@gmail.co mBackground:  Each year, one third of the world’ s population is estimated to be infected with  tuberculosis (TB).",Non-OADS,/arxiv_data1/oa_pdf/1e/fa/dhps-7-087.PMC4455843.pdf
"Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-healthcare-and-patient-safety-journa lDrug, Healthcare and Patient Safety is an international, peer-reviewed  open-access journal exploring patient safety issues in the healthcare  continuum from diagnostic and screening interventions through to treat - ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/1e/fa/dhps-7-087.PMC4455843.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/fa/dhps-7-087.PMC4455843.pdf
"Available from: http://dhsprogram.com/pubs/pdf/ FR179/FR179[23June2011].pd f. Accessed April 21, 2015.",Non-OADS,/arxiv_data1/oa_pdf/1e/fa/dhps-7-087.PMC4455843.pdf
"Available from: http://www.who.int/tb/ advisory_bodies/impact_measurement_taskforce/meetings/tf5doc06_key - resultsprevalencesurveyethiopia2010.pd f. Accessed April 21, 2015.",OADS,/arxiv_data1/oa_pdf/1e/fa/dhps-7-087.PMC4455843.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/1f/ndt-11-1371.PMC4455844.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNeuropsychiatric Disease and Treatment 2015:11 1371–1379Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1371OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8102 4Predictors of quality of life among individuals with  schizophrenia sirijit suttajit sutrak Pilakanta Department of Psychiatry, Faculty  of Medicine, chiang Mai University,   chiang Mai, ThailandPurpose:  The study reported here aimed to evaluate both biological and psychosocial factors  as predictors for quality of life as well as to examine the associations between the factors and  quality of life in individuals with schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/16/1f/ndt-11-1371.PMC4455844.pdf
"In addition, the objective measures of  QOL usually include indicators of external life conditions, sociodemographic items,  and a functioning role in society.2 The World Health Organization, however, focused correspondence: sirijit suttajit Department of Psychiatry, Faculty  of Medicine, 110 intavaroros road,  Muang, chiang Mai University,   chiang Mai 50200, Thailand Tel +66 53 945 422 Fax +66 53 945 426 email sirijits@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Suttajit and Pilakanta Running head recto: Quality of life in schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S81024",Non-OADS,/arxiv_data1/oa_pdf/16/1f/ndt-11-1371.PMC4455844.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/16/1f/ndt-11-1371.PMC4455844.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/1f/ndt-11-1371.PMC4455844.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/93/9d/cia-10-907.PMC4455845.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Interventions in Aging 2015:10 907–918Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  907OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8202 6Oral treatment with herbal formula B401 alleviates  penile toxicity in aging mice with manganism Correspondence: Chung-hsin Wu Department of life science, national  Taiwan normal University, 88, Ting-Chou  road, section 4, Taipei 11677, Taiwan Tel +886 2 7734 6363 Fax +886 2 2931 2904 email megawu@ntnu.edu.t w Chih-hsiang hsu1 Ching-lung lin1 sheue-er Wang1 shuenn-Jyi sheu2 Chiang-Ting Chien1 Chung-hsin Wu1 1Department of life science, national  Taiwan normal University, 2Brion  research Institute of Taiwan, Taipei,   TaiwanAbstract:  The present study aims to elucidate the roles of nitric oxide synthase activity,  oxidative stress, inflammation, and apoptosis in penile toxicity of aging mice associated with  excess manganese (Mn) treatment and to investigate the effect of oral treatment with the  herbal formula B401 in this respect.",Non-OADS,/arxiv_data1/oa_pdf/93/9d/cia-10-907.PMC4455845.pdf
"Activity of nitric oxide synthase (NOS) in the corpus cavernosum plays a key role  in penile erection.7,8 In the penile tissue, nitric oxide is released in the corpus caver - nosum by regional expression of neuronal, inducible, and endothelial NOSs (nNOS,  iNOS, and eNOS, respectively).9,10 Reduction of nitric oxide release in penile tissue Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Hsu et al Running head recto: Penile protection with B401 in aging mice with manganism DOI: http://dx.doi.org/10.2147/CIA.S82026 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/93/9d/cia-10-907.PMC4455845.pdf
Or use: http://youtu.be/gbSj13BQdR wVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/93/9d/cia-10-907.PMC4455845.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/93/9d/cia-10-907.PMC4455845.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/93/9d/cia-10-907.PMC4455845.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/13/93/ndt-11-1359.PMC4455846.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1359–1370Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1359Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S6573 5Profile of guanfacine extended release and its  potential in the treatment of attention-deficit  hyperactivity disorder Jose Martinez-Raga1,2 Carlos Knecht3 Raquel de Alvaro4 1Teaching Unit of Psychiatry and  Psychological Medicine, University  Hospital Doctor Peset, University  of Valencia, 2CEU Cardenal Herrera  University, 3Área de Salud Mental,  Hospital Padre Jofré, Valencia, 4Hospital  General, Consorcio Hospitalario  Provincial, Castellon, SpainAbstract:  The α2-adrenergic receptor agonist guanfacine, in its extended-release formulation  (GXR), is the most recent nonstimulant medication approved in several countries for the treat - ment of attention-deficit hyperactivity disorder (ADHD) as monotherapy and as adjunctive  pharmacotherapy to stimulants in children and adolescents.",Non-OADS,/arxiv_data1/oa_pdf/13/93/ndt-11-1359.PMC4455846.pdf
"Keywords:  guanfacine extended-release, attention-deficit hyperactivity disorder, ADHD,  oppositional symptoms, adjunctive therapy, cardiovascular safety Introduction Attention-deficit hyperactivity disorder (ADHD) is a complex, heterogeneous, and  highly prevalent neurodevelopmental disorder characterized by a persistent pattern of  age-inappropriate symptoms of inattention, hyperactivity, and/or impulsivity.1,2 The  prevalence of ADHD is approximately 5%–8% in children and 2.5%–4% in adults  worldwide.1,3,4 Along the life span, ADHD is associated with important personal,  medical, and social complications, significant functional impairment, and high rates  of associated psychiatric disorders.1,5–7 Conduct disorders, including oppositional  defiant disorder (ODD), anxiety disorders, and mood disorders, are the most common  psychiatric comorbidities in children and adolescents with ADHD.1,5,8,9 ADHD has multifactorial origins, resulting from the complex interaction of biologi - cal and environmental risk factors, including multiple genetic factors in conjunction  with prenatal events and infant complications.10,11 A growing body of evidence reveals Correspondence: Jose Martinez-Raga Teaching Unit of Psychiatry and  Psychological Medicine, University Hospital Doctor Peset, 90 Avenida  Gaspar Aguilar, Valencia 46017, Spain Tel +34 96 162 2328 Fax +34 96 162 2328 email martinez_josrag@gva.e s Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Martinez-Raga et al Running head recto: Guanfacine extended release for ADHD DOI: http://dx.doi.org/10.2147/NDT.S65735",Non-OADS,/arxiv_data1/oa_pdf/13/93/ndt-11-1359.PMC4455846.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/13/93/ndt-11-1359.PMC4455846.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/93/ndt-11-1359.PMC4455846.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d1/a3/ijwh-7-551.PMC4455847.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 551–563International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  551RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/IJWH.S6947 5Clinical utility of exemestane in the treatment  of breast cancer Giorgia Zucchini1 elena Geuna1 Andrea Milani1 Caterina Aversa2 Rossella Martinello2 Filippo Montemurro1 1Investigative Clinical Oncology,   Fondazione del Piemonte per  l’Oncologia-Candiolo Cancer Institute  (IRCCs), Candiolo, 2University of T urin  Medical School, T urin, ItalyAbstract:  Breast cancer is the most prevalent cancer in women, causing a significant mortality  worldwide.",Non-OADS,/arxiv_data1/oa_pdf/d1/a3/ijwh-7-551.PMC4455847.pdf
"Aromatase, a member of the cytochrome P-450 (CYP) family located  predominantly in the liver, adrenal glands, and fat tissue, is responsible for this  reaction.5Correspondence: Giorgia Zucchini Investigative Clinical Oncology,  Fondazione del Piemonte per  l’Oncologia–Candiolo Cancer Institute  (IRCCs), Strada Provinciale 142, Km 3.95,  CAP 10060, Candiolo, Turin, Italy Tel +39 011 993 3958 email giorgia.zucchini@ircc.i t Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2015 Volume: 7 Running head verso: Zucchini et al Running head recto: Exemestane for the treatment of breast cancer DOI: http://dx.doi.org/10.2147/IJWH.S69475",Non-OADS,/arxiv_data1/oa_pdf/d1/a3/ijwh-7-551.PMC4455847.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/d1/a3/ijwh-7-551.PMC4455847.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/a3/ijwh-7-551.PMC4455847.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ef/74/ndt-11-1339.PMC4455848.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1339–1347Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1339OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8256 3attitudes and beliefs of patients with chronic  depression toward antidepressants and depression sabrina anne Jacob1 ab Fatah ab rahman2 Mohamed azmi ahmad  hassali3 1school of Pharmacy, Monash  University Malaysia, sunway, 2Faculty  of health sciences, gong Badak  campus, Universiti sultan Zainal  abidin (UnisZa), Kuala T erengganu,   3school of Pharmaceutical sciences,   University of science Malaysia,   Minden, MalaysiaBackground:  Many patients have erroneous views with regard to depression and its management,  and it was noted that these attitudes and beliefs significantly affected their adherence rates.",Non-OADS,/arxiv_data1/oa_pdf/ef/74/ndt-11-1339.PMC4455848.pdf
"Therefore, subjects with negative attitudes missed their medications  more frequently.11,12,14 In fact, research has shown that compared to side effects and  demographics, patients’ beliefs about a disease and its perceived controllability or  consequences had a greater influence on patients’ adherence rates.15,16 Indeed, it is also correspondence: sabrina anne Jacob school of Pharmacy, Monash University  Malaysia, Jalan lagoon selatan, 47500  Bandar sunway, selangor, Malaysia Tel +60 35 514 5885 email sabyj@hotmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Jacob et al Running head recto: Patient attitudes toward antidepressants and depression DOI: http://dx.doi.org/10.2147/NDT.S82563",Non-OADS,/arxiv_data1/oa_pdf/ef/74/ndt-11-1339.PMC4455848.pdf
"Available from:  http://www.who.int/substance_abuse/research_tools/translation/en/ index.htm l. Accessed November 16, 2009.",Non-OADS,/arxiv_data1/oa_pdf/ef/74/ndt-11-1339.PMC4455848.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ef/74/ndt-11-1339.PMC4455848.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/74/ndt-11-1339.PMC4455848.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e8/4c/ndt-11-1331.PMC4455849.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNeuropsychiatric Disease and Treatment 2015:11 1331–1337Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1331OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8017 4ranitidine reduced levodopa-induced dyskinesia  by remodeling neurochemical changes in  hemiparkinsonian model of rats hongjuan shi1,2,* Xinxin Yang2,3,* hui Zhao4 shenyang Zhang2 Jie Zu2 Wei Zhang2 Xia shen2 guiyun cui2,3 Fang hua2,3 chuanzhu Yan1 1Department of Neurology, Qilu  hospital of shangdong University,   Jinan, 2Department of Neurology,   affiliated hospital of Xuzhou Medical  college, 3institute of Neurological  Diseases of Xuzhou Medical college,   4Department of Neurology, Xuzhou  central hospital, Xuzhou, People’s  republic of china  *These authors contributed equally  to this workBackground:  Levodopa ( l-dopa) remains the best drug in the treatment of Parkinson’s disease  (PD).",Non-OADS,/arxiv_data1/oa_pdf/e8/4c/ndt-11-1331.PMC4455849.pdf
"Numerous studies indicated that pul - satile dopamine (DA) stimulation plays an important role in LID,6–8 which changed the  plasticity of striatal neurons.9 Unregulated DA release from DA and non-DA neurons  causes upregulation and abnormal trafficking of D1 receptors in striatal neurons along  with abnormal downstream signaling responses.10 In addition to striatum, substantia  nigra also plays an important role in the expression of LID.11 It is reported that elevated  extracellular DA levels were observed in the substantia nigra of l-dopa-primed PD correspondence: chuanzhu Yan Department of Neurology, Qilu hospital  of shandong University, 107 West  Wenhua road, Jinan 250000, shandong  Province, People’s republic of china email chuanzhuyan@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Shi et al Running head recto: Treatment of levodopa-induced dyskinesia DOI: http://dx.doi.org/10.2147/NDT.S80174",OADS,/arxiv_data1/oa_pdf/e8/4c/ndt-11-1331.PMC4455849.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e8/4c/ndt-11-1331.PMC4455849.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/4c/ndt-11-1331.PMC4455849.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/dd/15/ndt-11-1299.PMC4455850.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNeuropsychiatric Disease and Treatment 2015:11 1299–1306Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1299OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8047 9Efficacy and safety of aripiprazole once-monthly in  obese and nonobese patients with schizophrenia:  a post hoc analysis Marc De hert1 anna eramo2 Wally landsberg3 Dusan Kostic4 Lan-Feng Tsai5 ross a Baker4 1Department of Neurosciences,   KU leuven, Belgium; 2lundbeck  llc, Deerfield, il, Usa; 3Otsuka  Pharmaceutical europe ltd., Wexham,   UK; 4Otsuka Pharmaceutical  Development & Commercialization,   inc., Princeton, NJ, Usa; 5Otsuka  Pharmaceutical Development &  Commercialization, Inc., Rockville,  MD, UsaPurpose:  To assess the efficacy and safety of aripiprazole once-monthly 400 mg (AOM 400),  an extended-release injectable suspension of aripiprazole, in obese and nonobese patients.",Non-OADS,/arxiv_data1/oa_pdf/dd/15/ndt-11-1299.PMC4455850.pdf
"Keywords:  antipsychotic, long-acting injectable, schizophrenia, obesity, aripiprazole once- monthly Introduction Schizophrenia is a chronic psychiatric disorder in which long-term antipsychotic  treatment is recommended to reduce the risk of relapse.1,2 Many second-generation  antipsychotics are associated with metabolic side effects such as weight gain.1,3–7  Patients with schizophrenia often have comorbid medical conditions that may require  continuous monitoring in addition to being observed for potential medication side  effects.1,6,8,9 In a national survey of International Classification of Diseases, Ninth  Edition  discharge codes for patients hospitalized for schizophrenia, 63% of patients  who had schizophrenia as their primary diagnosis had 1 comorbid condition.10 correspondence: Marc De hert University Psychiatric center,  KU leuven, campus Kortenberg,  Leuvensesteenweg 317, B-3070  Kortenberg, Belgium Tel +32 2758 0511 Fax +32 2259 5380 email marc.de.hert@uc-kortenberg.b e Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: De Hert et al Running head recto: Aripiprazole once-monthly in obese and nonobese patients DOI: http://dx.doi.org/10.2147/NDT.S80479",Non-OADS,/arxiv_data1/oa_pdf/dd/15/ndt-11-1299.PMC4455850.pdf
"Available from: http://psychiatryonline.org/pb/assets/raw/ sitewide/practice_guidelines/guidelines/schizophrenia-watch.pd f.  Accessed April 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/dd/15/ndt-11-1299.PMC4455850.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/dd/15/ndt-11-1299.PMC4455850.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/15/ndt-11-1299.PMC4455850.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/52/44/imcrj-8-117.PMC4455851.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 117–120International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  117Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S8044 1Calciphylaxis in a patient affected   by rheumatoid arthritis, chronic renal failure,   and hyperparathyroidism: a case report alfredomaria Lurati1 antonella Laria1 Donatella paolotti2 Magda scarpellini1 1Rheumatology Unit,  2Department  of pathology, Fornaroli Hospital  Magenta, Magenta, Italy Correspondence: alfredomaria Lurati   Rheumatology Unit, Fornaroli   Hospital Magenta, Via Donatore   sangue  50, Magenta, Italy   tel +39 02 9796 3843   email a lfredomaria.lurati@ao-legnano.i tAbstract:  Calciphylaxis, or calcific uremic arteriolopathy, is the tissue and vascular  calcification  that occurs mainly in chronic kidney disease.",Non-OADS,/arxiv_data1/oa_pdf/52/44/imcrj-8-117.PMC4455851.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/52/44/imcrj-8-117.PMC4455851.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/44/imcrj-8-117.PMC4455851.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e4/77/ndt-11-1307.PMC4455852.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1307–1311Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1307OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8571 1comparison of paroxetine and agomelatine in   depressed type 2 diabetes mellitus patients:  a double-blind, randomized, clinical trial ruiying Kang1 Yan he1 Yuxiang Yan1 Zhiwu li2 Yeqing Wu3 Xiaojuan guo4 Zhigang liang5 Jun Jiang2 1Department of epidemiology and  Biostatics, school of Public health,   capital Medical University, Beijing,   People’s republic of china; 2Fengtai  Nanyuan hospital of Beijing, Beijing,   People’s republic of china; 3Fengtai  District community health center,   Beijing, People’s republic of china;   4Department of Preventive Medicine,   school of environmental and Public  health, Wenzhou Medical University,   Wenzhou, People’s republic of china;  5Xuanwu hospital, capital Medical  University, Beijing, People’s republic  of chinaBackground:  Comorbid depression/anxiety in type 2 diabetes mellitus (DM) patients is  highly prevalent, affecting both diabetes control and quality of life.",Non-OADS,/arxiv_data1/oa_pdf/e4/77/ndt-11-1307.PMC4455852.pdf
"One  study reported that the biochemical changes in depressed patients stimulated the  hypothalamic–pituitary–adrenal axis, which resulted in increased cortisol level and  blood glucose, eventually progressing to diabetes.8 On the other hand, if not effectively  and timely treated, depression will increase the rates of complications9 and produce  negative effects on glucose regulation.10 Currently, due to lack of objective test for correspondence: Yan he Department of epidemiology and  Biostatics, school of Public health,  capital Medical University, No 10,  Xitoutiao, Youanmenwai street, Fengtai  District, 100069, Beijing, People’s  republic of china Tel +86 10 8391 1000 Fax +86 101 8391 1029 email YhYanhe@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Kang et al Running head recto: Paroxetine versus agomelatine for depression in type 2 DM patients DOI: http://dx.doi.org/10.2147/NDT.S85711",Non-OADS,/arxiv_data1/oa_pdf/e4/77/ndt-11-1307.PMC4455852.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e4/77/ndt-11-1307.PMC4455852.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/77/ndt-11-1307.PMC4455852.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1d/a4/ndt-11-1291.PMC4455853.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1291–1298Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1291OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7422 2Being parents with epilepsy: thoughts on its  consequences and difficulties affecting their  children helena gauffin1 gullvi Flensner2 anne-Marie landtblom1,3 1Department of Neurology and  Department of clinical and  experimental Medicine, linköping  University, linköping, sweden;   2Department of Nursing, health  and culture, University West,   Trollhättan, sweden; 3Department of  Neuroscience, Uppsala University,   Uppsala, swedenObjective:  Parents with epilepsy can be concerned about the consequences of epilepsy   affecting their children.",Non-OADS,/arxiv_data1/oa_pdf/1d/a4/ndt-11-1291.PMC4455853.pdf
"Epilepsy is associated  with an increased prevalence of mental-health disorder compared with the general Correspondence: Helena Gauffin Neurologmottagningen,  Universitetssjukhuset i linköping, s-581  85, linköping, sweden Tel +46 10 103 0000 Fax +46 10 103 4438 email helena.gauffin@regionostergotland.se  Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Gauffin et al Running head recto: Being parents with epilepsy DOI: http://dx.doi.org/10.2147/NDT.S74222",Non-OADS,/arxiv_data1/oa_pdf/1d/a4/ndt-11-1291.PMC4455853.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/1d/a4/ndt-11-1291.PMC4455853.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1d/a4/ndt-11-1291.PMC4455853.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4b/97/copd-10-975.PMC4455854.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 975–984International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  975OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8278 1evaluation of the COPD assessment T est and  gOlD patient types: a cross-sectional analysis Jose luis lopez-Campos1,2,* alberto Fernandez-Villar3,* Carmen Calero-acuña1 Cristina represas- represas3 Cecilia lopez-ramírez1 Virginia leiro Fernández3 Juan Jose soler-Cataluña2,4 ricard Casamor5 On behalf of the On-sint  study group 1Unidad Médico-Quirúrgica de  enfermedades respiratorias, Instituto  de Biomedicina de sevilla (IBis),   hospital Universitario Virgen del  rocio/Universidad de sevilla, sevilla,   spain; 2CIBer de enfermedades  respiratorias (CIB eres ), Instituto  de salud Carlos III, Madrid, spain;   3servicio de neumología, Instituto  de Investigación Biomédica de Vigo  (IBIV), Complexo hospitalario de Vigo,   Vigo, spain; 4servicio de neumología  hospital arnau de Vilanova, Valencia,   spain; 5Departamento Médico de  novartis Farmacéutica, Barcelona,   spain *These authors contributed equally  to this workBackground:  The COPD Assessment Test (CAT) has been recently developed to quantify  COPD impact in routine practice.",Non-OADS,/arxiv_data1/oa_pdf/4b/97/copd-10-975.PMC4455854.pdf
"Accordingly, new  multidimensional evaluation proposals have been developed in the context of patient- centered medicine.2 In this regard, the most widely accepted proposal is the diagnostic  approach proposed by the Global Initiative for Obstructive Lung Disease (GOLD) 2011,  which proposes a three axes scheme, including lung function, exacerbations, and chronic  symptoms.3 As a part of this multidimensional assessment, the estimation of health status  has become one of the pillars of the multidimensional evaluation, providing information  about other patient aspects not measured by other available and objective tools, which  may complement the clinical information from the patient’s perspective.4 The COPD Assessment Test (CAT) is a recently developed questionnaire to quan - tify the impact of COPD on a patient’s life and how this changes over time.5 Despite Correspondence: Jose luis lopez- Campos hospital Universitario Virgen del rocio,  avda Manuel siurot, s/n, 41013 sevilla,  spain email lcampos@separ.e s Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Lopez-Campos et al Running head recto: CAT and clinical outcomes DOI: http://dx.doi.org/10.2147/COPD.S82781",Non-OADS,/arxiv_data1/oa_pdf/4b/97/copd-10-975.PMC4455854.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/4b/97/copd-10-975.PMC4455854.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/97/copd-10-975.PMC4455854.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c3/29/ott-8-1259.PMC4455855.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1259–1264OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1259Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7700 3The clinical significances of the abnormal  expressions of Piwil1 and Piwil2 in colonic  adenoma and adenocarcinoma hai-ling Wang1 Bei-Bei chen1 Xin-guang cao1 Jin Wang2 Xiu-Feng hu1 Xiao-Qian Mu1 Xiao-Bing chen1 1The Affiliated Cancer Hospital  of Zhengzhou University, Henan  Cancer Hospital, Zhengzhou, People’s  Republic of China; 2The First Affiliated  Hospital of Zhengzhou University,   Zhengzhou, People’s Republic of  chinaObjective:  The objective of the present investigation was to study the clinical significances of the  abnormal expressions of Piwil1 and Piwil2 protein in colonic adenoma and adenocarcinoma.",Non-OADS,/arxiv_data1/oa_pdf/c3/29/ott-8-1259.PMC4455855.pdf
"The occurrence and development of colon cancer are related to many genes, correspondence: Xiao-Bing chen The Affiliated Cancer Hospital  of Zhengzhou University, Henan  Cancer Hospital, 127 Dongming Road,  Zhengzhou City, 450008, Henan  Province, People’s Republic of China   email hailingwangwhl@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Wang et al Running head recto: Expression of Piwil1 and Piwil2 in colonic adenoma and adenocarcinoma DOI: http://dx.doi.org/10.2147/OTT.S77003",Non-OADS,/arxiv_data1/oa_pdf/c3/29/ott-8-1259.PMC4455855.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c3/29/ott-8-1259.PMC4455855.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/29/ott-8-1259.PMC4455855.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d8/29/hiv-7-167.PMC4455856.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pHIV/AIDS – Research and Palliative Care 2015:7 167–174HIV/AIDS – Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  167ORIg InAl ReSeARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S8544 0Do loss to follow-up and death rates from ART  care vary across primary health care facilities  and hospitals in south ethiopia?,Non-OADS,/arxiv_data1/oa_pdf/d8/29/hiv-7-167.PMC4455856.pdf
Available from: http://www.snnprhb.gov.,Non-OADS,/arxiv_data1/oa_pdf/d8/29/hiv-7-167.PMC4455856.pdf
Available from: http://www.etharc.org/index.php/resources/ download/view.download/42/347.,Non-OADS,/arxiv_data1/oa_pdf/d8/29/hiv-7-167.PMC4455856.pdf
Available from: http://www.hapco.gov.et/index.,OADS,/arxiv_data1/oa_pdf/d8/29/hiv-7-167.PMC4455856.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/d8/29/hiv-7-167.PMC4455856.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/29/hiv-7-167.PMC4455856.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/61/33/imcrj-8-121.PMC4455857.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 121–126International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  121Case seRIesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IMCRJ.S8356 0Incidental retinal vascular occlusions on  hydroxychloroquine screening in patients   with systemic lupus erythematosus asima Bajwa1 Gitanjali Khurana2 Donald Kimpel2 ashvini K Reddy1 1Department of Ophthalmology,   University of Virginia, Charlottesville,   Va, Usa; 2Division of Clinical  Rheumatology, Department of Internal  Medicine, University of Virginia,   Charlottesville, V a, Usa Correspondence: ashvini K Reddy   Department of Ophthalmology,  University of Virginia, 1300 Jefferson Park  avenue, Charlottesville, Va 22908, Usa   Tel +1 434 243 5890   Fax +1 434 924 5180   email ash.vee.knee@gmail.co mObjective:  The proportion of patients with systemic lupus erythematosus (SLE) who manifest  retinal involvement increases many fold in patients with active systemic disease.",Non-OADS,/arxiv_data1/oa_pdf/61/33/imcrj-8-121.PMC4455857.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/61/33/imcrj-8-121.PMC4455857.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/61/33/imcrj-8-121.PMC4455857.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ce/5a/ppa-9-715.PMC4455858.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Preference and Adherence 2015:9 715–723Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  715OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8310 5Pre- and in-therapy predictive score models  of adult OsAs patients with poor adherence  pattern on ncPAP therapy Yeying Wang1,2 Alan F geater3 Yanling chai1 Jiahong luo2 Xiaoqun niu1 Bing hai1 Jingting Qin1 Y ongxia li1 1Department of respiratory  Medicine, The 2nd Affiliated hospital  of Kunming Medical University,   Kunming, Yunnan Province, People’s  republic of china; 2Department  of epidemiology and Biostatistics,   school of Public health, Kunming  Medical University, Kunming, Yunnan  Province, People’s republic of china;   3epidemiology Unit, Faculty of  Medicine, Prince of songkla University,   hat Yai, songkhla, ThailandObjectives:  To identify patterns of adherence to nasal continuous positive airway pressure  (nCPAP) use in the first 3 months of therapy among newly diagnosed adult patients with obstruc - tive sleep apnea/hypopnea syndrome (OSAS) and their predictors.",Non-OADS,/arxiv_data1/oa_pdf/ce/5a/ppa-9-715.PMC4455858.pdf
"Keywords:  OSAS, adherence, nCPAP, predictive model, K-means cluster analysis, bootstrap  analysis Background Obstructive sleep apnea/hypopnea syndrome (OSAS) is a common sleep disorder  characterized by repetitive obstruction of the upper airway that occurs in 2%–14% of  adult populations1–3 and 1% of pediatric age children,4,5 and causes oxygen desaturation correspondence: Yongxia li Department of respiratory Medicine,  The 2nd Affiliated Hospital of Kunming  Medical University, no 374, Dianmian  road, Kunming 650101, Yunnan Province,  People’s republic of china Tel +86 136 5881 0805 Fax +86 871 6535 2087 email liyongxia@hotmail.co mJournal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Wang et al Running head recto: Predictive score of nCPAP adherence DOI: http://dx.doi.org/10.2147/PPA.S83105",Non-OADS,/arxiv_data1/oa_pdf/ce/5a/ppa-9-715.PMC4455858.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/ce/5a/ppa-9-715.PMC4455858.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1c/5e/ndt-11-1349.PMC4455859.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNeuropsychiatric Disease and Treatment 2015:11 1349–1357Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1349OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7934 7A 6-year open-label study of the efficacy  and safety of olanzapine long-acting injection  in patients with schizophrenia: a post hoc analysis  based on the european label recommendation ernie anand1 lovisa Berggren2 claudia Deix3 Ágoston Tóth4 David P McDonnell5 1Neuroscience Medical affairs – eU,   eli lilly, Windlesham, United Kingdom;  2global statistical sciences, lilly  Deutschland gmbh, Bad homburg,   germany; 3Neuroscience, eli lilly  regional Operations gmbh, Vienna,   austria; 4lilly hungary, Budapest,   hungary; 5lilly research laboratories,   eli lilly and company, indianapolis,   iN, UsaPurpose:  To assess the long-term efficacy and safety of olanzapine long-acting injection (LAI)  in the treatment of schizophrenia, focusing on clinical trial data consistent with the approved  indication and dosing recommendations in the European label and which forms the basis for  treatment decisions made by clinicians in daily clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/1c/5e/ndt-11-1349.PMC4455859.pdf
"Studies that evaluate the long-term profile of depot  antipsychotics in the treatment of schizophrenia are clearly going to be more reflective  of clinical reality,9 and recently a 6-year, single-arm, open-label extension study of  olanzapine LAI assessing its safety and efficacy was published.10 That study, however,  was designed and implemented before olanzapine LAI was approved for clinical use, correspondence: ernie anand Neuroscience Medical affairs – eU, lilly  research centre, erl Wood Manor,  Windlesham, surrey, gU20 6Ph,  United Kingdom Tel +44 12 7648 3063 Fax +44 12 7648 3711 email anand_ernie@lilly.com  Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Anand et al Running head recto: Efficacy and safety of olanzapine long-acting injection DOI: http://dx.doi.org/10.2147/NDT.S79347",Non-OADS,/arxiv_data1/oa_pdf/1c/5e/ndt-11-1349.PMC4455859.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/1c/5e/ndt-11-1349.PMC4455859.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/5e/ndt-11-1349.PMC4455859.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/21/26/ndt-11-1313.PMC4455860.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNeuropsychiatric Disease and Treatment 2015:11 1313–1329Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1313Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S6556 4Brain in flames – animal models of psychosis:  utility and limitations Daniele Mattei1 Regina Schweibold1,2 Susanne A Wolf1 1Department of Cellular  Neuroscience, Max-Delbrueck- Center for Molecular Medicine,   Berlin, Germany; 2Department  of Neurosurgery, Helios Clinics,   Berlin,  GermanyAbstract:  The neurodevelopmental hypothesis of schizophrenia posits that schizophrenia is  a psychopathological condition resulting from aberrations in neurodevelopmental processes  caused by a combination of environmental and genetic factors which proceed long before the  onset of clinical symptoms.",Non-OADS,/arxiv_data1/oa_pdf/21/26/ndt-11-1313.PMC4455860.pdf
"Recently, microglia  have been identified as potential pathological key player in schizophrenia.13 Evaluat - ing postmortem tissue, an increase in reactive microglia density has been reported in  distinct subtypes of schizophrenia and different brain regions.14 Using a ligand for the  peripheral benzodiazepine receptor and PET (positron emission tomography) scans, a  state of neuro inflammation in vivo in schizophrenic patients have been confirmed.15,16 Correspondence: Susanne A Wolf Department of Cellular Neuroscience,  Max Delbrück Center for Molecular  Medicine, Robert Roessle Strasse 10,  13125 Berlin, Germany Tel +49 30 9406 3260 email s usanne.wolf@mdc-berlin.d e Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Mattei et al Running head recto: Animal models of schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S65564",Non-OADS,/arxiv_data1/oa_pdf/21/26/ndt-11-1313.PMC4455860.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/21/26/ndt-11-1313.PMC4455860.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/26/ndt-11-1313.PMC4455860.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/33/55/vhrm-11-271.PMC4455861.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 271–282Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  271ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S6259 5Current and emerging strategies in the  management of venous thromboembolism:  benefit–risk assessment of dabigatran Christina L Fanola Department of Cardiovascular and  Vascular Medicine, Boston University  School of Medicine, Boston, MA, USA Correspondence: Christina L Fanola   Department of Cardiovascular and  Vascular Medicine, Boston University  School of Medicine,  88 east Newton  Street, C-8, Boston, MA  02118, USA   Tel +1 617 638 8968  Fax +1 617 638 8969  email christina.cove@bmc.or gAbstract:  Venous thromboembolism (VTE) is a disease state that carries significant morbidity  and mortality, and is a known cause of preven table  death in hospitalized and orthopedic surgical  patients.",Non-OADS,/arxiv_data1/oa_pdf/33/55/vhrm-11-271.PMC4455861.pdf
Available from:  http://clinicaltrials.gov/show/NCT0238958 2.,Non-OADS,/arxiv_data1/oa_pdf/33/55/vhrm-11-271.PMC4455861.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/33/55/vhrm-11-271.PMC4455861.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/33/55/vhrm-11-271.PMC4455861.pdf
Available from:  http://clinicaltrials.gov/show/NCT0159082 3.,Non-OADS,/arxiv_data1/oa_pdf/33/55/vhrm-11-271.PMC4455861.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9e/6a/ott-8-1265.PMC4455869.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 1265–1270OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1265Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7851 4Hyperthermia combined with 5-fluorouracil  promoted apoptosis and enhanced thermotolerance  in human gastric cancer cell line sgc-7901 Tao liu* Yan-Wei Ye* a-li Zhu Zhen Yang Yang Fu chong-Qing Wei Qi liu chun-lin Zhao guo-Jun Wang Xie-Fu Zhang Department of gastrointestinal  surgery, The First affiliated hospital  of Zhengzhou University, Zhengzhou,   henan, People’s republic of china *These authors contributed equally  to this workAbstract:  This study was designed to investigate the proliferation inhibition and apo ptosis-   promoting effect under hyperthermia and chemotherapy treatment, at cellular level.",Non-OADS,/arxiv_data1/oa_pdf/9e/6a/ott-8-1265.PMC4455869.pdf
"Thermotherapy induces  malignant cell apoptosis and has a synergistic effect with chemotherapy, resulting in  improved outcomes and reduced side effects of chemotherapy, particularly in the later  stages of malignancy or in tumors resistant to other treatments.8 Over the past decades,  correspondence: Xie-Fu Zhang Department of gastrointestinal  Surgery, The First Affiliated Hospital  of Zhengzhou University, number 1 east  Jianshe road, Zhengzhou, henan 450052,  People’s republic of china email zhangxiefu163@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Liu et al Running head recto: Thermotolerance and apoptosis with hyperthermia and 5-FU combination DOI: http://dx.doi.org/10.2147/OTT.S78514",Non-OADS,/arxiv_data1/oa_pdf/9e/6a/ott-8-1265.PMC4455869.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9e/6a/ott-8-1265.PMC4455869.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/6a/ott-8-1265.PMC4455869.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6e/0b/cia-10-897.PMC4455870.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Interventions in Aging 2015:10 897–906Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  897OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8128 3Uncontrolled hypertension and orthostatic  hypotension in relation to standing balance  in elderly hypertensive patients shanshan shen1 Ting he1 Jiaojiao Chu1 Jin he2 Xujiao Chen1 1Department of geriatrics, Zhejiang  hospital, hangzhou, 2Department of  neurology, Fuyuan hospital of Yiwu,   Jinhua, People’s republic of ChinaObjective:  To investigate the associations among uncontrolled hypertension, orthostatic  hypotension (OH), and standing balance impairment in the elderly hypertensive patients referred  to comprehensive geriatric assessment (CGA).",Non-OADS,/arxiv_data1/oa_pdf/6e/0b/cia-10-897.PMC4455870.pdf
"Keywords:  hypertension, orthostatic hypotension, balance, elderly Introduction Orthostatic hypotension (OH) is a common clinical phenomenon in the elderly  population and has been thought to be an independent risk factor for falls, cardio - vascular events, frailty, and mortality.1–6 As reported, more than half of the elderly  suffer from hypertension, and the prevalence of OH in this population ranges from  6% to 30%.1,7–10 Due to aging blood vessels, blood pressure regulation declines  with advancing age, and both OH and hypertension indicate impaired blood pres - sure regulation.11–13 Hypertension itself increases the incidence of OH,14 especially  uncontrolled hypertension in the elderly patients, who often refuse antihypertensive  medication.15–17 Compared with participants with controlled hypertension and without  OH, those with uncontrolled hypertension and systolic OH at 1 minute were at greater  fall risk.15 Moreover, previous studies showed that standing balance impairment may be  a predisposing risk factor of falls and increase this risk threefold.18–20 The relationship Correspondence: Xujiao Chen Department of geriatrics, Zhejiang  hospital, no 12, lingyin road, hangzhou  310013, People’s republic of China Tel +86 180 6989 7567 Fax +86 571 8798 0175 email lily197459@163.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Shen et al Running head recto: Uncontrolled hypertension, OH, and standing balance impairment in elderly DOI: http://dx.doi.org/10.2147/CIA.S81283",Non-OADS,/arxiv_data1/oa_pdf/6e/0b/cia-10-897.PMC4455870.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/6e/0b/cia-10-897.PMC4455870.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/6e/0b/cia-10-897.PMC4455870.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/44/d1/ott-8-1251.PMC4455871.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 1251–1257OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1251Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S8183 1Clinical and pathological analysis of 116 cases  of adult adrenal cortical adenoma and literature  review Ai-Hua Jia1 Hong-Quan Du2 Min-Hua Fan2 Yu-Hong Li1 Jun-Long Xu1 Gui-Fen Niu2 Jie Bai2 Guang-Zhen Zhang2 Yu-Bo Ren1 1Department of Pathology, Liaocheng  People’s Hospital, Liaocheng, People’s  Republic of China; 2Department of  endocrinology, Liaocheng People’s  Hospital, Liaocheng, People’s  Republic of ChinaBackground:  The aim of this study is to investigate origin, gross features, microscopic features,  immunohistochemical properties, and differential diagnosis of adrenal cortical adenoma (ACA)  in patients $20 years old.",Non-OADS,/arxiv_data1/oa_pdf/44/d1/ott-8-1251.PMC4455871.pdf
"With recent advances in imaging techniques and new methods of hormone  determination, the detection of ACA will continue to improve in the future.4 Only a few reports have been published regarding the pathology of ACA.5 The  differences between malignant and benign adrenal disease,6,7 the characteristics of  functioning and non-functioning adenomas,8,9 and the distinction between patients  with bilateral and unilateral adrenal incidentalomas10 have been described, but little  is known about the differentiation of adult and pediatric ACAs.Correspondence: Ai-Hua Jia Department of Pathology, Liaocheng  People’s Hospital, Dongchang western  Road, 67#, Liaocheng 252000, People’s  Republic of China Tel/fax +86 635 827 2412 email  jah0711@yeah.ne t Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2015 Volume: 8 Running head verso: Jia et al Running head recto: Clinical and pathological analysis of adult ACA patients DOI: http://dx.doi.org/10.2147/OTT.S81831",Non-OADS,/arxiv_data1/oa_pdf/44/d1/ott-8-1251.PMC4455871.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/44/d1/ott-8-1251.PMC4455871.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/d1/ott-8-1251.PMC4455871.pdf
"The aim of our study is to investigate  the presence of LGR5 in SCs of healthy human tissues using  immunohistochemistry and to analyze possible changes in its  expression due to inflammation.Molecular Vision  2015; 21:644-648 <http://www.molvis.org/molvis/v 21/644> Received 22 January 2015 | Accepted 2 June 2015 | Published 4 June 2015© 2015 Molecular Vision 644The expression of LGR5 in healthy human stem cell niches and its  modulation in inflamed conditions Claudia Curcio,1 Manuela Lanzini,2 Roberta Calienno,2 Rodolfo Mastropasqua,3 Giorgio Marchini3 1Biological Eye Center Research, CeSI, University “G.",Non-OADS,/arxiv_data1/oa_pdf/e3/57/mv-v21-644.PMC4455891.pdf
Molecular Vision  2015; 21:644-648 <http://www.molvis.org/molvis/v 21/644> © 2015 Molecular Vision  645METHODS Sample preparation:  Seven human eye bank corneal buttons  with scleral rims (ages ranged from 73 to 80 years; mean  age 76.4±2.702 years) and two corneas (ages ranged from  73 to 79 years; mean age 76±4.243 years) not suitable for  transplantation were included in the study.,Non-OADS,/arxiv_data1/oa_pdf/e3/57/mv-v21-644.PMC4455891.pdf
Molecular Vision  2015; 21:644-648 <http://www.molvis.org/molvis/v 21/644> © 2015 Molecular Vision  646DISCUSSION The corneal epithelium is maintained by a pool of SCs that  resides predominantly in the corneoscleral limbus.,Non-OADS,/arxiv_data1/oa_pdf/e3/57/mv-v21-644.PMC4455891.pdf
Molecular Vision  2015; 21:644-648 <http://www.molvis.org/molvis/v 21/644> © 2015 Molecular Vision  647This study showed the expression of LGR5 in healthy  human LECs by immunohistochemistry for the first time.,Non-OADS,/arxiv_data1/oa_pdf/e3/57/mv-v21-644.PMC4455891.pdf
"Molecular Vision  2015; 21:644-648 <http://www.molvis.org/molvis/v 21/644> © 2015 Molecular Vision  648To the best of our knowledge, this study provides the first  immunohistochemical illustration of the expression of LGR5  in healthy and inflamed corneoscleral limbi and LECs.",Non-OADS,/arxiv_data1/oa_pdf/e3/57/mv-v21-644.PMC4455891.pdf
"Calcium depletion and readdition have been reported to  cause disassembly and reformation of TJ in corneal endothe - lial cells, respectively; however, pretreatment with Y-27632  prevents the normal redistribution of zonula occludens-1  (ZO-1) on the calcium add-back in these cells [ 15].Molecular Vision  2015; 21:633-643 <http://www.molvis.org/molvis/v 21/633> Received 12 December 2014 | Accepted 2 June 2015 | Published 4 June 2015© 2015 Molecular Vision 633Phenotypes of trypsin- and collagenase-prepared bovine corneal  endothelial cells in the presence of a selective Rho kinase  inhibitor, Y-27632 Chien-Chia Su,1,2,3 Chun-Wen Chen,3 Wei-Ting Ho,5 Fung-Rong Hu,3,4 Shwu-Huey Lee,6 I-Jong Wang3,4,5,7 1Department of Ophthalmology, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu, Taiwan; 2Graduate Institute  of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan; 3Department of Ophthalmology, National  Taiwan University Hospital College of Medicine, National Taiwan University, Taipei, Taiwan; 4National Taiwan University  College of Medicine, Taipei, Taiwan; 5Department of Ophthalmology, Far Eastern Memorial Hospital, New Taipei City, Taiwan;  6Department of Ophthalmology, Cathay General Hospital, Taipei, Taiwan; 7Graduate Institute of Clinical Medical Science, China  Medical University, Taichung, Taiwan Purpose:  To optimize isolation of viable bovine corneal endothelial cells (BCECs), we evaluated the effectiveness of  various preparation protocols.",Non-OADS,/arxiv_data1/oa_pdf/09/52/mv-v21-633.PMC4455892.pdf
"Molecular Vision  2015; 21:633-643 <http://www.molvis.org/molvis/v 21/633> © 2015 Molecular Vision  634Transmembrane proteins, such as ZO-1, localize to the TJ  domain and function as a barrier in the endothelial monolayer  [11,16,17].",Non-OADS,/arxiv_data1/oa_pdf/09/52/mv-v21-633.PMC4455892.pdf
"Molecular Vision  2015; 21:633-643 <http://www.molvis.org/molvis/v 21/633> © 2015 Molecular Vision  635with a 5-bromo-2’-deoxyuridine (BrdU) incorporation assay,  the BrdU enzyme-linked immunosorbent assay (ELISA) kit  from Roche (Indianapolis, IN), according to the manufac - turer’s instructions.",Non-OADS,/arxiv_data1/oa_pdf/09/52/mv-v21-633.PMC4455892.pdf
"Molecular Vision  2015; 21:633-643 <http://www.molvis.org/molvis/v 21/633> © 2015 Molecular Vision  636determined with immunostaining (Figure 2A,B,D,E,G,H).",Non-OADS,/arxiv_data1/oa_pdf/09/52/mv-v21-633.PMC4455892.pdf
"Molecular Vision  2015; 21:633-643 <http://www.molvis.org/molvis/v 21/633> © 2015 Molecular Vision  637cortical mat in the collagenase-prepared BCECs without  Y-27632 on days 1, 3, and 7 (Figure 3C,F,I), and normal and  intact ZO-1 expression was observed at the cellular junctions  of these BCECs on day 7 (Figure 3G).",Non-OADS,/arxiv_data1/oa_pdf/09/52/mv-v21-633.PMC4455892.pdf
"Molecular Vision  2015; 21:633-643 <http://www.molvis.org/molvis/v 21/633> © 2015 Molecular Vision  638Furthermore, the TrypLE- and collagenase-A-prepared  BCECs exhibited different proliferative patterns.",OADS,/arxiv_data1/oa_pdf/09/52/mv-v21-633.PMC4455892.pdf
"Molecular Vision  2015; 21:633-643 <http://www.molvis.org/molvis/v 21/633> © 2015 Molecular Vision  639BCECs; pretreatment with Y-27632 could interfere with the  myosin light chain phosphorylation and alter its downstream  actin cytoskeleton reorganization [ 39,40].",Non-OADS,/arxiv_data1/oa_pdf/09/52/mv-v21-633.PMC4455892.pdf
Molecular Vision  2015; 21:633-643 <http://www.molvis.org/molvis/v 21/633> © 2015 Molecular Vision  640to promote cyclin D expression and facilitate degradation of  p27Kip1 (p27) in the G1 phase [ 49].,Non-OADS,/arxiv_data1/oa_pdf/09/52/mv-v21-633.PMC4455892.pdf
Molecular Vision  2015; 21:633-643 <http://www.molvis.org/molvis/v 21/633> © 2015 Molecular Vision  641Y-27632 did not substantially increase the BrdU incorporation  in BCECs using TrypLE or the collagenase A culture system.,Non-OADS,/arxiv_data1/oa_pdf/09/52/mv-v21-633.PMC4455892.pdf
Molecular Vision  2015; 21:633-643 <http://www.molvis.org/molvis/v 21/633> © 2015 Molecular Vision  64220.,Non-OADS,/arxiv_data1/oa_pdf/09/52/mv-v21-633.PMC4455892.pdf
Molecular Vision  2015; 21:633-643 <http://www.molvis.org/molvis/v 21/633> © 2015 Molecular Vision  64347.,Non-OADS,/arxiv_data1/oa_pdf/09/52/mv-v21-633.PMC4455892.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/32/main.PMC4455911.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.05.006 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/32/main.PMC4455911.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/1b/main.PMC4455912.pdf
http://dx.doi.org/10.1016/j.ebcr.2015.04.0012213-3232/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/1b/main.PMC4455912.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/1b/main.PMC4455912.pdf
See http://creativecommons.org/licenses/by-nc/2.0/de/ HHS Public Access Author manuscript Demogr Res .,Non-OADS,/arxiv_data1/oa_pdf/10/32/nihms689195.PMC4455962.pdf
"As SimaPro includes many different databases (e.g., Ecoinvent, US LCI database, US IO dbase, Danish IO dbase, Dutch IO dbase, LCA food dbase, Industry data, Japanese IO dbase, IVAM dbase; see http://www.pre.nl/ simapro/inventory_databases.htm ), the actual data sources used in these studies remain unclear.",OADS,/arxiv_data1/oa_pdf/6b/8c/11367_2011_Article_369.PMC4456070.pdf
"Available at: http://www.fao.org/fishery/statistics/software/fishstat/en Frischknecht R, Althaus H-J, Bauer C, Doka G, Heck T, Jungbluth N, Kellenberger D, Nemecek T (2007) The environmental relevanceof capital goods in life cycle assessments of products and services.Int J Life Cycle Assess 12:7 –17 Gloria TP, Russell AJ, Atherton J, Baker SR, Cook M (2006) Ecological toxicity methods and metals —an examination of two case studies.",OADS,/arxiv_data1/oa_pdf/6b/8c/11367_2011_Article_369.PMC4456070.pdf
"Available at:http://www.pre.nl/eco-indicator99/ei99-reports.htm Grönroos J, Seppälä J, Silvenius F, Mäkinen T (2006) Life cycle assessment of Finnish cultivated rainbow trout.",Non-OADS,/arxiv_data1/oa_pdf/6b/8c/11367_2011_Article_369.PMC4456070.pdf
"The float data were obtained from the MedArgo Centre (http://nettuno.ogs.trieste.it/sire/medargo ) and the surface drifter data from MedSVP ( http://poseidon.ogs.trieste.it/sire/ medsvp ), OGS, Trieste, Italy.",OADS,/arxiv_data1/oa_pdf/b5/82/10236_2011_Article_437.PMC4456072.pdf
"Available at http://sedac.ciesin.columbia.edu/gpw Chang TY, Su TC, Lin SY, Jain RM, Chan CC (2007) Effects of occupational noise exposure on 24-hour ambulatory vascular prop- erties in male workers.",Non-OADS,/arxiv_data1/oa_pdf/04/36/11367_2011_Article_377.PMC4456074.pdf
"available online at: http://www.eea.europa.eu/publications/ good-practice-guide-on-noise ExternE (1995) Externalities of Energy, European Commission EUR 16520 EN, Volume 1-6 Available at: htrp:// www.ExrernE.irc.es Feynman R, Leighton RB, Sands M (1966) The Feynman Lectures on Physics, vol I and II.",Non-OADS,/arxiv_data1/oa_pdf/04/36/11367_2011_Article_377.PMC4456074.pdf
"Vught, The Netherlands Int ernational Life Cycle Data System (ILCD) Handbook (2010) available online at http://lct.jrc.ec.europa.eu/assessment/assessment/projects Ising H, Kruppa B (2004) Health effects caused by noise: evidence in the literature from the past 25 years.",OADS,/arxiv_data1/oa_pdf/04/36/11367_2011_Article_377.PMC4456074.pdf
Available at http://www.cdc.gov/niosh/docs/ 2001-103/ Navrud S (2002) The state of the art on economic valuation of noise.,OADS,/arxiv_data1/oa_pdf/04/36/11367_2011_Article_377.PMC4456074.pdf
Available at: http://europa.eu.int/com m/environment/noise/486 Int J Life Cycle Assess (2012) 17:471 –487,Non-OADS,/arxiv_data1/oa_pdf/04/36/11367_2011_Article_377.PMC4456074.pdf
Part of the work in this study used the facilities of the Shared Hierarchical Academic Research Computing Network (SHARCNET: http://www.sharcnet.ca ).,OADS,/arxiv_data1/oa_pdf/49/09/10712_2011_Article_9164.PMC4456078.pdf
Available at http://packageinserts.bms.com/pi/pi_coumadin.pdf (last accessed 6 August 2014).,Non-OADS,/arxiv_data1/oa_pdf/ff/27/bcp0079-0907.PMC4456123.pdf
Clinical Trial Registration—URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/a1/ac/cir-131-2041.PMC4456169.pdf
"Circulation is available at http://circ.ahajournals.org DOI: 10.1161/CIRCULATIONAHA.114.014245Received November 11, 2014; accepted March 27, 2015.From Department of Cardiology and Cardiovascular Research Institute Basel (R.T., K.W., C.J., M.R.G., M.R., T.R., A.W., M.G., L.K., N.M., Z.M.W.,  P.H., C.P., U.H., C.S., F.Z., M.F., C.S., S.O., C.M.",Non-OADS,/arxiv_data1/oa_pdf/a1/ac/cir-131-2041.PMC4456169.pdf
The online-only Data Supplement is available with this article at http://circ.ahajournals.org/lookup/suppl/doi:10.1161/CIRCULATIONAHA.,Non-OADS,/arxiv_data1/oa_pdf/a1/ac/cir-131-2041.PMC4456169.pdf
Clinical Trial Registration—URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/0d/82/cir-131-2032.PMC4456170.pdf
Circulation is available at http://circ.ahajournals.org DOI: 10.1161/CIRCULATIONAHA.114.014129Continuing medical education (CME) credit is available for this article.,Non-OADS,/arxiv_data1/oa_pdf/0d/82/cir-131-2032.PMC4456170.pdf
"Go to http://cme.ahajournals.org to take the quiz.Received July 22, 2014; accepted April 2, 2015.From Department of Cardiology and Cardiovascular Research Institute Basel (K.W., M.R.G., R.T., T.R., C.J., A.H., S.D., P.H., P.H., N.S., P.K., Y .T.,  T.H., Z.M.W., L.K., M.F., C.S., C.P., S.O., C.M.)",Non-OADS,/arxiv_data1/oa_pdf/0d/82/cir-131-2032.PMC4456170.pdf
*Drs Wildi and Gimenez contributed equally and should be considered the first author.The online-only Data Supplement is available with this article at http://circ.ahajournals.org/lookup/suppl/doi:10.1161/CIRCULATIONAHA.,Non-OADS,/arxiv_data1/oa_pdf/0d/82/cir-131-2032.PMC4456170.pdf
Go to http://cme.ahajournals.org to take the CME quiz for this article.,Non-OADS,/arxiv_data1/oa_pdf/0d/82/cir-131-2032.PMC4456170.pdf
"The intervention arm with six weeks interval rep resents a new proposed method to detection malaria infections, while the intervention arm with three mo nth interval represents the Ministry of Health current policy of active case detection in Indonesia, and the thir d arm will serve as the control for Ministry of Health’s policy No arm without PQ Outcomes Malaria incidence (time frame: six months) Anemia (time frame: six months) Starting date June 2013 Contact information Indonesia University/ Walter and Eliza Hall Institute of Me dical Research Notes http://clinicaltrials.gov/show/NCT01878357 Stated to be completed Saunders ongoing T rial name or title Active Surveillance for P .",Non-OADS,/arxiv_data1/oa_pdf/f4/f3/CD008152-0001.PMC4456193.pdf
"Adult obesity facts, 13 August 2012, http://www.cdc.gov/obesity/data/adult.html (accessed 6 November 2012).",Non-OADS,/arxiv_data1/oa_pdf/d3/a2/10.1177_2041731415579215.PMC4456321.pdf
"National diabetes fact sheet, 2011, http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf (accessed 6 November 2012).",Non-OADS,/arxiv_data1/oa_pdf/d3/a2/10.1177_2041731415579215.PMC4456321.pdf
"Proteome Software,  http://www.proteomesoftware.com/products/scaffold/  34.",Non-OADS,/arxiv_data1/oa_pdf/0f/57/10.1177_2041731415575857.PMC4456328.pdf
"Accession number The complete mRNA-seq data used to produce intensity maps  have been uploaded to the GEO (Gene Expression Omnibus, http://www.ncbi.nlm.nih.gov/geo) website under accession number  GSE58465.",OADS,/arxiv_data1/oa_pdf/fc/55/cr201558a.PMC4456625.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/dd/main.PMC4456682.pdf
http://dx.doi.org/10.1016/j.pmedr.2015.03.0022211-3355/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/68/dd/main.PMC4456682.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/dd/main.PMC4456682.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/68/dd/main.PMC4456682.pdf
http://dx.doi.org/10.1007/s10935-005- 0014-8 .,Non-OADS,/arxiv_data1/oa_pdf/68/dd/main.PMC4456682.pdf
http://dx.doi.org/10.1111/j.1532-7795.,Non-OADS,/arxiv_data1/oa_pdf/68/dd/main.PMC4456682.pdf
"HI, Honolulu (Available at: http://www.hawaii.gov/dbedt/db00/ index.html ).211 Y.",Non-OADS,/arxiv_data1/oa_pdf/68/dd/main.PMC4456682.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/68/dd/main.PMC4456682.pdf
"), 36s –39s.http://dx.doi.org/10.1177/1524839913486150 .",Non-OADS,/arxiv_data1/oa_pdf/68/dd/main.PMC4456682.pdf
"29 (3), 191 –197.http://dx.doi.org/10.1111/j.1525- 1446.2011.00979.x .",Non-OADS,/arxiv_data1/oa_pdf/68/dd/main.PMC4456682.pdf
http://dx.doi.org/10.1007/s10935-010- 0220-x (Review).,Non-OADS,/arxiv_data1/oa_pdf/68/dd/main.PMC4456682.pdf
http://dx.doi.org/10.1080/10826080701801550 .,Non-OADS,/arxiv_data1/oa_pdf/68/dd/main.PMC4456682.pdf
http://dx.doi.org/10.1016/1054-139x(94)00097-x .212 Y.,OADS,/arxiv_data1/oa_pdf/68/dd/main.PMC4456682.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/bc/f0/srep08307.PMC4456730.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/53/1b/CCD-6-148.PMC4456733.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/53/1b/CCD-6-148.PMC4456733.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/SOS/VOD: current situation and perspective M Mohty et al 789 © 2015 Macmillan Publishers Limited Bone Marrow Transplantation (2015) 781 –789",Non-OADS,/arxiv_data1/oa_pdf/2d/6a/bmt201552a.PMC4456788.pdf
Available from: http://unesdoc.unesco.org/ images/0005/000595/059558eo.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1a/43/JEHP-4-36.PMC4456860.pdf
Available from: http://www.iranpa.org/ portal/default.aspx?tabid=437andArticleId=264.,Non-OADS,/arxiv_data1/oa_pdf/f1/ed/JEHP-4-37.PMC4456867.pdf
Available from: http://www.parentsasteachers.org/images/stories/documents/Fatherhood_Resources/ImportantRoleofFathers.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f1/ed/JEHP-4-37.PMC4456867.pdf
Marriage and Divorce Rates for the US Atlanta:  CDC; 2012: http://www.cdc.gov/[Last cited on 15 Oct 2012].,Non-OADS,/arxiv_data1/oa_pdf/86/55/JEHP-4-42.PMC4456869.pdf
Available from: http://www.amar.org.ir/Default.,Non-OADS,/arxiv_data1/oa_pdf/86/55/JEHP-4-42.PMC4456869.pdf
United States Cencus Beaureu: US Department  of Commerce; 2007‑2011: https://www.census.gov.,Non-OADS,/arxiv_data1/oa_pdf/86/55/JEHP-4-42.PMC4456869.pdf
Available from: http://www.journal.ahima.,Non-OADS,/arxiv_data1/oa_pdf/96/0c/JEHP-4-48.PMC4456871.pdf
Available from: http://www.process‑improvement‑japan.,Non-OADS,/arxiv_data1/oa_pdf/96/0c/JEHP-4-48.PMC4456871.pdf
Available from:  http://www.bizjournals.com/seattle/stories/2005/10/31/focus11.,Non-OADS,/arxiv_data1/oa_pdf/96/0c/JEHP-4-48.PMC4456871.pdf
Available from: http://www.ohsu.edu/xd/education/schools/ school‑of‑medicine/departments/clinical‑departments/ radiation‑medicine/education‑training/upload/Lean‑Hospitals‑2012.,Non-OADS,/arxiv_data1/oa_pdf/96/0c/JEHP-4-48.PMC4456871.pdf
Available  from: http://www.healthcare.philips.com/pwc_hc/main/shared/ Assets/Documents/About/News/Articles/Deploying_Lean.pdf.,OADS,/arxiv_data1/oa_pdf/96/0c/JEHP-4-48.PMC4456871.pdf
Available from: http://www.blogs.,Non-OADS,/arxiv_data1/oa_pdf/96/0c/JEHP-4-48.PMC4456871.pdf
Available from: http://www.blogs.perficient.,Non-OADS,/arxiv_data1/oa_pdf/96/0c/JEHP-4-48.PMC4456871.pdf
Available from: http://www.informit.com/ articles/article.aspx?p=1621871.,Non-OADS,/arxiv_data1/oa_pdf/96/0c/JEHP-4-48.PMC4456871.pdf
Available  from: http://www.leanhealthcareexchange.com/wp‑content/ uploads/2011/03/HPP_CaseStudy_MedRec_Time1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/96/0c/JEHP-4-48.PMC4456871.pdf
Available from: http://www.is2.lse.ac.uk/asp/aspecis/20080163.pdf.,Non-OADS,/arxiv_data1/oa_pdf/96/0c/JEHP-4-48.PMC4456871.pdf
Available from: http://www.kellogg.northwestern.,Non-OADS,/arxiv_data1/oa_pdf/96/0c/JEHP-4-48.PMC4456871.pdf
Available  from: http://www.mnwastewise.org/resources/documents/ LeaningintoHealthcareImprovement‑Mayo.pdf.,Non-OADS,/arxiv_data1/oa_pdf/96/0c/JEHP-4-48.PMC4456871.pdf
Available  from: http://www.ijsrp.org/research‑paper‑1301/ijsrp‑p1352.pdf.,Non-OADS,/arxiv_data1/oa_pdf/96/0c/JEHP-4-48.PMC4456871.pdf
Available from: http://www.en.,Non-OADS,/arxiv_data1/oa_pdf/e1/67/JEHP-4-32.PMC4456876.pdf
"**All currency values are in US dollars ($), based on the world’s favorite currency site;  Available at: http://www.currency.me.uk/.",Non-OADS,/arxiv_data1/oa_pdf/b6/3a/JEHP-4-38.PMC4456877.pdf
** Based on the world’s favorite currency  site; Available at: http://www.currency.me.uk/.,Non-OADS,/arxiv_data1/oa_pdf/b6/3a/JEHP-4-38.PMC4456877.pdf
Available from: http://www.biology.clemson.,Non-OADS,/arxiv_data1/oa_pdf/8b/b1/IJABMR-5-124.PMC4456887.pdf
Available from: http://www.allamaiqbal.com/ works/prose/english/reconstruction.,Non-OADS,/arxiv_data1/oa_pdf/8b/b1/IJABMR-5-124.PMC4456887.pdf
Available  from: http://www.biology.clemson.edu/bpc/bp/Lab/110/reaction.,OADS,/arxiv_data1/oa_pdf/8b/b1/IJABMR-5-124.PMC4456887.pdf
Available from: http://www.who.int/gho/ncd/risk_factors/obesity_text/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/3e/8f/IJABMR-5-157.PMC4456896.pdf
Available from: http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ucm312468.htm.,Non-OADS,/arxiv_data1/oa_pdf/3e/8f/IJABMR-5-157.PMC4456896.pdf
Available from:  http://www.uptodate.com.,Non-OADS,/arxiv_data1/oa_pdf/3e/8f/IJABMR-5-157.PMC4456896.pdf
Available from: http://www.ir.vivus.com/ releasedetail.cfm?ReleaseID=634920.,Non-OADS,/arxiv_data1/oa_pdf/3e/8f/IJABMR-5-157.PMC4456896.pdf
Available from: http://www.ispor.org/news/ articles/oct07/rld.asp.,Non-OADS,/arxiv_data1/oa_pdf/b9/1d/IJABMR-5-82.PMC4456898.pdf
Available from: http://www.medscape.org/ viewarticle/830506_slide.,Non-OADS,/arxiv_data1/oa_pdf/b9/1d/IJABMR-5-82.PMC4456898.pdf
Available from: http://www.amar.org.ir/Portals/1/Iran/ census‑2.pdf.,OADS,/arxiv_data1/oa_pdf/4e/a2/IJABMR-5-83.PMC4456899.pdf
Available from: http://www.cdsco.nic.in/forms/list.aspx?lid=  1820andId=11.,Non-OADS,/arxiv_data1/oa_pdf/60/98/IJABMR-5-87.PMC4456900.pdf
Editor: Michael Feig./C2112015 The Authors 0006-3495/15/05/2585/6 $2.00 http://dx.doi.org/10.1016/j.bpj.2015.04.012 Biophysical Journal Volume 108 May 2015 2585–2590 2585,Non-OADS,/arxiv_data1/oa_pdf/b2/1a/main.PMC4457000.pdf
Editor: Sean Sun./C2112015 The Authors 0006-3495/15/05/2448/9 $2.00 http://dx.doi.org/10.1016/j.bpj.2015.03.035 2448 Biophysical Journal Volume 108 May 2015 2448–2456,Non-OADS,/arxiv_data1/oa_pdf/43/91/main.PMC4457008.pdf
1 can be numerically solved (see PYTHON script ( https://www.python.,Non-OADS,/arxiv_data1/oa_pdf/43/91/main.PMC4457008.pdf
The corresponding PYTHON script ( https://www.python.org/psf/ ) is provided in the Supporting Material .,OADS,/arxiv_data1/oa_pdf/43/91/main.PMC4457008.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/95/a2/12630_2015_Article_376.PMC4457100.pdf
"Web portal: http://www.lussierlab.org/transition-to-ICD9CM/ Tables annotated with levels of translation complexity: http://www.lussierlab.org/publications/ICD10to9 ............................................................................................................................... ..................... Key words : ICD-10-CM, medical informatics, network patterns, patient cohort, financial analyses, ICD-9-CM INTRODUCTION For the last 30 years, health care managers and clinical staff have relied on health data analytics based on diagnosis codesthat are recorded via the International Classification ofDiseases, ninth version, Clinical Modification (ICD-9-CM).",Non-OADS,/arxiv_data1/oa_pdf/8f/8a/ocu003.PMC4457110.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/8a/ocu003.PMC4457110.pdf
"Web portal: http://www.lussierlab.org/transition-to-ICD9CM/ Tables annotated with levels of translation complexity: http://www.lussierlab.org/publications/ICD10to9 RESULTS Figure 1 provides an overview of a bidirectional network map of Centers for Medicare & Medicaid Services (CMS) approved translations between ICD-9-CM and ICD-10-CM diagnosis codes, using GEMs mappings.",OADS,/arxiv_data1/oa_pdf/8f/8a/ocu003.PMC4457110.pdf
"Applying our novel, web-based tool ( http://www.lussierlab.",Non-OADS,/arxiv_data1/oa_pdf/8f/8a/ocu003.PMC4457110.pdf
"Audience: clini-cal informaticians and analysts.http://www.lussierlab.net/publications/ICD10to9/ 2014Update.pdf Tables of mapping motifs and categories (.xls format)Rapid reuse in software developed by health information technologists and informaticians.http://www.lussierlab.net/publications/ICD10to9/ 2014categories-motifs.xlsx SQL database of mapping motifs and categoriesLookup of sql queries and specific results by health system analysts to strategicallyimprove health system operations andplan transition to ICD-9-CM.http://www.lussierlab.net/publications/ICD10to9/ ICD10ToICD9.sql.gz Web portal Administrator, clinicians, and other users studying a practice pattern in ICD-10-CM.By typing or pasting in the ICD-10-CMcodes the motifs will be generatedhttp://www.lussierlab.org/transition-to-ICD9CM/ Input: Insert multiple ICD-10-CMs codes of interestOutput: Visualization of ICD-10-CM, ICD-9-CM, re- lationships and associated mapping categories intwo formats: dynamic network figure or tabular.",OADS,/arxiv_data1/oa_pdf/8f/8a/ocu003.PMC4457110.pdf
2011. https://www.cms.gov/ ICD10/ .,Non-OADS,/arxiv_data1/oa_pdf/8f/8a/ocu003.PMC4457110.pdf
2014. https://www.cms.,Non-OADS,/arxiv_data1/oa_pdf/8f/8a/ocu003.PMC4457110.pdf
2011. http://www.himss.,Non-OADS,/arxiv_data1/oa_pdf/8f/8a/ocu003.PMC4457110.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/f0/ocu023.PMC4457111.pdf
Full information on individual CDM transformation canbe found on the OMOP website ( http://omop.org/CDM ).,OADS,/arxiv_data1/oa_pdf/64/f0/ocu023.PMC4457111.pdf
"Leveraging the OMOP Vocabulary The OMOP CDM provides a common format for diverse rawdataset, and integration of the OMOP Vocabulary into the CDM is a requisite process (detailed information on the OMOP Vocabulary and its curation and maintenance process can befound at http://omop.org/Vocabularies ).",Non-OADS,/arxiv_data1/oa_pdf/64/f0/ocu023.PMC4457111.pdf
http://www.gpo.gov/fdsys/pkg/PLAW-110publ85/html/PLAW-110publ85.,Non-OADS,/arxiv_data1/oa_pdf/64/f0/ocu023.PMC4457111.pdf
http://www.fda.gov/safety/FDAsSentinelInitiative/ ucm2007250.htm .,Non-OADS,/arxiv_data1/oa_pdf/64/f0/ocu023.PMC4457111.pdf
Observational Medical Outcomes Partnership Website.http://omop.org .,Non-OADS,/arxiv_data1/oa_pdf/64/f0/ocu023.PMC4457111.pdf
http://www.ohdsi.org .,Non-OADS,/arxiv_data1/oa_pdf/64/f0/ocu023.PMC4457111.pdf
http://omop.org/CDM .,Non-OADS,/arxiv_data1/oa_pdf/64/f0/ocu023.PMC4457111.pdf
http://omop.org/Vocabularies .,Non-OADS,/arxiv_data1/oa_pdf/64/f0/ocu023.PMC4457111.pdf
https://github.com/OHDSI/WhiteRabbit .,Non-OADS,/arxiv_data1/oa_pdf/64/f0/ocu023.PMC4457111.pdf
http://www.mini-sentinel.,Non-OADS,/arxiv_data1/oa_pdf/64/f0/ocu023.PMC4457111.pdf
http://omop.org/sites/default/files/34_Weinstein_ ALI%20seasonality.pdf .,Non-OADS,/arxiv_data1/oa_pdf/64/f0/ocu023.PMC4457111.pdf
The RCT confidence predictions described here have been made available to users as a web service with a user query form front end at: http://arrowsmith.psych.uic.edu/cgi-bin/arrowsmith_uic/RCT_Tagger.cgi .,OADS,/arxiv_data1/oa_pdf/c6/22/ocu025.PMC4457112.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/22/ocu025.PMC4457112.pdf
The manual review was based onthe MEDLINE definition of an RCT ( http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/c6/22/ocu025.PMC4457112.pdf
"Algorithm After some initial experimentation with several machine learn-ing approaches and implementations including the Weka(http://www.cs.waikato.ac.nz/ml/weka/ ) implementation of lo- gistic regression, decision trees, K-nearest neighbors, and the SVMLight ( http://svmlight.joachims.org/ ) 12implementation of support vector machines (SVMs), the Liblinear13fast linear im- plementation of SVM was selected.",OADS,/arxiv_data1/oa_pdf/c6/22/ocu025.PMC4457112.pdf
"The RCT confidence predictions described here have been made available to users as a free, public web service with a user query form front end at: http://arrowsmith.psych.uic.edu/ cgi-bin/arrowsmith_uic/RCT_Tagger.cgi .",Non-OADS,/arxiv_data1/oa_pdf/c6/22/ocu025.PMC4457112.pdf
2008. http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/c6/22/ocu025.PMC4457112.pdf
2014 http://www.sciencedirect.com/science/article/pii/ S1046202314003661 .,Non-OADS,/arxiv_data1/oa_pdf/c6/22/ocu025.PMC4457112.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/5d/ocu041.PMC4457113.pdf
The Twitter corpus contains 1340 tweets fortraining (Twitter train set) and 444 test tweets (Twitter test set).The Twitter annotated corpus is available for download fromhttp://diego.asu.edu/downloads/publications/ADRMine/download_tweets.zip .,OADS,/arxiv_data1/oa_pdf/b8/5d/ocu041.PMC4457113.pdf
Generating the embedding clustersfrom raw input texts is very fast and takes around 30 s. Thegenerated word embeddings and clusters are made avail-able for download http://diego.asu.edu/Publications/ADRMine.,OADS,/arxiv_data1/oa_pdf/b8/5d/ocu041.PMC4457113.pdf
http://www.dailystrength.org/ .,Non-OADS,/arxiv_data1/oa_pdf/b8/5d/ocu041.PMC4457113.pdf
http://dx.doi.org/10.1561/2000000039.,Non-OADS,/arxiv_data1/oa_pdf/b8/5d/ocu041.PMC4457113.pdf
http://sideeffects.embl.,Non-OADS,/arxiv_data1/oa_pdf/b8/5d/ocu041.PMC4457113.pdf
2007. http://www.chokkan.org/soft- ware/crfsuite/ .,Non-OADS,/arxiv_data1/oa_pdf/b8/5d/ocu041.PMC4457113.pdf
http://lucene.apache.org/ .,Non-OADS,/arxiv_data1/oa_pdf/b8/5d/ocu041.PMC4457113.pdf
http://wordlist.aspell.net/ .,Non-OADS,/arxiv_data1/oa_pdf/b8/5d/ocu041.PMC4457113.pdf
https://code.google.com/p/word2vec/ .,Non-OADS,/arxiv_data1/oa_pdf/b8/5d/ocu041.PMC4457113.pdf
2006. http://www.nlpado.de/ ~sebastian/software/sigf.shtml .,Non-OADS,/arxiv_data1/oa_pdf/b8/5d/ocu041.PMC4457113.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c2/9b/copd-10-969.PMC4457217.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2015:10 969–973International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  969OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8285 6acute vasoreactivity test results in severe  pulmonary hypertension patients with chronic  obstructive pulmonary disease: our experience  with 29 cases selvi asker1 Muntecep asker2 ¹Department of Chest Diseases, Van  Yuksek Ihtisas Training and research  hospital, Van, T urkey; 2Department of  Cardiology, Van Yuksek Ihtisas Training  and research hospital, Van, T urkeyAim:   The aim of the current study is to evaluate acute vasoreactivity test (AVT) results in severe  pulmonary hypertension patients with chronic obstructive pulmonary disease and to compare  the demographical, clinical, and laboratory variables in positive and negative cases.",Non-OADS,/arxiv_data1/oa_pdf/c2/9b/copd-10-969.PMC4457217.pdf
"These cases not only display better functional class and hemodynamics,  but they also have superior survival rates compared to non-responders.1,3,4Correspondence: selvi asker Department of Chest Diseases, Yuzuncu  Yil University Faculty of Medicine, 65170,  Van, Turkey Tel +90 505 251 4704 Fax +90 432 212 1954 email selviasker@yahoo.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Asker and Asker Running head recto: Acute vasoreactivity test in severe PH with COPD DOI: http://dx.doi.org/10.2147/COPD.S82856",Non-OADS,/arxiv_data1/oa_pdf/c2/9b/copd-10-969.PMC4457217.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/c2/9b/copd-10-969.PMC4457217.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/9b/copd-10-969.PMC4457217.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a5/fd/bctt-7-133.PMC4457218.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2015:7 133–146Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  133Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/BCTT .S8001 4Development and psychometric testing of a  breast cancer patient-profiling questionnaire alessandra gorini1,2 Ketti Mazzocco1,2 sara gandini2 elisabetta Munzone2 gordon McVie2 gabriella Pravettoni1,2 1Department of health science,   University of Milan, Milan, italy;   2european institute of Oncology,   Milan, italy Correspondence: alessandra gorini   Via a Di rudinì 8, Milan, italy   Tel +39 02 5031 2240   email alessandra.gorini@unimi.i tIntroduction:  The advent of “personalized medicine” has been driven by technological advances  in genomics.",Non-OADS,/arxiv_data1/oa_pdf/a5/fd/bctt-7-133.PMC4457218.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/a5/fd/bctt-7-133.PMC4457218.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4e/8f/ceor-7-273.PMC4457219.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 273–280ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  273ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S7093 6adherence to statin treatment following   a myocardial infarction: an italian   population-based survey Bruno Monaldi1 giovanni Bologna2 geeta giulia Costa3 Carlo D’agostino4 Fulvio Ferrante5 Maurizio Filice6 anna Maria grion7 alessandra Mingarelli8 leonardo Paloscia9 Roberto T ettamanti10 Chiara Veronesi11 luca Degli Esposti11 1servizio Farmaceutico, Ospedale g  Mazzoni, asUR Marche, ascoli Piceno,   2Dipartimento Farmaceutico, Ospedale  di Piacenza, aUsl di Piacenza, ssR  Emilia-Romagna, Piacenza, 3Dipartimento  scienze Cardiologiche, Toraciche e  Vascolari, Università degli studi di Padova,   Padua, 4Unità Operativa Cardiologia,   Ospedale Di Venere, asl di Bari, Bari,   5sC Monitoraggio attività Farmaceutica,   azienda Usl Frosinone, Frosinone,   6Dipartimento Medico, Ospedale Piero  Palagi, azienda sanitaria di Firenze (asF),   Florence, 7servizio Farmaceutico, Ulss 16  Padova, Padua, 8Dipartimento Funzionale  del Farmaco, asl di latina, latina,   9Unità Operativa UT iC e Cardiologia  interventistica, Ospedale santo spirito,   asl di Pescara, Pescara, 10Unità Operativa  Complessa Osservatorio Epidemiologico e  sistemi informativi, asl della Provincia di  Como, Como, 11CliCon health, Economics  and Outcomes Research, Ravenna, italy Correspondence: luca Degli Esposti   CliCon health, Economics and Outcomes  Research, 36 Via salara, Ravenna 48100,  italy  Tel +39 0544 38 393   Fax +39 0544 212 699   Email luca.degliesposti@clicon.i tBackground:  Statins are standard therapies after myocardial infarction (MI) in the general  population.",Non-OADS,/arxiv_data1/oa_pdf/4e/8f/ceor-7-273.PMC4457219.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/4e/8f/ceor-7-273.PMC4457219.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/8f/ceor-7-273.PMC4457219.pdf
Available from:  http://www.salute.gov.it /.,Non-OADS,/arxiv_data1/oa_pdf/4e/8f/ceor-7-273.PMC4457219.pdf
"Available from: http://www.whocc.n o. Accessed  October 14, 2014.",Non-OADS,/arxiv_data1/oa_pdf/4e/8f/ceor-7-273.PMC4457219.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4d/91/dhps-7-097.PMC4457220.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug, Healthcare and Patient Safety 2015:7 97–102Drug, Healthcare and Patient Safety Dove press submit your manuscript | www.dovepress.co m Dove press  97Original reSearcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DHPS.S8076 2antifungal agent utilization evaluation in  hospitalized neutropenic cancer patients at a large  teaching hospital afsaneh Vazin1 Mohammad ali Davarpanah2 Setareh ghalesoltani3 1Department of clinical Pharmacy,  Faculty of Pharmacy, Shiraz University  of Medical Sciences, Shiraz, iran;  2HiV research center, Shiraz  University of Medical Sciences, Shiraz,  iran; 3international Branch of Faculty  of Pharmacy, Shiraz University of  Medical Sciences, Shiraz, iran correspondence: afsaneh Vazin   Department of clinical Pharmacy,   Faculty of Pharmacy, Shiraz   University of Medical Sciences,   PO Box  71439-14693, Shiraz, iran   Tel +98 711 242 4128  Fax +98 711 242 4126  email vazeena@sums.ac.i rAbstract:  To evaluate pattern of using of three antifungal drugs: fluconazole, amphotericin B  and voriconazole, at the hematology–oncology and bone marrow transplant wards of one large  teaching hospital.",Non-OADS,/arxiv_data1/oa_pdf/4d/91/dhps-7-097.PMC4457220.pdf
"Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-healthcare-and-patient-safety-journa lDrug, Healthcare and Patient Safety is an international, peer-reviewed  open-access journal exploring patient safety issues in the healthcare  continuum from diagnostic and screening interventions through to treat - ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/4d/91/dhps-7-097.PMC4457220.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/91/dhps-7-097.PMC4457220.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/79/d6/cmar-7-121.PMC4457221.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pCancer Management and Research 2015:7 121–131Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  121Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S6416 5The impact of mindfulness-based interventions  on symptom burden, positive psychological  outcomes, and biomarkers in cancer patients Codie R Rouleau1 Sheila N Garland2 Linda e Carlson3 1Department of Psychology, Faculty  of Arts, University of Calgary,  Calgary, AB, Canada; 2Department  of Family Medicine and Community  Health, Perelman School of  Medicine, University of Pennsylvania,  Philadelphia, PA, USA; 3Department  of Oncology, Cumming School of  Medicine, University of Calgary,  Calgary, AB, Canada Correspondence: Linda e Carlson   Department of Psychosocial Resources,  Alberta Health Services – Cancer Care,  2202 2nd Street Sw, Calgary, AB T2S  3C1, Canada   Tel +1 403 355 3207   Fax +1 403 283 6032   email l.carlson@ucalgary.c aAbstract:  Research on the use of mindfulness-based stress reduction and related mindfulness- based interventions (MBIs) in cancer care has proliferated over the past decade.",Non-OADS,/arxiv_data1/oa_pdf/79/d6/cmar-7-121.PMC4457221.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/79/d6/cmar-7-121.PMC4457221.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/79/d6/cmar-7-121.PMC4457221.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJuly 2014 |  89  | e51516 | Page 1 of 10Video Article Characterization of G Protein-coupled Receptors by a Fluorescence-based Calcium Mobilization Assay Jelle Caers1, Katleen Peymen1, Nick Suetens1, Liesbet Temmerman1, Tom Janssen1, Liliane Schoofs1, Isabel Beets1 1Department of Biology, KU Leuven Correspondence to: Isabel Beets at Isabel.Beets@bio.kuleuven.be URL: http://www.jove.com/video/51516 DOI: doi:10.3791/51516 Keywords: Cellular Biology, Issue 89, G protein-coupled receptor (GPCR), calcium mobilization assay, reverse pharmacology, deorphanization, cellular expression system, HEK293T, Fluo-4, FlexStation Date Published: 7/28/2014 Citation: Caers, J., Peymen, K., Suetens, N., Temmerman, L., Janssen, T., Schoofs, L., Beets, I.",Non-OADS,/arxiv_data1/oa_pdf/d6/0b/jove-89-51516.PMC4457351.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51516/ Introduction G protein-coupled receptors (GPCRs) constitute one of the largest and most diverse families among all cell surface proteins.,Non-OADS,/arxiv_data1/oa_pdf/d6/0b/jove-89-51516.PMC4457351.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/2a/main.PMC4457384.pdf
Direct link to deposited data All data can be found at http://www.ncbi.nlm.nih.gov/geo/query/ acc.cgi?acc=GSE56520 .,OADS,/arxiv_data1/oa_pdf/8a/2a/main.PMC4457384.pdf
Consent N/ASample source location N/A http://dx.doi.org/10.1016/j.gdata.2015.04.029 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/2a/main.PMC4457384.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/2a/main.PMC4457384.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/8a/2a/main.PMC4457384.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/77/main.PMC4457433.pdf
http://dx.doi.org/10.1016/j.ebiom.2014.10.014 2352-3964/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/77/main.PMC4457433.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/77/main.PMC4457433.pdf
"Contents lists available at ScienceDirect Taiwan Journal of Ophthalmology journal homepage: www.e-tjo.com http://dx.doi.org/10.1016/j.tjo.2015.01.003 2211-5056/Copyright ©2015, The Ophthalmologic Society of Taiwan.",Non-OADS,/arxiv_data1/oa_pdf/ad/18/TJO-5-3.PMC4457437.pdf
Andrew Gall and Cristian Ilioaia contributed equally to this work.Editor: Catherine Royer./C2112015 The Authors 0006-3495/15/06/2713/8 $2.00 http://dx.doi.org/10.1016/j.bpj.2015.04.017 Biophysical Journal Volume 108 June 2015 2713–2720 2713,Non-OADS,/arxiv_data1/oa_pdf/f3/56/main.PMC4457476.pdf
27 ( http://www.dsmz.de )a t 2852/C14C in glass bottles located between banks of incandescent lamps.,Non-OADS,/arxiv_data1/oa_pdf/f3/56/main.PMC4457476.pdf
Editor: Andreas Engel./C2112015 The Authors 0006-3495/15/06/2680/11 $2.00 http://dx.doi.org/10.1016/j.bpj.2015.04.027 2680 Biophysical Journal Volume 108 June 2015 2680–2690,Non-OADS,/arxiv_data1/oa_pdf/ae/0a/main.PMC4457492.pdf
Editor: Markus Deserno./C2112015 The Authors 0006-3495/15/06/2633/15 $2.00 http://dx.doi.org/10.1016/j.bpj.2015.04.028 Biophysical Journal Volume 108 June 2015 2633–2647 2633,Non-OADS,/arxiv_data1/oa_pdf/4d/44/main.PMC4457497.pdf
"USB-6356 (National Instruments, Austin, TX) or a Personal DAQ3000 (IOtech, National Instruments) controlled by the software jClamp (SciSoft, http://www.scisoftco.com/jclamp.html ).",Non-OADS,/arxiv_data1/oa_pdf/4d/44/main.PMC4457497.pdf
All physicians who wanted to include patients in the EAP were required to register and complete an e-learning course on the management of drug toxicities and patterns of response before requesting the treatment by accessing the website http://www.ipilimumabcu.es .,Non-OADS,/arxiv_data1/oa_pdf/48/59/cmr-24-577.PMC4457498.pdf
Available at: http://globocan.iarc.fr [Accessed 28 May 2013].,Non-OADS,/arxiv_data1/oa_pdf/48/59/cmr-24-577.PMC4457498.pdf
Available at: http://www.emea.europa.eu/docs/ en_GB/document_library/EPAR_-_Product_Information/human/002213/ WC500109299.pdf.,Non-OADS,/arxiv_data1/oa_pdf/48/59/cmr-24-577.PMC4457498.pdf
"The primary study was a double-blind, randomized, controlled trial comparing vilazodone 20 and 40 mg/day with placebo; citalopram 40 mg/day was an active control (NCT01473381; http://www.clinicaltrials.gov ).",Non-OADS,/arxiv_data1/oa_pdf/7d/a4/yic-30-216.PMC4457500.pdf
In a recent phase IV study (NCT01473381; http://www.clin icaltrials.gov )( M a t h e w set al.,Non-OADS,/arxiv_data1/oa_pdf/7d/a4/yic-30-216.PMC4457500.pdf
Systemically administered nicotinic receptor agonists increase odor  This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first 12 months after the full-issue publication  date (see http://learnmem.cshlp.org/site/misc/terms.xhtml ).,Non-OADS,/arxiv_data1/oa_pdf/b8/7d/nihms4648.PMC4457520.pdf
"After 12 months, it is available under a Creative Commons License  (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/ .",Non-OADS,/arxiv_data1/oa_pdf/b8/7d/nihms4648.PMC4457520.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/c8/nihms-682669.PMC4457572.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distributio n, and reproduction in any medium, provided the original work is properly cited.1 Citation: Diabetic Foot & Ankle 2015, 6: 25508 - http://dx.doi.org/10.3402/dfa.v6.25508 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/1e/75/DFA-6-25508.PMC4457780.pdf
"2 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2015, 6: 25508 - http://dx.doi.org/10.3402/dfa.v6.25508",Non-OADS,/arxiv_data1/oa_pdf/1e/75/DFA-6-25508.PMC4457780.pdf
"Average waiting times in weeks per risk category, per time frame.Audit of podiatry services Citation: Diabetic Foot & Ankle 2015, 6: 25508 - http://dx.doi.org/10.3402/dfa.v6.25508 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/1e/75/DFA-6-25508.PMC4457780.pdf
Available from: http://www.hse.ie/eng/about/Who/ clinical/natclinprog/diabetesprogramme/modelofcarediabetes.pdf[cited 3 November 2014].,Non-OADS,/arxiv_data1/oa_pdf/1e/75/DFA-6-25508.PMC4457780.pdf
Available from: http://www.sign.ac.uk/pdf/sign116.pdf [cited 3 November 2014].,Non-OADS,/arxiv_data1/oa_pdf/1e/75/DFA-6-25508.PMC4457780.pdf
Available from: http://guidance.nice.org.uk/CG10 [cited 3November 2014].,Non-OADS,/arxiv_data1/oa_pdf/1e/75/DFA-6-25508.PMC4457780.pdf
Available from: http://www.tynedalecomputers.co.uk/Podiatry-Software-Home.htm [cited 3 November 2014].,Non-OADS,/arxiv_data1/oa_pdf/1e/75/DFA-6-25508.PMC4457780.pdf
"4 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2015, 6: 25508 - http://dx.doi.org/10.3402/dfa.v6.25508",Non-OADS,/arxiv_data1/oa_pdf/1e/75/DFA-6-25508.PMC4457780.pdf
National Comprehensive Cancer Network Guidelines Colon Cancer Version 3.2013 http://www.nccn.org/professionals/physician_gls/f_ guidelines.asp5.,Non-OADS,/arxiv_data1/oa_pdf/27/0e/11523_2014_Article_333.PMC4457933.pdf
Glivec® summary of product characteristics http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/27/0e/11523_2014_Article_333.PMC4457933.pdf
SUTENT® summary of product characteristics http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/27/0e/11523_2014_Article_333.PMC4457933.pdf
Nexavar® summary of product characterstics http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/27/0e/11523_2014_Article_333.PMC4457933.pdf
Stivarga® summary of product characteristics http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/27/0e/11523_2014_Article_333.PMC4457933.pdf
EMA summary of opinion initial authorization —Stivarga® (regorafenib) http://www.ema.europa.eu/docs/en_GB/document_ library/Summary_of_opinion_-_ Initial_authorisation/human/ 002573/WC500144844.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/27/0e/11523_2014_Article_333.PMC4457933.pdf
The NHS cancer plan and the pharmacy contribution to cancer care (January 2001) http://www.bopawebsite.org/contentimages/ publications/OncologyPharmacy.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/27/0e/11523_2014_Article_333.PMC4457933.pdf
ClinicalTrials.gov Identifier:NCT01774344 http://clinicaltrials.gov/ct2/show/record/ NCT01774344 Accessed November 2013 31.,Non-OADS,/arxiv_data1/oa_pdf/27/0e/11523_2014_Article_333.PMC4457933.pdf
Avastin® summary of product characteristics http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/27/0e/11523_2014_Article_333.PMC4457933.pdf
http://clinicaltrials.gov/show/ NCT01949194 Accessed November 2013.,Non-OADS,/arxiv_data1/oa_pdf/27/0e/11523_2014_Article_333.PMC4457933.pdf
http://clinicaltrials.gov/show/ NCT01875380 Accessed November 2013.,Non-OADS,/arxiv_data1/oa_pdf/27/0e/11523_2014_Article_333.PMC4457933.pdf
"Chan School of Public Health, Boston, MA 02115, USA*Correspondence: lp.lucapagani@gmail.com http://dx.doi.org/10.1016/j.ajhg.2015.04.019 ./C2112015 The Authors This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/1a/ad/main.PMC4457944.pdf
Supplemental Data Supplemental Data include seven ﬁgures and four tables and canbe found with this article online at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1a/ad/main.PMC4457944.pdf
"Received: January 21, 2015 Accepted: April 29, 2015Published: May 28, 2015 Web Resources The URL for data presented in this paper is as follows: European Genome-phenome Archive (EGA), https://www.ebi.ac.",Non-OADS,/arxiv_data1/oa_pdf/1a/ad/main.PMC4457944.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/6b/e6/iranjradiol-12-02-11303.PMC4457962.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b6/f5/iranjradiol-12-02-13955.PMC4457963.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a4/fd/iranjradiol-12-02-20619.PMC4457964.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/82/8f/iranjradiol-12-02-19302.PMC4457965.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/04/11/iranjradiol-12-02-17916.PMC4457966.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e5/dd/iranjradiol-12-02-11076.PMC4457967.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a5/4d/iranjradiol-12-02-11197.PMC4457968.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/iranjradiol-12-02-11637.PMC4457969.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/de/4c/iranjradiol-12-02-7157.PMC4457970.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/1c/94/iranjradiol-12-02-13257.PMC4457971.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e7/63/iranjradiol-12-02-7349.PMC4457972.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/31/a3/10.1177_2054270415579779.PMC4458255.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/34/5f/10.1177_2054270415579027.PMC4458256.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/b3/69/10.1177_2054270414554247.PMC4458257.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/29/ehv007.PMC4458286.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/38/b4/jjm-08-05-19082.PMC4458349.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/32/25/jjm-08-05-17802.PMC4458350.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/28/10/jjm-08-05-20834.PMC4458351.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/cf/c1/jjm-08-05-17138.PMC4458352.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e6/73/jjm-08-05-18984.PMC4458353.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/61/eb/jjm-08-05-16750.PMC4458354.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/54/fa/jjm-08-05-14814.PMC4458355.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/8c/d7/jjm-08-05-14874.PMC4458356.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a5/fb/jjm-08-05-16784.PMC4458357.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/48/b0/jjm-08-05-18119.PMC4458358.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/59/fd/jjm-08-05-18573.PMC4458359.pdf
"Supplementary Material For supplementary material accompanying this paper, visit http://dx.doi.org/10.1017/S00000000000000.",Non-OADS,/arxiv_data1/oa_pdf/1a/73/pyv009.PMC4458439.pdf
"Keywords:  Anterior cruciate ligament, Chronic tear, Muscle strength, Postural balanceOriginal Article Knee Surg Relat Res 2015;27(2):101-107 http://dx.doi.org/10.5792/ksrr.2015.27.2.101 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received June 15, 2014; Revised (1st) November 26, 2014;   (2nd) January 19, 2015; Accepted February 9, 2015 Correspondence to: Dae-Hee Lee, MD Department of Orthopaedic Surgery, Samsung Medical Center, 81 Irwon- ro, Gangnam-gu, Seoul 135-710, Korea Tel: +82-2-3410-3507, Fax: +82-2-3410-0061 E-mail: eoak22@empal.com 101This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/ff/ksrr-27-101.PMC4458480.pdf
"Keywords:  Patella, Fracture, Ultrasound-guided, Nerve blockOriginal Article Knee Surg Relat Res 2015;27(2):108-116 http://dx.doi.org/10.5792/ksrr.2015.27.2.108 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received September 15, 2014; Revised (1st) December 28, 2014;   (2nd) January 28, 2015; Accepted March 26, 2015 Correspondence to: Y ong-Bum Joo, MD Department of Orthopaedic Surgery, Chungnam National University  Hospital, 282 Munhwa-ro, Jung-gu, Daejeon 301-721, Korea Tel: +82-42-338-2482, Fax: +82-42-338-2480 E-mail: longman76@hanmail.net 108This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/eb/ksrr-27-108.PMC4458481.pdf
"Keywords:  Anterior cruciate ligament, Reconstruction, Single-bundle, Transtibial techniqueTechnical Note Knee Surg Relat Res 2015;27(2):117-122 http://dx.doi.org/10.5792/ksrr.2015.27.2.117 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received July 14, 2014; Revised (1st) October 12, 2014;   (2nd) December 9, 2014; Accepted January 20, 2015 Correspondence to: Jae-Gwang Song, MD Department of Orthopaedic Surgery, Inje University Ilsan Paik Hospital,  170 Juhwa-ro, Ilsanseo-gu, Goyang 411-706, Korea  Tel: +82-31-910-7312, Fax: +82-31-910-7319 E-mail: sjgwang@naver.com 117This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/04/ksrr-27-117.PMC4458482.pdf
"Keywords:  Patella, Tendon rupture, Revision, ArthroplastyCase Report Knee Surg Relat Res 2015;27(2):123-128 http://dx.doi.org/10.5792/ksrr.2015.27.2.123 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received October 30, 2014; Revised January 17, 2015;   Accepted January 29, 2015 Correspondence to: Jeung Tak Suh, MD Department of Orthopaedic Surgery, Pusan National University  Hospital, 179 Gudeok-ro, Seo-gu, Busan 602-739, Korea Tel: +82-51-240-7248, Fax: +82-51-247-8395 E-mail: jtsuh@pusan.ac.kr 123This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/57/ksrr-27-123.PMC4458483.pdf
"Keywords:  Tibial plateau fracture, Anterior cruciate ligament, Arthroscopic reconstructionCase Report Knee Surg Relat Res 2015;27(2):129-132 http://dx.doi.org/10.5792/ksrr.2015.27.2.129 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received November 24, 2014; Revised (1st) February 22, 2015;  (2nd) April 27, 2015; Accepted May 4, 2015 Correspondence to: Ki Cheor Bae, MD Department of Orthopedic Surgery, Keimyung University Dongsan  Medical Center, 56 Dalseong-ro, Jung-gu, Daegu 700-712, Korea Tel: +82-53-250-7729, Fax: +82-53-250-7205  E-mail: bkc@dsmc.or.kr 129This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/82/ksrr-27-129.PMC4458484.pdf
"Keywords:  Anterior cruciate ligament, Anatomical reconstruction, Single-bundle, Knee kinematics, Robotic testing systemReview Article Knee Surg Relat Res 2015;27(2):69-75 http://dx.doi.org/10.5792/ksrr.2015.27.2.69 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received February 4, 2015; Revised March 5, 2015;   Accepted April 16, 2015 Correspondence to: Guoan Li, PhD Bioengineering Laboratory, Department of Orthopaedic Surgery, Massa- chusetts General Hospital/Harvard Medical School, 55 Fruit Street - GRJ  1215, Boston, MA 02114, USA Tel: +1-617-726-6472, Fax: +1-617-724-4392 E-mail: gli1@mgh.harvard.edu 69This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/91/ksrr-27-69.PMC4458485.pdf
"Keywords:  Knee, Meniscus, Contralateral meniscectomy, ArthroplastyOriginal Article Knee Surg Relat Res 2015;27(2):76-81 http://dx.doi.org/10.5792/ksrr.2015.27.2.76 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received May 8, 2014; Revised (1st) September 1, 2014;   (2nd) October 15, 2014; Accepted October 28, 2014 Correspondence to: Seong-Il Bin, MD Department of Orthopedic Surgery, Asan Medical Center, University of  Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138- 736, Korea  Tel: +82-2-3010-3528, Fax: +82-2-488-7877 E-mail: sibin@amc.seoul.kr 76This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/86/ksrr-27-76.PMC4458486.pdf
"Keywords:  Knee, Arthroplasty, Infection, Two-stage revision, ComorbiditiesOriginal Article Knee Surg Relat Res 2015;27(2):82-89 http://dx.doi.org/10.5792/ksrr.2015.27.2.82 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received May 26, 2014; Revised (1st) August 24, 2014;   (2nd) December 23, 2014; (3rd) April 13, 2015; Accepted May 4, 2015 Correspondence to: Sun Chul Hwang, MD Department of Orthopaedic Surgery, Gyeongsang National University                               School of Medicine, 79 Gangnam-ro, Jinju 660-702, Korea Tel: +82-55-750-8102, Fax: +82-55-761-9477 E-mail: hscspine@hanmail.net 82This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/13/ksrr-27-82.PMC4458487.pdf
"Keywords:  Knee, Degenerative arthritis, Medial meniscus, Root tear, ArthroplastyOriginal Article Knee Surg Relat Res 2015;27(2):90-94 http://dx.doi.org/10.5792/ksrr.2015.27.2.90 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received November 3, 2014; Revised February 20, 2015;   Accepted April 2, 2015 Correspondence to: Eui-Sung Choi, MD Department of Orthopaedic Surgery, Chungbuk National University  Hospital, 776 1(il)sunhwan-ro, Heungdeok-gu, Cheongju 361-711,  Korea  Tel: +82-43-269-6077, Fax: +82-43-274-8719 E-mail: oseschoi@chungbuk.ac.kr 90This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/65/ksrr-27-90.PMC4458488.pdf
"Keywords:  Knee, Magnetic resonance imaging, OveruseOriginal Article Knee Surg Relat Res 2015;27(2):95-100 http://dx.doi.org/10.5792/ksrr.2015.27.2.95 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received August 19, 2014; Revised (1st) October 9, 2014;   (2nd) November 16, 2014; (3rd) January 19, 2015;   (4th) January 27, 2015; Accepted January 28, 2015 Correspondence to: Tae Kyun Kim, MD  Department of Orthopaedic Surgery, Seoul National University Bundang  Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 463-707,  Korea Tel: +82-31-787-7196, Fax: +82-31-787-4056 E-mail: osktk@snubh.org 95This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/c8/ksrr-27-95.PMC4458489.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distributio n, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2015, 7: 27156 - http://dx.doi.org/10.3402/jom.v7.27156 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f9/26/JOM-7-27156.PMC4458513.pdf
"2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2015, 7: 27156 - http://dx.doi.org/10.3402/jom.v7.27156",Non-OADS,/arxiv_data1/oa_pdf/f9/26/JOM-7-27156.PMC4458513.pdf
"The composition of the PCR and cyclingconditions were as in a previously published method (13).Herpesviruses and BS Citation: Journal of Oral Microbiology 2015, 7: 27156 - http://dx.doi.org/10.3402/jom.v7.27156 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f9/26/JOM-7-27156.PMC4458513.pdf
"4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2015, 7: 27156 - http://dx.doi.org/10.3402/jom.v7.27156",Non-OADS,/arxiv_data1/oa_pdf/f9/26/JOM-7-27156.PMC4458513.pdf
"CMV IgG level of expression.Herpesviruses and BS Citation: Journal of Oral Microbiology 2015, 7: 27156 - http://dx.doi.org/10.3402/jom.v7.27156 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f9/26/JOM-7-27156.PMC4458513.pdf
"6 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2015, 7: 27156 - http://dx.doi.org/10.3402/jom.v7.27156",Non-OADS,/arxiv_data1/oa_pdf/f9/26/JOM-7-27156.PMC4458513.pdf
"(c) Negative sample of HHV-8.Herpesviruses and BS Citation: Journal of Oral Microbiology 2015, 7: 27156 - http://dx.doi.org/10.3402/jom.v7.27156 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f9/26/JOM-7-27156.PMC4458513.pdf
"8 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2015, 7: 27156 - http://dx.doi.org/10.3402/jom.v7.27156",Non-OADS,/arxiv_data1/oa_pdf/f9/26/JOM-7-27156.PMC4458513.pdf
http://www.ssi.dk/Vaccination/ Boernevaccination/Boernevaccinationsprogrammet.aspx(accessed 8 March 2015).,Non-OADS,/arxiv_data1/oa_pdf/08/69/bmjopen-2014-007151.PMC4458579.pdf
http://www.cdc.gov/vaccines/schedules/ hcp/imz/child-adolescent.html (accessed 8 March 2015).,Non-OADS,/arxiv_data1/oa_pdf/08/69/bmjopen-2014-007151.PMC4458579.pdf
http://www.immunise.,Non-OADS,/arxiv_data1/oa_pdf/08/69/bmjopen-2014-007151.PMC4458579.pdf
2010. http://www.ssi.,Non-OADS,/arxiv_data1/oa_pdf/08/69/bmjopen-2014-007151.PMC4458579.pdf
http://www.ssi.dk/Smitteberedskab/Sygdomsover vaagning.aspx.,Non-OADS,/arxiv_data1/oa_pdf/08/69/bmjopen-2014-007151.PMC4458579.pdf
27. http://www.statistikbanken.dk.,Non-OADS,/arxiv_data1/oa_pdf/08/69/bmjopen-2014-007151.PMC4458579.pdf
http://www.cancer.dk/forebyg/roegfri/fakta +rygning/Voksnes+rygevaner/.,Non-OADS,/arxiv_data1/oa_pdf/08/69/bmjopen-2014-007151.PMC4458579.pdf
http://www.statistikbanken.dk/statbank5a/ default.asp?w=1440 (accessed 21 November 2012).,OADS,/arxiv_data1/oa_pdf/08/69/bmjopen-2014-007151.PMC4458579.pdf
2012. http://www.danmap.org.,Non-OADS,/arxiv_data1/oa_pdf/08/69/bmjopen-2014-007151.PMC4458579.pdf
http://laegehaandbogen.dk/ore-nese-hals/ tilstande-og-sygdomme/mellemore/mellemorebetendelse-seros- 3531.html 42.,OADS,/arxiv_data1/oa_pdf/08/69/bmjopen-2014-007151.PMC4458579.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-007500).,Non-OADS,/arxiv_data1/oa_pdf/b1/a8/bmjopen-2014-007500.PMC4458580.pdf
"This is particularly important in the current era of reporting and comparing the quality of healthcare, for example, using Hospital Mortality Ratiossuch as the HSMR (hospital standardized mortality ratio), 12 13or the national and international complication registrations for heart surgery in adults (LCRHV; http://www.nvtnet.nl), or the NSQIP .",Non-OADS,/arxiv_data1/oa_pdf/b1/a8/bmjopen-2014-007500.PMC4458580.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-006572).,Non-OADS,/arxiv_data1/oa_pdf/8d/27/bmjopen-2014-006572.PMC4458581.pdf
"Recommendations, Assessment, Development and Evaluation (GRADE)97using the Appraisal of Guidelines for Research and Evaluation (AGREE) format (http://www.agreecollaboration.org).",Non-OADS,/arxiv_data1/oa_pdf/8d/27/bmjopen-2014-006572.PMC4458581.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi: 10.5061/dryad.7s3mt.,OADS,/arxiv_data1/oa_pdf/8d/27/bmjopen-2014-006572.PMC4458581.pdf
"Edinburgh: SIGN, 2001. http://www.sign.ae.",Non-OADS,/arxiv_data1/oa_pdf/8d/27/bmjopen-2014-006572.PMC4458581.pdf
China Guideline Clearinghouse (CGC).http://cgc.bjmu.edu.cn:820/ index.aspx (accessed Jun 2014).,OADS,/arxiv_data1/oa_pdf/8d/27/bmjopen-2014-006572.PMC4458581.pdf
http://www.nsf.gov/statistics/seind02/c7/c7s5.htm#c7s5l2a.2015.2.8 9.,OADS,/arxiv_data1/oa_pdf/8d/27/bmjopen-2014-006572.PMC4458581.pdf
http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM145405.pdf (accessed 8 Feb2015).,Non-OADS,/arxiv_data1/oa_pdf/8d/27/bmjopen-2014-006572.PMC4458581.pdf
Traditional Chinese medicine: an introduction.https://nccih.nih.gov/health/whatiscam/chinesemed.,Non-OADS,/arxiv_data1/oa_pdf/8d/27/bmjopen-2014-006572.PMC4458581.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-007206).,Non-OADS,/arxiv_data1/oa_pdf/fa/66/bmjopen-2014-007206.PMC4458582.pdf
"http://www.cochrane-handbook.org 10 Dragioti E, et al.BMJ Open 2015; 5:e007206.",OADS,/arxiv_data1/oa_pdf/fa/66/bmjopen-2014-007206.PMC4458582.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007200).,Non-OADS,/arxiv_data1/oa_pdf/e9/e1/bmjopen-2014-007200.PMC4458583.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e9/e1/bmjopen-2014-007200.PMC4458583.pdf
"Common Terminology Criteriafor Adverse Events (CTCAE) Version 4.03, 2010. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010 –06–14_QuickReference_5×7.",OADS,/arxiv_data1/oa_pdf/e9/e1/bmjopen-2014-007200.PMC4458583.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 007599).,Non-OADS,/arxiv_data1/oa_pdf/84/b0/bmjopen-2015-007599.PMC4458585.pdf
http://www.folkhalsomyndigheten.se/pagefiles/12920/halsoundersokningar-nyanlanda-invandrare.pdf 18.,Non-OADS,/arxiv_data1/oa_pdf/84/b0/bmjopen-2015-007599.PMC4458585.pdf
"Institute of Population Health, 2012. http://www.folkhalsomyndigheten.se/documents/livsvillkor-levnadsvanor/andts/tobak/uppdrag/nationella-tobaksuppdraget/samverkansprojektet/slutrapport-tobaksprevention-invandrargrupper.pdf 19.",Non-OADS,/arxiv_data1/oa_pdf/84/b0/bmjopen-2015-007599.PMC4458585.pdf
http://www.worldbank.org/en/ country (accessed 7 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/84/b0/bmjopen-2015-007599.PMC4458585.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007140).,Non-OADS,/arxiv_data1/oa_pdf/d2/ae/bmjopen-2014-007140.PMC4458586.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d2/ae/bmjopen-2014-007140.PMC4458586.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-007527).,Non-OADS,/arxiv_data1/oa_pdf/33/d7/bmjopen-2014-007527.PMC4458587.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/33/d7/bmjopen-2014-007527.PMC4458587.pdf
http://www.gene.com/media/press-releases/12827/2010-06-22/fda-approves-lucentis-ranibizumab-inject(accessed 12 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/33/d7/bmjopen-2014-007527.PMC4458587.pdf
2014.http://files.shareholder.com/downloads/REGN/3424387345x0x761325/f94e4471-a4bc-45c9-b44a-a7b6aab4e66b/REGN_News_2014_6_11_General_Releases.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/33/d7/bmjopen-2014-007527.PMC4458587.pdf
http://publications.nice.org.uk/the-guidelines-manual-appendices-bi-pmg6b/appendix-c-methodology-checklist-randomised-controlled-trials (accessed 13 Nov 2014).21.,Non-OADS,/arxiv_data1/oa_pdf/33/d7/bmjopen-2014-007527.PMC4458587.pdf
http://clinicaltrials.gov/show/NCT01599650(accessed 14 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/33/d7/bmjopen-2014-007527.PMC4458587.pdf
http://ClinicalTrials.gov/show/NCT00168324 (accessed14 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/33/d7/bmjopen-2014-007527.PMC4458587.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-007390).,Non-OADS,/arxiv_data1/oa_pdf/04/7f/bmjopen-2014-007390.PMC4458601.pdf
The questionnaires were initially developed in Norwegian and English; these were translated into theother relevant languages and then rolled out via QuestBack (http://www.questback.com/) after being piloted in four countries in order to evaluate its compre-hension and suitability to the national setting.,Non-OADS,/arxiv_data1/oa_pdf/04/7f/bmjopen-2014-007390.PMC4458601.pdf
"Vienna, Austria, 2012. http://www.R-project.org/ 17.",Non-OADS,/arxiv_data1/oa_pdf/04/7f/bmjopen-2014-007390.PMC4458601.pdf
"Evanston, Illinois: Northwestern University, 2013. http://CRAN.R-project.org/package=psych19.",Non-OADS,/arxiv_data1/oa_pdf/04/7f/bmjopen-2014-007390.PMC4458601.pdf
http://www.fda.gov/drugs/developmentapprovalprocess/developmentresources/labeling/ucm093310.htm 20.,Non-OADS,/arxiv_data1/oa_pdf/04/7f/bmjopen-2014-007390.PMC4458601.pdf
http://www.nhs.uk/chq/Pages/917.aspx?CategoryID=54#close 30.,Non-OADS,/arxiv_data1/oa_pdf/04/7f/bmjopen-2014-007390.PMC4458601.pdf
http://www.motherisk.org/women/drugs.jsp 40.,Non-OADS,/arxiv_data1/oa_pdf/04/7f/bmjopen-2014-007390.PMC4458601.pdf
http://www.uktis.org/41.,Non-OADS,/arxiv_data1/oa_pdf/04/7f/bmjopen-2014-007390.PMC4458601.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007171).,Non-OADS,/arxiv_data1/oa_pdf/85/50/bmjopen-2014-007171.PMC4458602.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ References 1.World Health Organisation.,Non-OADS,/arxiv_data1/oa_pdf/91/90/ebmed-2015-110173.PMC4458603.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007532).,Non-OADS,/arxiv_data1/oa_pdf/87/25/bmjopen-2014-007532.PMC4458604.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007526).,Non-OADS,/arxiv_data1/oa_pdf/72/a3/bmjopen-2014-007526.PMC4458605.pdf
"Registers of clinical trials such as ClinicalTrials.gov (htt p://www.clinicaltrials.gov), the Meta Register of Controlled Trials (http://www.controlled-trials.com) and the Chinese Clinical Trial Registry (http://www.chictr.org/cn/) will also be searched.",Non-OADS,/arxiv_data1/oa_pdf/72/a3/bmjopen-2014-007526.PMC4458605.pdf
http://www.gradeworkinggroup.org/publications/index.htm (accessed 11 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/72/a3/bmjopen-2014-007526.PMC4458605.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007079).,Non-OADS,/arxiv_data1/oa_pdf/11/20/bmjopen-2014-007079.PMC4458606.pdf
http://www.euro.who.int/__data/assets/pdf_file/0006/96450/E91732.pdf.,OADS,/arxiv_data1/oa_pdf/11/20/bmjopen-2014-007079.PMC4458606.pdf
"1948 Constitution of the World Health Organization, 2006 http://www.who.int/governance/eb/who_constitution_en.pdf 7. WHO.",Non-OADS,/arxiv_data1/oa_pdf/11/20/bmjopen-2014-007079.PMC4458606.pdf
Geneva: 2004. http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/11/20/bmjopen-2014-007079.PMC4458606.pdf
Updated August2014: http://www.who.int/mediacentre/factsheets/fs220/en/ 13.,Non-OADS,/arxiv_data1/oa_pdf/11/20/bmjopen-2014-007079.PMC4458606.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 007156).,Non-OADS,/arxiv_data1/oa_pdf/9a/bb/bmjopen-2014-007156.PMC4458611.pdf
"The speci ﬁc training for the CFT intervention involved the treating physiotherapists (1) observing CFT-trained tutors (http://www.pain-ed.com) assess and treat real patients with NSCLBP using CFT , and (2)assessing and treating patients with NSCLBP in front of the same CFT tutors.",Non-OADS,/arxiv_data1/oa_pdf/9a/bb/bmjopen-2014-007156.PMC4458611.pdf
"Treating phy- siotherapists were also provided with additional resources to support both the interventions, including written andweb-based resources (eg, http://www.pain-ed.com) regarding the biopsychosocial nature of pain, the limited role of imaging in NSCLBP , and the role of behaviouralchanges such as activity, stress management and sleep hygiene in managing NSCLBP .",Non-OADS,/arxiv_data1/oa_pdf/9a/bb/bmjopen-2014-007156.PMC4458611.pdf
"Where considered appropriate, patients will be advised to read resources and watch patient videos on http://www.pain-ed.com and will be given lea ﬂets on sleep, relax- ation and mindfulness, the role of spinal imaging, such as MRIs, and regarding exercise and physical activity ifthese are considered relevant to their pain presentation by the treating physiotherapist.",Non-OADS,/arxiv_data1/oa_pdf/9a/bb/bmjopen-2014-007156.PMC4458611.pdf
"In addition, all participants will be advised to watch patient videos and read resources on http://www.pain-ed.com, and willreceive the aforementioned lea ﬂets on sleep, relaxation and mindfulness, the role of spinal imaging, such as MRI, and on exercise and physical activity.",Non-OADS,/arxiv_data1/oa_pdf/9a/bb/bmjopen-2014-007156.PMC4458611.pdf
"PO, KO and WD have developed the http://www.pain-ed.com online platform which will be available to support both physiotherapists and patients duringthe study.",Non-OADS,/arxiv_data1/oa_pdf/9a/bb/bmjopen-2014-007156.PMC4458611.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008192).,Non-OADS,/arxiv_data1/oa_pdf/51/71/bmjopen-2015-008192.PMC4458616.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-007352).,Non-OADS,/arxiv_data1/oa_pdf/17/7d/bmjopen-2014-007352.PMC4458627.pdf
Retrieved from: http://eprints.ioe.ac.uk/16381/ 22.,Non-OADS,/arxiv_data1/oa_pdf/17/7d/bmjopen-2014-007352.PMC4458627.pdf
15 Jan 2014.Retrieved from: http://www.oireachtas.ie/parliament/media/committees/healthandchildren/Vol-2-Final-2 –04-14_Part2.pdf 27.,Non-OADS,/arxiv_data1/oa_pdf/17/7d/bmjopen-2014-007352.PMC4458627.pdf
25 Jan 2015. http://www.bbc.com/news/ uk-politics-30926973 41.,Non-OADS,/arxiv_data1/oa_pdf/17/7d/bmjopen-2014-007352.PMC4458627.pdf
Heath Services Executive 2015. http://www.hse.ie/eng/about/Who/TobaccoControl/Research/smokinginireland2014.pdf 42.,Non-OADS,/arxiv_data1/oa_pdf/17/7d/bmjopen-2014-007352.PMC4458627.pdf
Retrieved on 12 Sep 2014. http://www.hse.ie/eng/about/Who/TobaccoControl/Research/ 45.,Non-OADS,/arxiv_data1/oa_pdf/17/7d/bmjopen-2014-007352.PMC4458627.pdf
2007. http://www.raosoft.,Non-OADS,/arxiv_data1/oa_pdf/17/7d/bmjopen-2014-007352.PMC4458627.pdf
Data sharing statement The Norwegian data are freely available at http:// www.ssb.no and http://met.no/english/.,OADS,/arxiv_data1/oa_pdf/3f/05/bmjopen-2014-007403.PMC4458628.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007470).,Non-OADS,/arxiv_data1/oa_pdf/eb/f3/bmjopen-2014-007470.PMC4458630.pdf
"The fundingsource had no role in study design, data collection, data analysis, data interpretation or writing of the report.Competing interests The Department of Pharmacoepidemiology and Clinical Pharmacology employing authors MTB and FdV received unrestricted funding for pharmacoepidemiological research from GlaxoSmithKline, Novo Nordisk, the private –public-funded Top Institute Pharma (http://www.tipharma.nl; includes co-funding from universities, government and industry), the Dutch Medicines Evaluation Board and the Dutch Ministry of Health.",Non-OADS,/arxiv_data1/oa_pdf/eb/f3/bmjopen-2014-007470.PMC4458630.pdf
"Research funding from public-private partnerships, forexample, IMI and TI Pharma (http://www.tipharma.nl), is accepted under the condition that no company-specific product or company related study is conducted.",Non-OADS,/arxiv_data1/oa_pdf/eb/f3/bmjopen-2014-007470.PMC4458630.pdf
"Brussels, Belgium: International Diabetes Federation, 2013.http://www.idf.org/diabetesatlas 2.",Non-OADS,/arxiv_data1/oa_pdf/eb/f3/bmjopen-2014-007470.PMC4458630.pdf
"Lyon, France: International Agency for Research onCancer, 2013. http://globocan.iarc.fr 5.",Non-OADS,/arxiv_data1/oa_pdf/eb/f3/bmjopen-2014-007470.PMC4458630.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007297).,Non-OADS,/arxiv_data1/oa_pdf/8e/0c/bmjopen-2014-007297.PMC4458631.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8e/0c/bmjopen-2014-007297.PMC4458631.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006957).,Non-OADS,/arxiv_data1/oa_pdf/30/89/bmjopen-2014-006957.PMC4458632.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007258).,Non-OADS,/arxiv_data1/oa_pdf/43/62/bmjopen-2014-007258.PMC4458633.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/43/62/bmjopen-2014-007258.PMC4458633.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 006510).,Non-OADS,/arxiv_data1/oa_pdf/a9/74/bmjopen-2014-006510.PMC4458634.pdf
http://www.alter-migration.ch/fileadmin/templates/pdf/Wie_gesund_sind_MigrantInnen_(BAG).pdf.,OADS,/arxiv_data1/oa_pdf/a9/74/bmjopen-2014-006510.PMC4458634.pdf
http://www.unece.org/fileadmin/DAM/stats/publications/CES_2010_Census_Recommendations_English.pdf.,OADS,/arxiv_data1/oa_pdf/a9/74/bmjopen-2014-006510.PMC4458634.pdf
http://www.statistik.at/wcm/idc/idcplg?IdcService=GET_PDF_FILE&RevisionSelectionMethod=LatestReleased&dDocName=029865 21.,OADS,/arxiv_data1/oa_pdf/a9/74/bmjopen-2014-006510.PMC4458634.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 007987).,Non-OADS,/arxiv_data1/oa_pdf/68/f4/bmjopen-2015-007987.PMC4458635.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/68/f4/bmjopen-2015-007987.PMC4458635.pdf
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/ 20.,Non-OADS,/arxiv_data1/oa_pdf/68/f4/bmjopen-2015-007987.PMC4458635.pdf
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma.cfm 21.,OADS,/arxiv_data1/oa_pdf/68/f4/bmjopen-2015-007987.PMC4458635.pdf
Updated 11 August 2014. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma_pas.cfm?t_id=102621&c_id=207#tt (accessed 28 Apr 2014).,OADS,/arxiv_data1/oa_pdf/68/f4/bmjopen-2015-007987.PMC4458635.pdf
"FDA, 2012. http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDRH/CDRHReports/ucm301912.htm 40.",OADS,/arxiv_data1/oa_pdf/68/f4/bmjopen-2015-007987.PMC4458635.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-007959).,Non-OADS,/arxiv_data1/oa_pdf/43/c3/bmjopen-2015-007959.PMC4458680.pdf
17. http://www.escardio.org/congresses/hf2013/congress-to-you/Pages/ vildagliptin-shows-no-adverse-effect-ejection-fraction-diabetic-patients-with-heart-failure.aspx (accessed 18 Nov 2014).18.,Non-OADS,/arxiv_data1/oa_pdf/43/c3/bmjopen-2015-007959.PMC4458680.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007354).,Non-OADS,/arxiv_data1/oa_pdf/12/55/bmjopen-2014-007354.PMC4458683.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 007612).,Non-OADS,/arxiv_data1/oa_pdf/67/cf/bmjopen-2015-007612.PMC4458684.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/67/cf/bmjopen-2015-007612.PMC4458684.pdf
https://www.gov.uk/ government/uploads/system/uploads/attachment_data/file/385733/UK_AMR_annual_report.pdf (accessed Apr 2015).,OADS,/arxiv_data1/oa_pdf/67/cf/bmjopen-2015-007612.PMC4458684.pdf
"1,2Dys, in fact, represent the third most frequent movement disorder after essential tremor (ET) and Parkinson’s disease (PD).3A number of efforts have led to various classification systems of Dys,4–8 attempts to characterize their biological bases,9–13and multiple pro- posals of clinical guidelines for their treatment.14–16However, although important progress has been achieved in understanding some of the neurological bases of Dys, especially in terms of molecular mechanisms17 and genetic causes,18the distinct characteristic neuropathologic features of Dys remain poorly defined19with some very rare exceptions.20,21Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
Fewer Nigral Pigmented Neurons in Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
Fewer Nigral Pigmented Neurons in Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
Fewer Nigral Pigmented Neurons in Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services7,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
Fewer Nigral Pigmented Neurons in Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services8,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services9,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
Fewer Nigral Pigmented Neurons in Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services10,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services11,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
Fewer Nigral Pigmented Neurons in Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services12,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services13,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
Fewer Nigral Pigmented Neurons in Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services14,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services15,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
Fewer Nigral Pigmented Neurons in Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services16,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services17,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
Fewer Nigral Pigmented Neurons in Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services18,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services19,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
Fewer Nigral Pigmented Neurons in Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services20,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services21,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
Fewer Nigral Pigmented Neurons in Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services22,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/tre-05-301-6570-1.PMC4458735.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License ( <http://creativecommons.org/licenses/by-nc/4.0/ >) which permits any non- commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 31, Number 6, 2015Mary Ann Liebert, Inc.DOI: 10.1089/aid.2014.0153 649",Non-OADS,/arxiv_data1/oa_pdf/14/db/aid.2014.0153.PMC4458737.pdf
"In the absence of radiological and histological evidence for occult malignancy and given the initial laboratory ﬁndings, a rarer differential http://dx.doi.org/10.1016/j.gynor.2014.05.005 2211-338X/© 2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/16/4c/main.PMC4458743.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/4c/main.PMC4458743.pdf
The cervix was incompletely excised without representation of the Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gynor.2014.03.002 2211-338X/© 2014 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/5f/f0/main.PMC4458744.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/f0/main.PMC4458744.pdf
http://dx.doi.org/10.1097/01.pas.0000213434.91868.b0 .,Non-OADS,/arxiv_data1/oa_pdf/5f/f0/main.PMC4458744.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gynor.2013.06.0032211-338X/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/89/main.PMC4458745.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/89/main.PMC4458745.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gynor.2014.06.001 2211-338X/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/02/bc/main.PMC4458746.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/bc/main.PMC4458746.pdf
"Therefore, we hypothesized that PVCCA may share common genetic characteristics with CCA arising in http://dx.doi.org/10.1016/j.gynor.2014.05.006 2211-338X/© 2014 The Authors.",OADS,/arxiv_data1/oa_pdf/26/51/main.PMC4458747.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/26/51/main.PMC4458747.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gynor.2014.05.004 2211-338X/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/a4/main.PMC4458748.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/a4/main.PMC4458748.pdf
"78, 30 –40.http://dx.doi.org/10.1016/j.ejrad.",OADS,/arxiv_data1/oa_pdf/d9/a4/main.PMC4458748.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Vitamin D and metabolic control A Sadiya et al 711 © 2015 Macmillan Publishers Limited European Journal of Clinical Nutrition (2015) 707 –711",Non-OADS,/arxiv_data1/oa_pdf/07/fc/ejcn2014251a.PMC4458894.pdf
Supporting information Additional Supporting Information may be found in the online version of this article at the publisher’s web-site: http://dx.doi.org/10.1111/bph.13038 Table S1 Effects of peptide infusion before global ischaemia on recovery of LVDP (in mmHg) during reperfusion of ratisolated perfused heart.BJPCardiometabolic protection by apelin peptides British Journal of Pharmacology (2015) 172 2933–2945 2945,Non-OADS,/arxiv_data1/oa_pdf/bc/fb/bph0172-2933.PMC4459014.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1016/j.nicl.2015.03.0092213-1582/© 2015 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
"Preprocessing of DTI data 3D Slicer ( http://www.slicer.org , version 4) was used to convert the raw data from DICOM format into NRRD format ( Gering et al., 2001 ).",OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
"DTIPrep ( http://www.nitrc.org/projects/dtiprep ) was used to perform quality control ( Liu et al., 2010 ), which included artifact correction/ removal as well as eddy-current and head motion artifacts correction by registration to the baseline image.",OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
"34 (1), 51 –61.http://dx.doi.org/10.1007/ s12031-007-0029-018157658 .",Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1002/ 1522-2594(200010)44:4 b625::AID-MRM17 N3.0.CO;2-O11025519 .821 Z. Chen et al.,OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1093/brain/awp20619690094 .,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1093/neuonc/nor18822015596 .,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1016/j.cortex.2008.04.00218614162 .,OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1016/j.cortex.2008.05.00418619589 .,OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1016/S1474- 4422(08)70163-718635020 .,OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1109/TMI.2008.,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1111/j.1528-1167.2009.02421.x20002151 .,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
"81 (1), 56 –58.http://dx.doi.org/ 10.1016/j.wneu.2013.01.11623376386 .",OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1227/NEU.0b013e318203628221135719 .,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1016/j.wneu.2013.,OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.3171/2012.10.JNS12180023540267 .,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.01.08320132894 .,OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/ 10.1093/brain/awu11324951631 .,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1523/JNEUROSCI.2388-08.200818987180 .,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1002/jmri.113911382961 .,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1227/NEU.0b013e3182061ebb21135713 .,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
"2, 156. http://dx.doi.org/10.3389/fpsyg.2011.0015621779271 .",Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1089/brain.2011.003322433046 .,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
Insight J. http://hdl.handle.net/1926/ 1291.,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1007/s00429-012- 0498-y23288254 .,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1016/j.neuroimage.2004.07.07615784421 .,OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.4236/ jbise.2013.6202325328583 .,OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1093/neuonc/noq19721297125 .,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
Proc Soc Photo Opt Instrum Eng 7628. http://dx.doi.org/10.1117/12.84474824353379 .,OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1109/TMI.2010.,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
"121 (2), 349 –358.http://dx.doi.org/10.3171/2014.",Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1007/s00415-008-0005-918821045 .,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.3174/ajnr.,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1016/j.wneu.2013.08.03524007693 .,OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1227/01.neu.0000279214.00139.3b18813171 .,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1016/j.neuroimage.2013.,OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1016/0028-3932(71)90067- 45146491 .,OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/ 10.1002/mrm.2205519623619 .,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1016/j.mri.2010.10.00521277725 .,OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.11.01516427322 .,OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
http://dx.doi.org/10.1002/mrm.2292421469191 .,Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
"Radiology 230 (1), 77 –87.http://dx.doi.org/ 10.1148/radiol.230102164014645885 .",Non-OADS,/arxiv_data1/oa_pdf/6a/4f/main.PMC4459040.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/j.nicl.2015.03.015 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
"2.4. fMRI preprocessing During each fMRI run, individual images in which the fMRI signal exceeded plus or minus four standard deviations from the mean for the run were considered to be outliers and were replaced by the mean of the two nearest neighbors using the Analysis of Functional NeuroImages (AFNI) ( Cox, 1996 )s o f t w a r ec o m m a n d “3dDespike ” (http://afni.nimh.nih.gov/afni/ ).",Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1111/j.1369-1600.2012.00497.x22978709 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1002/hbm.2134721901794 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/ 10.1016/j.pharmthera.2006.08.00417049611 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1097/FBP.0b013e328345f90d21499079 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1097/ FBP.0b013e3283305ea219696658 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1093/brain/awg06712566291 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/j.drugalcdep.2011.05.,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1523/JNEUROSCI.0864-05.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1038/4603510647008 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/ S0079-6123(08)00916-318772040 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
"25 (1), 35 –45.http://dx.doi.org/10.1002/hbm.2012815846821 .",Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1038/ nrn347523571845 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
"Neural Circuits 8, 58. http://dx.doi.org/10.3389/fncir.2014.0005824966814 .",OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
"Psy- chiatry 20 (3), 255 –261.http://dx.doi.org/10.1097/YCO.0b013e3280ba498917415079 .",Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1097/YCO.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
"213 (1), 39 –46.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1371/ journal.pone.000114317989775 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
"121 (1 – 2), 45 –53.http://dx.doi.org/10.1016/j.drugalcdep.2011.08.",OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1002/(SICI)1096- 9861(19990628)409:2 b187::AID-CNE2 N3.0.CO;2-P10379914 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
"37 (1), 11 –23.http://dx.doi.org/10.1016/j.neubiorev.2012.",OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/j.neuron.2011.,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/j.physd.2009.08.00219862351 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
"6, 103. http://dx.doi.org/10.3389/fncom.2012.0010323346055 .",Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.04.06122579726 .845 L. Ma et al.,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
"J .N e u r o s c i .3 2( 1 ) ,1 2 –20.http://dx.doi.org/10.1523/JNEUROSCI.3405-11.",Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/j.neuroimage.2009.03.03319327402 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1523/JNEUROSCI.,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/S0006-8993(00)02062-X10802024 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1093/brain/awr13821690575 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/ 10.1016/j.neubiorev.2010.03.00120223263 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/S0376- 8716(01)00206-X12062461 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1038/npp.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/S1053-8119(03)00202-712948688 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.12.,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.03.06221459150 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1007/s11065-007-9034- x17680368 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1124/pr.114.00951425505168 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1002/syn.8900102042463687 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1002/mrm.108111283987 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1523/JNEUROSCI.,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1038/sj.npp.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/j.drugalcdep.2006.,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/j.neuroscience.2007.02.06417467185 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1007/ PL000050759349630 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1089/brain.2014.026424999822 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1002/ hbm.2132921692148 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1002/hbm.2221223151990 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1126/science.288.5472.183510846167 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/S1053-8119(03)00169- 112880848 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.3109/00952990.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/ 10.3389/fpsyt.2014.0001624578695 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/ 10.1016/0740-5472(92)90062- S1334156 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.3109/00952990.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/S0740-5472(01)00202-111777668 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/S0926-6410(03)00144- 712880912 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1007/s00213-014-3709-925138647 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/S0306-4522(01)00593-011955720 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/ 10.1016/j.conb.2013.01.01823395462 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1006/nimg.2001.100511848715 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/S0166-4328(03)00156-614659579 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/0169-328X(94)90223- 28028479 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
",2 0 1 2 .N e u r o c o g n i t i v e endophenotypes of impulsivity and compulsivity: towards dimensional psy- c h i a t r y .T r e n d sC o g n .S c i .1 6( 1 ) ,8 1 –91.http://dx.doi.org/10.1016/j.tics.2011.",Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1093/ cercor/bhh07015115744 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
4. http://dx.doi.org/10.3389/fnsys.2010.0014220838471 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/j.neuropsychologia.,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1523/JNEUROSCI.4766-06.200717392467 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/j.neuroimage.2009.11.01519914382 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
"http://dx.doi.org/10.1016/j.neuroimage.2011.02.07021376819 .Tomasi, D., Goldstein, R.Z., Telang, F., Maloney, T., Alia-Klein, N., Caparelli, E.C., Volkow, N.D., 2007.",OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
"1171, 83 –92.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1093/brain/awh64316195242 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1006/nimg.2001.097811771995 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
"1542, 56 –69.http://dx.doi.org/ 10.1016/j.brainres.2013.10.01724505625 .",OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1111/j.1369-1600.2012.00472.x22784032 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1016/j.neubiorev.2007.11.00318295884 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/ 10.1016/j.addbeh.2006.06.03216876962 .,OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
"5 (1), 67 –73.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1196/annals.1401.02417846162 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1111/j.1530-0277.2010.01215.,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.3109/00952990.2013.84821124200210 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
http://dx.doi.org/10.1037/a002909222775772 .,Non-OADS,/arxiv_data1/oa_pdf/af/b6/main.PMC4459041.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/e2/main.PMC4459042.pdf
http://dx.doi.org/10.1016/j.nicl.2015.03.001 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/e2/main.PMC4459042.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/e2/main.PMC4459042.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b6/e2/main.PMC4459042.pdf
"http://dx.doi.org/10.1097/00004728-198308000-000086602820 .B u e n t j e n ,L .",Non-OADS,/arxiv_data1/oa_pdf/b6/e2/main.PMC4459042.pdf
"92 (1), 25 –30.http://dx.doi.org/10.1159/ 00035152524216749 .",Non-OADS,/arxiv_data1/oa_pdf/b6/e2/main.PMC4459042.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b6/e2/main.PMC4459042.pdf
http://dx.doi.org/10.1097/00004728- 199607000-000318708076 .,Non-OADS,/arxiv_data1/oa_pdf/b6/e2/main.PMC4459042.pdf
http://dx.doi.org/10.1111/j.1528-1167.2010.02536.,Non-OADS,/arxiv_data1/oa_pdf/b6/e2/main.PMC4459042.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b6/e2/main.PMC4459042.pdf
http://dx.doi.org/10.1111/j.0013-9580.2004.,Non-OADS,/arxiv_data1/oa_pdf/b6/e2/main.PMC4459042.pdf
http://dx.doi.org/10.1159/00033999122922474 .,Non-OADS,/arxiv_data1/oa_pdf/b6/e2/main.PMC4459042.pdf
http://dx.doi.org/10.1093/brain/ awl12716720681 .,Non-OADS,/arxiv_data1/oa_pdf/b6/e2/main.PMC4459042.pdf
http://dx.doi.org/10.1159/00032334321336007 .,Non-OADS,/arxiv_data1/oa_pdf/b6/e2/main.PMC4459042.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b6/e2/main.PMC4459042.pdf
http://dx.doi.org/10.3171/ jns.2004.101.2.018115309906 .,OADS,/arxiv_data1/oa_pdf/b6/e2/main.PMC4459042.pdf
http://dx.doi.org/10.3174/ajnr.,Non-OADS,/arxiv_data1/oa_pdf/b6/e2/main.PMC4459042.pdf
"Corrigendum Corrigendum to “Statistical normalization techniques for magnetic resonance imaging ” [NeuroImage: Clinical 6 (2014) 9 –19] Russell T. Shinoharaa,⁎, Elizabeth M. Sweeneyb,c, Jeff Goldsmithd,N a v i dS h i e ee,F a r r a hJ .M a t e e nf, Peter A. Calabresig,S a m s o nJ a r s oh, Dzung L. Phame,D a n i e lS .R e i c hb,c,g,h, Ciprian M. Crainiceanuc, for the Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing1, and the Alzheimer's Disease Neuroimaging Initiative2 aDepartment of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA 19104, USA bTranslational Neurology Unit, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, B ethesda, MD 20892, USA cDepartment of Biostatistics, Johns Hopkins University, Baltimore, MD 21205, USA dDepartment of Biostatistics, Columbia University, New York, NY 10032, USA eCenter for Neuroscience and Regenerative Medicine, Henry M. Jackson Foundation, Bethesda, MD 20892, USA fDepartment of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA gDepartment of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA hDepartment of Radiology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA In the initially published version of this article, the af ﬁliation of one author was incorrect: Ciprian Crainiceanu is Professor in the Department of Biostatistics, Johns Hopkins University, Baltimore, MD 21205, USA.NeuroImage: Clinical 7 (2015) 848 DOI of original article: http://dx.doi.org/10.1016/j.nicl.2014.08.008 .",Non-OADS,/arxiv_data1/oa_pdf/6e/21/main.PMC4459043.pdf
A comp lete listing of ADNI investigators can be found at: http://adni.loni.ucla.edu/wpcontent/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf .,OADS,/arxiv_data1/oa_pdf/6e/21/main.PMC4459043.pdf
Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl http://dx.doi.org/10.1016/j.nicl.2015.02.011 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/21/main.PMC4459043.pdf
"6, 86 –92.NeuroImage: Clinical 7 (2015) 18 DOI of original article: http://dx.doi.org/10.1016/j.nicl.2014.08.016 .",Non-OADS,/arxiv_data1/oa_pdf/37/0a/main.PMC4459047.pdf
Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl http://dx.doi.org/10.1016/j.nicl.2014.10.001 Open access under CC BY-NC-ND license.,Non-OADS,/arxiv_data1/oa_pdf/37/0a/main.PMC4459047.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1016/j.nicl.2015.03.010 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
"Emotional faces were obtained from the KDEF databank( http://www.emotionlab.se/resources/kdef ) and included male and female Caucasian faces expressing one of seven emotions (sad, happy, disgusted, fear, surprised, angry, neu- tral).",OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1016/j.schres.2004.01.00415329307 .,OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1016/j.neuron.2010.09.02321040841 .,OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
"157 (1 –3), 40 –47.http://dx.doi.org/10.1016/j.schres.2014.",OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1016/j.ijpsycho.2009.10.,OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/ 10.1177/107385840326211115070487 .,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1016/j.schres.2014.06.03425086658 .,OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
"Psychiatry 12, 64. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
"http://dx.doi.org/10.1093/schbul/sbt232 .Fisher, M., Subramaniam, K., Panizzutti, R., Vinogradov, S., 2013.",Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1523/JNEUROSCI.4813- 13.2014 .,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1017/ S003329171000060720380784 .,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1111/j.1469-8986.2005.00299.x16008770 .,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
"6, 74.http://dx.doi.org/10.3389/fnhum.2012.0007422514527 .",Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1038/sj.mp.400155815263907 .,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
"4, 186. http://dx.doi.org/10.3389/fnhum.",Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.4088/JCP.9101tx3c .,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1093/schbul/ 13.2.261 .,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1016/j.jneurometh.,OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.3389/fnhum.2014.0038525018719 .,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1037/a001470819413446 http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1146/annurev- clinpsy-05212-18554023297790 .,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1001/archgenpsychiatry.2009.,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1016/j.neuropharm.2013.004.,OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
"2011, 156869. http://dx.doi.org/10.1155/2011/15686921253357 .",Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1038/nature0505116929307 .,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1523/JNEUROSCI.2763-122013223554483 .,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1371/journal.pone.003905122815697 .,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.3758/s13415-013-0194- 223943514 .,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1016/j.nicl.2014.08.,OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1021/j.schres.,OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1093/ oxfordjournals.schbul.a00712215954183 .,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1176/appi.ajp.2010.0907105920634366 .,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1016/j.cub.2012.10.,OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1093/schbul/ sbn06218562344 .,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1038/ nrn277420087360 .,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1093/cercor/ bht11323645711 .,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
http://dx.doi.org/10.1176/appi.ajp.2010.1006085521406461 .,Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
"J Abnorm Psychol 119 (1), 31 –39.http://dx.doi.org/10.1037/ a001826520141240 .814 T.G.",Non-OADS,/arxiv_data1/oa_pdf/9b/29/main.PMC4459048.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0 ).,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1016/j.nicl.2014.12.007 2213-1582/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0 ).,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
Brainstorm is a documented and freely available package downloaded online under a GNU general public license ( http://neuroimage.usc.edu/brainstorm/ ).,OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
Additional information about CIFASD can be found at http://cifasd.org/.,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
"Lancet 2 (8517), 1222. http://dx.doi.org/10.1016/S0140-6736(86)92234- 82877359 .",OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.11.08022178817 .,OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
"http://dx.doi.org/10.1503/cmaj.104030215738468 .Church, M.W., 1987.",Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1016/0741-8329(87) 90017-63620090 .,OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
"36 (1), 83 –96.http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/ 10.1016/j.alcohol.2012.01.00322572057 .,OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1109/42.,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
"Neuroimage 53 (1), 1 –15.http://dx.doi.org/10.1016/j.neuroimage.2010.06.",OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1016/j.ijpsycho.,OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
Cor- texhttp://dx.doi.org/10.1093/cercor/bhu16225092900 .,OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1111/acer.1213223551175 .,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1016/S0013-4694(97)00119-39741777 .,OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1371/journal.pone.005134423227262 .,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1523/JNEUROSCI.2825-10.201021084608 .,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.3389/ fnhum.2010.0018621119777 .,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
"20 (1), 35 –42.http://dx.doi.org/10.1111/j.1530-0277.1996.tb01040.x8651459 .",Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
"98 (1), 20–28.http://dx.doi.org/10.1016/0013-4694(95)00189-18689990 .",Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1016/j.tics.2012.10.,OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1002/ddrr.,OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1007/s11065-011-9163-021369875 .,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1016/ S0304-3940(97)13361-49111741 .,OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1111/acer.,OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1037/0894- 4105.12.1.1469460742 .,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1002/ddrr.6819731384 .,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1111/acer.1201723094678 .,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1016/0028-3932(71)90067- 45146491 .,OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
"8, 199. http://dx.doi.org/10.3389/fnins.2014.0019925100931 .",Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1016/j.clinph.2007.04.01917573239 .,OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
"21 (2), 73 –80.http://dx.doi.org/10.1007/s11065-011- 9166-x21499711 .",Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1007/s11065-010- 9150-x20978945 .,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
"Hippocampus 24, 54 –64.http://dx.doi.org/10.1002/ hipo.2220323996604 .",Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1615/CritRevNeurobiol.v14.i3-4.2012645958 .,OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1111/j.1530-0277.,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1109/IEMBS.,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1111/j.1530-0277.2012.01769.x22458372 .,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
"8 (329), 329. http://dx.doi.org/10.3389/fnhum.2014.0032924904369 .",Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1088/0031-9155/51/7/00816552102 .,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1016/0304-3940(91)90486-D1745412 .,OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1523/JNEUROSCI.5004-12.201323761905 .,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
"2, 73. http://dx.doi.org/10.3389/ fpsyg.2011.0007321687444 .",Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1007/s11065-011-9162-121347880 .,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1016/j.heares.2005.11.01016459037 .,OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
http://dx.doi.org/10.1093/cercor/ bhr19321799209 .587 C.D.,Non-OADS,/arxiv_data1/oa_pdf/ca/f3/main.PMC4459049.pdf
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1016/j.nicl.2014.02.009 2213-1582/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
We obtained averaged positive Zscores in the target VOIs with MRIcron ( http://www.mccauslandcenter.sc.edu/ mricro/mricron/ ).,OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1002/mds.1045912722160 .,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1002/ana.1057012833363 .,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1212/WNL.46.4.9228780065 .,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1002/mds.2053616092076 .,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1212/WNL.55.9.136811087783 .,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1001/archneur.55.5.,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.3174/ajnr.A172119833793 .,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1007/s00234-007- 0265-617632713 .,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1212/ WNL.54.3.69710680806 .,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1007/s00702-002-0785-512589575 .,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/ 10.1212/01.wnl.0000203342.77115.bf16567726 .,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
"Ar- chives of Neurology 63, 81 –86.http://dx.doi.org/10.1001/archneur.63.1.8116401739 .Josephs, K.A., Whitwell, J.L., Dickson, D.W., et al., 2008.",Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.07.00717761438 .,OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/ 10.1007/s00234-013-1138-923322456 .,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1111/j.1600-0404.1999.tb07345.x10100966 .,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.3174/ajnr.A161519589886 .,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1093/brain/awn195 Pubmed: 18819991 .,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1212/WNL.,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1093/brain/awr19821908872 .,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1007/s12031-011-9533-321556732 .,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1016/S0002-9440(10)61154-612057909 .,OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1212/01.,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1111/j.1460- 9568.2010.07304.x20597976 .,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1002/mds.2496822488922 .,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1111/ene.1221223746093 .,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1148/ radiol.245306170317991785 .,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/ 10.1212/WNL.48.1.1199008506 .,Non-OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
http://dx.doi.org/10.1093/brain/awq12320584946 .610 K. Sakurai et al.,OADS,/arxiv_data1/oa_pdf/72/8f/main.PMC4459051.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/be/main.PMC4459076.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2015) 27, 75–80 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2014.11.007 1013-9052 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/81/be/main.PMC4459076.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/be/main.PMC4459076.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2015) 27, 55–56 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2014.11.008 1013-9052 ª2015 The Author.",Non-OADS,/arxiv_data1/oa_pdf/0a/1a/main.PMC4459077.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0a/1a/main.PMC4459077.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/bf/main.PMC4459094.pdf
"This hypothesis arises from the observations of the amino terminal sequences from the processed proteins by this enzyme, before and after the oct1 action, and, from the direct analysis of the stability of three known http://dx.doi.org/10.1016/j.fob.2015.05.004 2211-5463/ /C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/be/bf/main.PMC4459094.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: Abz, ortho -aminobenzoic acid; EDDnp, N-(2,4-dinitrophenyl)-et hylenediamine; FRET, ﬂuorescence resonance energy transfer; hMIP, human mitochondrial intermediate peptidase; HOBt, hydroxybenzotriazole; TBTU,O-(benzotriazol-1-yl)- N,N,N 0,N0-tetramethyluronium tetraﬂuoroborate; NMM, N-methylmorpholine; DMF, dimethylformamide; DIPEA, N,N- diisopropylethylamine; DCM, dichloromethane ⇑Corresponding authors at: Universidade Federal de São Paulo (UNIFESP), Department of Biophysics, Rua Pedro de Toledo, 669, Enzymology Laboratory –7th Floor, São Paulo, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/be/bf/main.PMC4459094.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2015.05.004 .M.F.M.",OADS,/arxiv_data1/oa_pdf/be/bf/main.PMC4459094.pdf
"Acta 1819, 1098–1106, http://dx.doi.org/10.1016/j.bbagrm.2011.11.007 S1874-9399(11)00213-6[pii].",OADS,/arxiv_data1/oa_pdf/be/bf/main.PMC4459094.pdf
"Cell 139, 428–439, http://dx.doi.org/10.1016/ j.cell.2009.07.045 S0092-8674(09)01032-0 [pii] .",OADS,/arxiv_data1/oa_pdf/be/bf/main.PMC4459094.pdf
"1Epidemiology and HealthEpidemiology and Health Volume: 37, Article ID: e2015017, 5 pages  http://dx.doi.org/10.4178/epih/e2015017   ORIGINAL ARTICLEOpen Access Intestinal obstruction: predictor of poor prognosis in colorectal  carcinoma?",Non-OADS,/arxiv_data1/oa_pdf/04/40/epih-37-e2015017.PMC4459110.pdf
"In the present study, we assessed the  prognosis of colorectal carcinoma patients with and without in -Correspondence:  Mohd Azri Mohd Suan Clinical Research Center, Sultanah Bahiyah Hospital, 05640 Alor Setar,  Kedah, Malaysia Tel: +60-134395159, Fax: +60-47407373, E-mail: irzah96@yahoo.com Received:  Jan 5, 2015, Accepted:  Mar 30, 2015, Published:  Mar 30, 2015 This article is available from: http://e-epih.org/  2015, Korean Society of Epidemiology  This is an open-access article distributed under the terms of the Creative Commons  Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits  unrestricted use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/40/epih-37-e2015017.PMC4459110.pdf
Available from: http://globocan.iarc.fr/ Default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/04/40/epih-37-e2015017.PMC4459110.pdf
Available from: http://www.moh.gov.my/images/gallery/ Report/Cancer/MalaysiaCancerStatistics_2006.pdf.,Non-OADS,/arxiv_data1/oa_pdf/04/40/epih-37-e2015017.PMC4459110.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/4a/main.PMC4459113.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2015) 27, 99–104 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2014.11.004 1013-9052 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/57/4a/main.PMC4459113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/4a/main.PMC4459113.pdf
"Materials and methods This cross-sectional study was conducted over a 6-month per- iod from March to August 2013 in Riyadh, Kingdom of SaudiArabia, using a self-administered, two-page structured questionnaire derived from the Global Tobacco Survey (http://www.cdc.gov/tobacco/gl obal/gats/questionnaire/index.htm [updated 25 May 2009, accessed June 2009]).",OADS,/arxiv_data1/oa_pdf/57/4a/main.PMC4459113.pdf
http://dx.doi.org/10.2147/ IJGM.S48630 .,Non-OADS,/arxiv_data1/oa_pdf/57/4a/main.PMC4459113.pdf
http://dx.doi.org/ 10.4103/1817-1737.65044 .,Non-OADS,/arxiv_data1/oa_pdf/57/4a/main.PMC4459113.pdf
http://dx.doi.org/ 10.1159/000092181 .,Non-OADS,/arxiv_data1/oa_pdf/57/4a/main.PMC4459113.pdf
http://dx.doi.org/ 10.1007/s13187-013-0527-4 .,Non-OADS,/arxiv_data1/oa_pdf/57/4a/main.PMC4459113.pdf
http://dx.doi.org/10.4103/0019- 509X.63873 .,Non-OADS,/arxiv_data1/oa_pdf/57/4a/main.PMC4459113.pdf
http://dx.doi.org/ 10.1111/j.1600-051X.2005.00786.x .,Non-OADS,/arxiv_data1/oa_pdf/57/4a/main.PMC4459113.pdf
"210 (7), E10.http://dx.doi.org/10.1038/sj.bdj.2011.241 .",Non-OADS,/arxiv_data1/oa_pdf/57/4a/main.PMC4459113.pdf
"3 (1), 88– 101.http://dx.doi.org/10.1902/annals.1998.3.1.88 .",Non-OADS,/arxiv_data1/oa_pdf/57/4a/main.PMC4459113.pdf
"6 (1), 19. http://dx.doi.org/10.1038/ sj.ebd.6400297 .",Non-OADS,/arxiv_data1/oa_pdf/57/4a/main.PMC4459113.pdf
http://dx.doi.org/10.1016/j.oraloncology.2004.08.010 .,Non-OADS,/arxiv_data1/oa_pdf/57/4a/main.PMC4459113.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4a/ae/main.PMC4459114.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2015) 27, 81–87 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2014.11.002 1013-9052 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/4a/ae/main.PMC4459114.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4a/ae/main.PMC4459114.pdf
http://dx.doi.org/ 10.1111/joor.12230 [Epub ahead of print].,Non-OADS,/arxiv_data1/oa_pdf/4a/ae/main.PMC4459114.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/8b/main.PMC4459115.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2015) 27, 88–92 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2014.11.012 1013-9052 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/e9/8b/main.PMC4459115.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/8b/main.PMC4459115.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2015) 27, 93–98 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2014.10.003 1013-9052 ª2015 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/20/d1/main.PMC4459116.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/d1/main.PMC4459116.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/d1/main.PMC4459116.pdf
From < http://www.who.int/oralhealth/publica- tions/orh_cdoe05_vol33.pdf.,Non-OADS,/arxiv_data1/oa_pdf/20/d1/main.PMC4459116.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/1e/main.PMC4459117.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2015) 27, 105–111 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2014.11.003 1013-9052 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/4f/1e/main.PMC4459117.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/1e/main.PMC4459117.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/17/main.PMC4459118.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2015) 27, 70–74 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2014.11.006 1013-9052 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/10/17/main.PMC4459118.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/17/main.PMC4459118.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2015) 27, 63–69 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2014.11.005 1013-9052 ª2015 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/f7/a6/main.PMC4459119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/a6/main.PMC4459119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/a6/main.PMC4459119.pdf
",2010]archivedinthePlanetaryDataSystem (LOLA/PDS Data Node, http://imbrium.mit.edu).",OADS,/arxiv_data1/oa_pdf/a6/8a/grl0041-3367.PMC4459178.pdf
Localizedcorrelations were computed usingthe freely available SHTOOLS library (http://shtools.ipgp.fr).,OADS,/arxiv_data1/oa_pdf/a6/8a/grl0041-3367.PMC4459178.pdf
[Available at http://go.nature.com/VbldYY.],Non-OADS,/arxiv_data1/oa_pdf/4b/23/grl0042-1205.PMC4459179.pdf
"(b) Area-averaged sub-surface temperature anomalies i n the subtropical North Atlantic (5–82°W, 26.5 –41°N) calculated relative to the 1991 –2010 seasonal cycle using monthly means from the EN3 v2a griddedobjective analysis of quality-controlled subsurface tem-perature observations [ Ingleby and Huddleston , 2007], (http://www.metof ﬁce.gov.uk/hadobs/en3/).",Non-OADS,/arxiv_data1/oa_pdf/3c/00/grl0040-6202.PMC4459181.pdf
"Data from the RAPID-MOC/MOCHA array are funded by theNatural Environment Research Council (NERC) and National ScienceFoundation (NSF), and are freely available from http://www.rapid.ac.uk/rapidmoc.",OADS,/arxiv_data1/oa_pdf/3c/00/grl0040-6202.PMC4459181.pdf
"Florida Current transport estimates are funded by the National Oceanic and Atmospheric Administration (NOAA), and are availablefrom http://www.aoml.noaa.gov/phod/ ﬂoridacurrent.",OADS,/arxiv_data1/oa_pdf/3c/00/grl0040-6202.PMC4459181.pdf
[Available at http://gmao.gsfc.nasa.gov/pubs/tm/.],Non-OADS,/arxiv_data1/oa_pdf/24/c5/grl0041-3282.PMC4459184.pdf
"In addition, the data usedto produce the ﬁgures are available at http://dx.doi.org/10.1594/PANGAEA.",OADS,/arxiv_data1/oa_pdf/37/57/grl0042-1459.PMC4459193.pdf
[Available at http://mitgcm.org/public/r2_manual/latest/online_documents/manual.html.],Non-OADS,/arxiv_data1/oa_pdf/37/57/grl0042-1459.PMC4459193.pdf
LPSC E-Poster at http://www.lpi.usra.edu/meetings/lpsc2013/eposter/ 1712.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b0/24/grl0040-6033.PMC4459194.pdf
"1Epidemiology and HealthEpidemiology and Health Volume: 37, Article ID: e2015020, 5 pages  http://dx.doi.org/10.4178/epih/e2015020   REVIEWOpen Access Antimicrobial properties of nanomolecules: potential  candidates as antibiotics in the era of multi-drug resistance Venkataramana Kandi1, Sabitha Kandi2 1Department of Microbiology, Prathima Institute of Medical Sciences, Karimnagar; 2Department of Biochemistry, Chalmeda Anand Rao Institute  of Medical Sciences, Karimnagar, India OBJECTIVES:  The emergence of multi-drug resistance among various microbial pathogens has been a cause  of serious concern to the medical world, limiting the choice of antibiotics.",Non-OADS,/arxiv_data1/oa_pdf/5e/1c/epih-37-e2015020.PMC4459197.pdf
"Physiochemical properties of nanomolecules antimicrobial Correspondence:  Venkataramana Kandi  Department of Microbiology, Prathima Institute of Medical Sciences,  Nagunur, Karimnagar 505 417, India Tel: +91-8728222779, Fax: +91-8728222779   E-mail: ramana_20021@rediffmail.com Received:  Feb 1, 2015, Accepted:  Apr 17, 2015, Published:  Apr 17, 2015 This article is available from: http://e-epih.org/  2015, Korean Society of Epidemiology  This is an open-access article distributed under the terms of the Creative Commons  Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits  unrestricted use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/1c/epih-37-e2015020.PMC4459197.pdf
Available from: http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/  scenihr_o_003b.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5e/1c/epih-37-e2015020.PMC4459197.pdf
",2010],archivedinthePlanetaryDataSystem(LOLA/Lunar ReconnaissanceOrbiterRadioSciencePlanetaryDataSystemDataNode,http://imbrium.mit.edu).Theplan-etaryradiationpressure,includingthereﬂectedsolar radiationduetothelunaralbedo,andtheradiation fromthelunarthermalemissionaremodeledasdescribedin Lemoine et al.",OADS,/arxiv_data1/oa_pdf/b9/fd/grl0041-3382.PMC4459205.pdf
"Kruizinga, G., W. Bertiger, and N. Harvey (2012), Timing of science data for the GRAIL mission, JPL D-75620 , Jet Propulsion Laboratory, California Institute of Technology, Pasadena, Calif. [Available at http://pds-geosciences.wustl.edu/grail/grail-l-lgrs-3-cdr-v1/grail_0 101/ document/grail_timing.pdf.]",OADS,/arxiv_data1/oa_pdf/b9/fd/grl0041-3382.PMC4459205.pdf
The GRAIL Level 1B data used in this study are available from the Geo- sciences Node of the Planetary DataSystem http://pds-geosciences.wustl.edu/missions/grail/default.htm.,OADS,/arxiv_data1/oa_pdf/b9/fd/grl0041-3382.PMC4459205.pdf
"Willmott air temperature (University of Delaware) datawere provided by the NOAA/OAR/ESRL PSD, Boulder, Colorado, USA, from their Web site at http://www.esrl.noaa.gov/psd/.",OADS,/arxiv_data1/oa_pdf/6e/e3/grl0041-0128.PMC4459216.pdf
http://www.museunacional.ufrj.br/mndi/Aracnologia/opiliones.html.,Non-OADS,/arxiv_data1/oa_pdf/37/5f/cla0031-0202.PMC4459239.pdf
"Mesquite: a modular system for evolutionary analysis, Version 2.75. http://mesquiteproject.org Omland, K.E., 1999.",Non-OADS,/arxiv_data1/oa_pdf/37/5f/cla0031-0202.PMC4459239.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1016/j.nicl.2015.02.010 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
"Circulation 107 (1), 68 –73.http://dx.doi.org/10.1161/01.",Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1523/JNEUROSCI.1103-13.,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/ 10.1378/chest.103.6.17638404098 .,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1164/ajrccm.154.5.89127708912770 .,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1113/expphysiol.2013.07751124887112 .,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1152/jn.,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1002/(SICI)1096- 9861(20000207)417:2 b195::AID-CNE5 N3.0.CO;2-V10660897 .,OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1152/japplphysiol.00881.200212514164 .,OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
"R e s p i r .J .8( 2 ) ,2 2 2 –229.http://dx.doi.org/10.1183/09031936.95.080202227758555 .",Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1152/jn.00107.200212466462 .,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/ 10.1152/japplphysiol.00852.200314565965 .,OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
"NeuroImage 70, 59–65.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1371/journal.pone.008252524358198 .,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1186/rr7911737928 .,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/ 10.1164/rccm.200201-050OC12421746 .,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1016/j.resp.2003.09.00214609516 .,OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
"168 (1 –2), 72 –81.http://dx.doi.org/10.1016/j.autneu.2012.01.00922342370 .",OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1161/01.HYP.32.6.10399856970 .,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1046/j.1365-201X.2003.,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1001/jama.,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1002/ (SICI)1096-9861(19981130)401:4 b480::AID-CNE4 N3.3.CO;2-69826274 .,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
"47 (5), 513 –519.http://dx.doi.org/10.1001/archneur.1990.005300500290082185720 .",Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1056/NEJM20000511342190110805822 .,OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1152/japplphysiol.91539.200820185626 .,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1002/cne.,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1016/S0034-5687(00)00126-210963773 .,OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1016/S0006-8993(00)02170- 310869520 .,OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1164/ajrccm.153.4.86165638616563 .,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1097/00001756- 200110290-0001811711862 .,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1016/j.neuroimage.2006.12.02717291781 .,OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1016/S0006-8993(97)00284-99237541 .,OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1016/S0006-8993(00)02068-010773190 .,OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
http://dx.doi.org/10.1016/S0006-8993(00)01990-910760486 .806 R.H. Fatouleh et al.,OADS,/arxiv_data1/oa_pdf/7c/9a/main.PMC4459270.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2015) 27, 57–62 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2014.11.011 1013-9052 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/71/58/main.PMC4459275.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/58/main.PMC4459275.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/58/main.PMC4459275.pdf
Available at:<http://www.ada.org/en/coda/current-accreditation-standards/ > (accessed 01.05.14).,Non-OADS,/arxiv_data1/oa_pdf/71/58/main.PMC4459275.pdf
Available at: < https://drive.google.com/fold- erview?id=0B3-LU4_uuUKsdDlxX1p4S0Z4TVk&usp=sharing& tid=0B3-LU4_uuUKseWFDZTI0RHpRM0U > (accessed 01.06.14).,Non-OADS,/arxiv_data1/oa_pdf/71/58/main.PMC4459275.pdf
"The clinical importance of this behavioral and cognitive overlap has beenhighlighted by changes to the upcoming DSM-V, which allowsco-diagnosis of ADHD and ASD ( http://www.dsm5.org ).",Non-OADS,/arxiv_data1/oa_pdf/5f/37/bht365.PMC4459282.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/37/bht365.PMC4459282.pdf
Total scan- ning time was 1 h. fMRI Image Analysis The XBAM software package was used ( http://www.brainmap.co.uk ; Brammer et al.,OADS,/arxiv_data1/oa_pdf/5f/37/bht365.PMC4459282.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/54/bht429.PMC4459289.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attributio n Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduc tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/42/ddv118.PMC4459392.pdf
Web-based tools and databases Retnet-Retinal Information Network (http://www.sph.uth.tmc.edu/Retnet/) OMIM (http://www.ncbi.nlm.nih.gov/omim) The 1000 genomes database (http://www.1000genomes.org/)EVS NHLBI Exome Sequencing Project (ESP) Exome VariantServer (http://evs.gs.washington.edu/EVS/) dbSNP (http://www.ncbi.nlm.nih.gov/SNP/) PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/)Mutation Taster (http://www.mutationtaster.org/)Analyzer Splice Tool (http://ibis.tau.ac.il/ssat/SpliceSiteFrame.,OADS,/arxiv_data1/oa_pdf/41/42/ddv118.PMC4459392.pdf
htm)Human Splicing Finder Version 3.0 (http://www.umd.be/ HSF3/) Ensembl genome browser (http://www.ensembl.org/index.html)CADD (http://cadd.gs.washington.edu/)Ocular Tissue Database (https://genome.uiowa.edu/otdb/) Human Retinal Transcriptome (http://oculargenomics.meei.,OADS,/arxiv_data1/oa_pdf/41/42/ddv118.PMC4459392.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/3f/ddv128.PMC4459396.pdf
One crite - rion for assessing the effectiveness of a screening programme is that ‘There should be evidence from high quality Randomised Con- trolled T rials that the screening programme is effective in re ducing mortality or morbidity’ ( http://www.screening.nhs.uk/criteria ).,Non-OADS,/arxiv_data1/oa_pdf/0c/1f/CD010866-0001.PMC4459401.pdf
Searching trials registers: •WHO International Clinical T rials Registry Platform (ICTRP) portal ( http://apps.who.int/trialsearch/ ): inception to present.,OADS,/arxiv_data1/oa_pdf/0c/1f/CD010866-0001.PMC4459401.pdf
•ClinicalT rials.gov ( http://clinicaltrials.gov/ ): inception to present.,Non-OADS,/arxiv_data1/oa_pdf/0c/1f/CD010866-0001.PMC4459401.pdf
Searching for grey literature in System for Information on Grey Literature in Europe “OpenGrey” ( http://www.opengrey.eu/ ): in- ception to present.,Non-OADS,/arxiv_data1/oa_pdf/0c/1f/CD010866-0001.PMC4459401.pdf
"Handsearching conference proceeding abstracts from the fol- lowing events: •The International Society for Sexually T ransmitted Disease s Research - ISSTDR ( http://www.isstdr.org/ ): 2007, 2009 and 2011.",Non-OADS,/arxiv_data1/oa_pdf/0c/1f/CD010866-0001.PMC4459401.pdf
"•The British Association for Sexual Health and HIV - BASHH ( http://www.bashh.org/ ): 2004, 2006, 2007 and 2009.",Non-OADS,/arxiv_data1/oa_pdf/0c/1f/CD010866-0001.PMC4459401.pdf
•International Congress on Infectious Diseases - ICID ( http://www.isid.org/ ): 2010 and 2012.,Non-OADS,/arxiv_data1/oa_pdf/0c/1f/CD010866-0001.PMC4459401.pdf
•The International Union against Sexually T ransmitted Infections - IUSTI ( http://www.iusti.org/ ): 2011 and 2012.,Non-OADS,/arxiv_data1/oa_pdf/0c/1f/CD010866-0001.PMC4459401.pdf
"•International Meeting on Emerging Diseases and Surveillance - IMED ( http://www.isid.org/ ): 2007, 2009 and 2011.",Non-OADS,/arxiv_data1/oa_pdf/0c/1f/CD010866-0001.PMC4459401.pdf
•Interscience Conference on Antimicrobial Agents and Chemotherapy - ICAAC ( http://www.icaac.org/ ): 2011 and 2012.,Non-OADS,/arxiv_data1/oa_pdf/0c/1f/CD010866-0001.PMC4459401.pdf
"http://publications.nice.org.uk/pmg6 , London: National Institute of Health and Care Excellence, November 2012:21–4.",Non-OADS,/arxiv_data1/oa_pdf/0c/1f/CD010866-0001.PMC4459401.pdf
"http://www.racgp.org.au/redbook/static/index.htm,.",OADS,/arxiv_data1/oa_pdf/0c/1f/CD010866-0001.PMC4459401.pdf
"He  has  been  a  grantee  of  the http://dx.doi.org/10.1016/j.bjhh.2015.04.001 1516-8484/© 2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/ce/d8/main.PMC4459432.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.02.002 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/b2/b5/main.PMC4459433.pdf
Available from:  http://www.who.int/nutrition/topics/ida/en/ 4.,Non-OADS,/arxiv_data1/oa_pdf/b2/b5/main.PMC4459433.pdf
"Hb  F  is  produced by a  fraction  of  RBCs  denominated  F-cells,  which  contain  vari- able  concentrations  of  Hb  F.4Studies  suggest  that  when  F-cells contain around  10  pg  of  Hb  F  there  is  complete  inhibition  of polymer  formation  even  when  oxygen  saturation  is  from  40% to 70%.5F-cells  are  RBCs  that  have  a  much  longer  survival than  non-F-cells,  with  their  survival  being  related  to  their  Hb F  content:  the  higher  the  Hb  F  content  the  longer  the  life  span of F-cells.6The  survival  of  non-F-cells  is  inversely  correlated DOI  of  original  article:  http://dx.doi.org/10.1016/j.bjhh.2015.01.008 .",Non-OADS,/arxiv_data1/oa_pdf/2c/88/main.PMC4459434.pdf
"An  observational  multicen- ter  study  of  415  SCA  patients  who  were  followed-up  for  a median of  2.4  years  reported  that  patients  with  an  hemolytic component  (assessed  by  measuring  LDH,  aspartate  amino- transferase, total  bilirubin  and  reticulocyte  count)  in  the  upper tertile presented over  three  times  greater  risk  of  death  (Haz- ard  ratio  of  3.44).8Furthermore,  the  hemolytic  component was positively  associated  with  higher  systemic  pulse  pressure, serum  N-terminal  pro-brain  natriuretic  peptide  (NT -proBNP) concentration, tricuspid  regurgitation  velocity  and  several other  cardiac  side  effects.8There  was  also  an  inverse  correla- tion  between  the  rate  of  hemolysis  and  oxygen  saturation  as measured by  pulse  oximetry,  which  persisted  after  adjustment http://dx.doi.org/10.1016/j.bjhh.2015.03.015 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/2c/88/main.PMC4459434.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.03.013 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/0e/5d/main.PMC4459435.pdf
Available from: http://www.pnud.org.br/atlas/ranking/ Ranking-IDHM-UF-2010.aspx  [cited 30.01.15].,OADS,/arxiv_data1/oa_pdf/0e/5d/main.PMC4459435.pdf
"After  recognizing http://dx.doi.org/10.1016/j.bjhh.2015.03.001 1516-8484/©  2015  Associac ¸ão  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/cd/34/main.PMC4459437.pdf
Available  at:  http://bvsms.saude.gov.br/bvs/ saudelegis/anvisa/2014/rdc0034 11  06  2014.pdf 8.,Non-OADS,/arxiv_data1/oa_pdf/cd/34/main.PMC4459437.pdf
Available from: http://www.shotuk.org/wp-content/uploads/2012/07/ SHOT -ANNUAL-REPORT FinalWebVersionBookmarked 2012  06  22.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/cd/34/main.PMC4459437.pdf
Available  from: http://www.jrc.or.jp/vcms  lf/anzen  HVreport2008  en.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/cd/34/main.PMC4459437.pdf
Available  from:http://www.lifesci.dundee.ac.uk/services/ﬂow  Cytometry/ ca/celldeath 25.,Non-OADS,/arxiv_data1/oa_pdf/cd/34/main.PMC4459437.pdf
"This  result  in  an  improvement  of  the  circulatory competence  of  these  cells,  a  reduction  of  hemolysis,  and  a DOI  of  original  article:  http://dx.doi.org/10.1016/j.bjhh.2015.03.010 .",Non-OADS,/arxiv_data1/oa_pdf/7d/38/main.PMC4459467.pdf
"These  authors studied four patients  with  an  Hb  A  concentration  above  38% and  a  very  mild  form  of  the  disease,  and  identiﬁed  two  muta- tions  for  the  ﬁrst  time  in  the  Brazilian  population.16It  is important to  point  out  that  these  cases  could  be  wrongly  inter- preted  as  sickle  cell  trait,  since  they  had  no  anemia,  despite http://dx.doi.org/10.1016/j.bjhh.2015.02.008 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/7d/38/main.PMC4459467.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.02.001 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/50/a3/main.PMC4459468.pdf
Available  from: http://www.sbn.org.br/pdf/censo 2013-14-05.pdf  [cited 31.10.14].,Non-OADS,/arxiv_data1/oa_pdf/50/a3/main.PMC4459468.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.03.011 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/41/2a/main.PMC4459471.pdf
"Laboratoire Ge ´nome, Populations, Interactions, CNRS UMR 5000, Universite ´de Montpellier II, Montpellier (France) [available on inter- net at http://www.genetix.univ-montp2.fr/genetix/genetix.",Non-OADS,/arxiv_data1/oa_pdf/d5/1d/10750_2011_Article_698.PMC4459472.pdf
"Department of Physics, Canisius College, Buffalo [avail- able on internet at http://www3.canisius.edu/ *sheets/ morphsoft.html ].",Non-OADS,/arxiv_data1/oa_pdf/d5/1d/10750_2011_Article_698.PMC4459472.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.01.008 1516-8484/©  2015  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC4459481.pdf
"In  January  2014, after  completing  treatment  for  the  infections,  she  was  sub- mitted  to  chemotherapy  induction  using  the  hyperCVAD http://dx.doi.org/10.1016/j.bjhh.2015.03.008 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/f7/4b/main.PMC4459482.pdf
"Chil- dren  had  hemoglobin  FSA  patterns  diagnosed  by  isoelectric focusing  and  high-performance  liquid  chromatography  in  the Newborn Screening  Program  and  have  been  followed  up  since http://dx.doi.org/10.1016/j.bjhh.2015.03.010 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/b2/0c/main.PMC4459483.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.02.006 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/47/6e/main.PMC4459484.pdf
"Received 19 September 2014 Accepted 25  February  2015 Available  online  15  April  2015 http://dx.doi.org/10.1016/j.bjhh.2015.03.012 1516-8484/©  2015 Associac ¸ã o Brasileira  de  Hematologia, Hemoterapia e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/df/84/main.PMC4459485.pdf
"The  molecular  structure  of  the  Indian  deletion- inversion [G/H9253(A/H9253/H9254/H9252 )0-thal]  is  caused  by  a  major  rearrangement http://dx.doi.org/10.1016/j.bjhh.2014.12.002 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/eb/6f/main.PMC4459486.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/Translational Medicine: Bench to Bedside 3 Clinical and Translational Gastroenterology",Non-OADS,/arxiv_data1/oa_pdf/1b/c9/ctg201512a.PMC4459531.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Clinical and Trans lational Gastroenterology website ( http://www.nat ure.com/ctg)DNA Hypomethylation in H. pylori -Associated Gastritis and Gastric Cancer Leodolter et al.",Non-OADS,/arxiv_data1/oa_pdf/91/fe/ctg201514a.PMC4459532.pdf
Accessed 29 December 2014; http://www.abim.org/pdf/pass-rates/cert.pdf.,Non-OADS,/arxiv_data1/oa_pdf/65/9a/ctg20156a.PMC4459533.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Gut Instincts: My Perspective 2 Clinical and Translational Gastroenterology",Non-OADS,/arxiv_data1/oa_pdf/65/9a/ctg20156a.PMC4459533.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Editorial 2 Clinical and Translational Gastroenterology",Non-OADS,/arxiv_data1/oa_pdf/bc/de/ctg20151a.PMC4459535.pdf
The Internal Medicine Milestone Project http://www.acgme.org/acgmeweb/Portals/0/PDFs/Milestones/InternalMedicineMilestones.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/4a/ctg20154a.PMC4459536.pdf
The Internal Medicine Subspecialty Milestones Project http://www.acgme.org/acgmeweb/Portals/0/PDFs/Milestones/InternalMedicineSubspecialtyMilestones.pdf Accessed 12 January 2015.,Non-OADS,/arxiv_data1/oa_pdf/80/4a/ctg20154a.PMC4459536.pdf
wiley.com/doi/10.1111/nmo.12392/full; http://gi.org/wp-content/uploads/2014/06/EPA_for_ Gastroenterology_Fellowship_Training.pdf.11.,Non-OADS,/arxiv_data1/oa_pdf/80/4a/ctg20154a.PMC4459536.pdf
http://www.gastro.org/2007_Version_Core_Curriculum.pdf Accessed12 January 2015.,Non-OADS,/arxiv_data1/oa_pdf/80/4a/ctg20154a.PMC4459536.pdf
http://www.ownyourfellowship.org Accessed 12 January 2015.,Non-OADS,/arxiv_data1/oa_pdf/80/4a/ctg20154a.PMC4459536.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c3/c8/vhrm-11-283.PMC4459540.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 283–295Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  283ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S5563 0Angiotensin receptor-neprilysin inhibitors:   clinical potential in heart failure and beyond Jagdeep SS Singh Chim C Lang Division of Cardiovascular and  Diabetes Medicine, Ninewells  Hospital and Medical School,  University of Dundee, Dundee, UK Correspondence: Chim C Lang   Division of Cardiovascular and   Diabetes Medicine, Ninewells   Hospital and Medical School,   DD1 9SY, Dundee, UK   Fax +44 13 8249 6378  email c.c.lang@dundee.ac.u k.Abstract:  Heart failure remains a major concern across the globe as life expectancies and  delivery of health care continue to improve.",Non-OADS,/arxiv_data1/oa_pdf/c3/c8/vhrm-11-283.PMC4459540.pdf
"Available from:  http://www.cardiorentis.com/de/rd/true-ahf.ph p. Accessed January  26,  2015.",Non-OADS,/arxiv_data1/oa_pdf/c3/c8/vhrm-11-283.PMC4459540.pdf
Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2013/20920s033lbl.pd f.  52.,Non-OADS,/arxiv_data1/oa_pdf/c3/c8/vhrm-11-283.PMC4459540.pdf
Available from: http://www.medscape.com/viewarticle/   83229 0.,Non-OADS,/arxiv_data1/oa_pdf/c3/c8/vhrm-11-283.PMC4459540.pdf
Available from: http://www.isrctn.com/ISRCTN1195899 3.,Non-OADS,/arxiv_data1/oa_pdf/c3/c8/vhrm-11-283.PMC4459540.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/c3/c8/vhrm-11-283.PMC4459540.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/c8/vhrm-11-283.PMC4459540.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/c5/64/mtna201459a.PMC4459545.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/4e/04/mtna201460a.PMC4459546.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/d6/0c/mtna201462a.PMC4459548.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2014 |  90  | e51644 | Page 1 of 17Video Article Analysis of Nephron Composition and Function in the Adult Zebrafish Kidney Kristen K. McCampbell1, Kristin N. Springer1, Rebecca A. Wingert1 1Department of Biological Sciences, University of Notre Dame Correspondence to: Rebecca A. Wingert at rwingert@nd.edu URL: http://www.jove.com/video/51644 DOI: doi:10.3791/51644 Keywords: Cellular Biology, Issue 90, zebrafish; kidney; nephron; nephrology; renal; regeneration; proximal tubule; distal tubule; segment; mesonephros; physiology; acute kidney injury (AKI) Date Published: 8/9/2014 Citation: McCampbell, K.K., Springer, K.N., Wingert, R.A.",Non-OADS,/arxiv_data1/oa_pdf/4f/31/jove-90-51644.PMC4459603.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51644/ Introduction The kidney is a complex organ that fulfills a multitude of physiological functions in the body.,Non-OADS,/arxiv_data1/oa_pdf/4f/31/jove-90-51644.PMC4459603.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c4/43/opth-9-967.PMC4459608.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 967–970Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  967Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S7642 0Delusional infestation: are you being bugged?,Non-OADS,/arxiv_data1/oa_pdf/c4/43/opth-9-967.PMC4459608.pdf
"He denied a history of illicit drug use or exposure to unusual  chemicals.Correspondence: Minas Coroneo Department of Ophthalmology,  prince of Wales Hospital, Barker street,  randwick, NsW 2031, australia email m.coroneo@unsw.edu.a u Journal name: Clinical Ophthalmology Article Designation: Case report Y ear: 2015 Volume: 9 Running head verso: Thakkar et al Running head recto: Delusional infestation DOI: http://dx.doi.org/10.2147/OPTH.S76420",Non-OADS,/arxiv_data1/oa_pdf/c4/43/opth-9-967.PMC4459608.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/c4/43/opth-9-967.PMC4459608.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/43/opth-9-967.PMC4459608.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b6/cb/ott-8-1315.PMC4459609.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 1315–1319OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1315Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8015 9Bevacizumab plus cisplatin and helical  tomotherapy in treatment of locally advanced  nasopharyngeal carcinoma Jianxiong li1,* Zhifei Zhao1,* Xuan Wu1,* Jie Yao2,* lin Ma1 rui Ye1 Baolong niu1 lanqing liang1 Xiao Zhao1 Qianqian Wang1 1radiology Department, cancer  center, The general hospital  of the People’s liberation army,   Beijing, People’s republic of  china; 2Department of Oncology,   The People’s liberation army  161 hospital, Wuhan, People’s  republic of china *These authors contributed equally  to this workBackground:  In recent years, chemotherapy, radiotherapy, and targeted drugs have been  respectively used in nasopharyngeal carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/b6/cb/ott-8-1315.PMC4459609.pdf
"Some trials have demonstrated that combining correspondence: Jianxiong li The general hospital of the People’s  liberation army, 28 Fuxing road, Beijing  100853, People’s republic of china email jianxiogl@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Li et al Running head recto: Bevacizumab plus cisplatin and helical tomotherapy DOI: http://dx.doi.org/10.2147/OTT.S80159",Non-OADS,/arxiv_data1/oa_pdf/b6/cb/ott-8-1315.PMC4459609.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b6/cb/ott-8-1315.PMC4459609.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/cb/ott-8-1315.PMC4459609.pdf
"Available from: http://www.nccn.org/professionals/physi - cians_gls/pdf/head-and-nec k. Accessed May 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b6/cb/ott-8-1315.PMC4459609.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/32/11/dddt-9-2839.PMC4459610.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2839–2846Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2839Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7315 0cost-effectiveness analysis of lamivudine,  telbivudine, and entecavir in treatment of chronic  hepatitis B with adefovir dipivoxil resistance guiliang Wang1,2 Yan liu2 Ping Qiu1 shu-Feng Zhou3,4 linfang Xu1 Ping Wen1 Jianbo Wen1 Xianzhong Xiao5 1Department of Digestive internal  Medicine, gannan Medical University  Pingxiang hospital, Pingxiang, People’s  republic of china; 2Department of  Digestive internal Medicine, 307  hospital of P la, Beijing, People’s  republic of china; 3Department of  Pharmaceutical sciences, college of  Pharmacy, University of south Florida,   Tampa, Fl, Usa; 4guizhou Provincial  Key laboratory for regenerative  Medicine, stem cell and Tissue  engineering research center and  sino-U s Joint laboratory for Medical  sciences, guiyang Medical University,   guiyang, People’s republic of china;   5laboratory of shock, Department  of Pathophysiology, Xiangya school  of Medicine, central south University,   changsha, People’s republic of chinaAbstract:  The purpose of this study was to analyze the cost-effectiveness of lamivudine (LMV),  telbivudine (LdT), and entecavir (ETV) in treatment of chronic hepatitis B with adefovir dipivoxil  (ADV) resistance.",Non-OADS,/arxiv_data1/oa_pdf/32/11/dddt-9-2839.PMC4459610.pdf
"The ratio of therapy with ADV for 1-3  years associatied with mutations in the polymerase (particularly in N236T or N181T)  is about 0%, 1.6%, and 3.1%, respectively.13 If the HBV develops a mutant, ADV is correspondence: Xianzhong Xiao Department of Pathophysiology, Xiangya  school of Medicine, central south  University, 110 Xiangya road, changsha  410008, hunan, People’s republic  of china Tel +86 731 2355019 Fax +86 731 2355019 email csxianzhongxiaoxy@126.co mJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Wang et al Running head recto: Lamivudine, telbivudine, and entecavir in adefovir dipivoxil resistance DOI: http://dx.doi.org/10.2147/DDDT.S73150",Non-OADS,/arxiv_data1/oa_pdf/32/11/dddt-9-2839.PMC4459610.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/32/11/dddt-9-2839.PMC4459610.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/11/dddt-9-2839.PMC4459610.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/55/7b/ott-8-1285.PMC4459611.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1285–1289OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1285Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8264 9sudden bilateral hearing loss in gastric cancer   as the only symptom of disease Zoran rakusic1 ana Misir Krpan1 Darija stupin polancec2 antonia Jakovcevic3 Vesna Bisof1 1Department of Oncology, University  Hospital Center Zagreb, 2Fidelta  Ltd for research and Development,   3Department of p athology, University  Hospital Center Zagreb, Zagreb,   CroatiaAbstract:  This paper reports a case of sudden bilateral deafness as the first symptom of gastric  cancer, an extremely rare and atypical clinical situation.",Non-OADS,/arxiv_data1/oa_pdf/55/7b/ott-8-1285.PMC4459611.pdf
"Standard laboratory tests were normal as well as neurological Correspondence: Zoran rakusic Department of Oncology, University  Hospital Center Zagreb, Kispaticeva 12,  10 000 Zagreb, Croatia Tel +385 98 350 391 Fax +385 1 2388 583 email zrakusic@kbc-zagreb.h rJournal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2015 Volume: 8 Running head verso: Rakusic et al Running head recto: Bilateral hearing loss in gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S82649",OADS,/arxiv_data1/oa_pdf/55/7b/ott-8-1285.PMC4459611.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/55/7b/ott-8-1285.PMC4459611.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/55/7b/ott-8-1285.PMC4459611.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/7f/cia-10-919.PMC4459612.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 919–930Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  919RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5430 4epidemiology and management of chronic  constipation in elderly patients Maria vazquez Roque ernest P Bouras Gastroenterology and Hepatology  Department, Mayo Clinic, Jacksonville,   FL, USAAbstract:  Constipation is a common functional gastrointestinal disorder, with prevalence in  the general population of approximately 20%.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cia-10-919.PMC4459612.pdf
"Epidemiologic studies demonstrate a  higher prevalence laxative use in the elderly,3,7–10 and elderly patients residing in nurs - ing homes have a greater prevalence of constipation (up to 50%), with up to 74% of  them using daily laxatives.4,10,11Correspondence: ernest P Bouras Gastroenterology and Hepatology  Department, Mayo Clinic, 4500 San Pablo  Road, Jacksonville, FL 32224, USA Tel +1 904 953 2594 Fax +1 904 953 6225 email bouras.ernest@mayo.ed u Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Roque and Bouras Running head recto: Constipation and the elderly DOI: http://dx.doi.org/10.2147/CIA.S54304",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cia-10-919.PMC4459612.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cia-10-919.PMC4459612.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/70/7f/cia-10-919.PMC4459612.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ff/0c/copd-10-1027.PMC4459613.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1027–1033International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1027OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8174 8lobe-based computed tomography assessment  of airway diameter, airway or vessel number,  and emphysema extent in relation to the clinical  outcomes of COPD Kazuyoshi Kurashima1 Y otaro Takaku1 T oshiko hoshi2 T etsu Kanauchi2 Keitaro nakamoto1 noboru Takayanagi1 Tsutomu Yanagisawa1 Yutaka sugita1 Y oshinori Kawabata3 1respiratory Medicine, 2radiology,   3Pathology, saitama Cardiovascular  and respiratory Center, saitama, JapanObjective:  The aim of this study was to evaluate the relationship between computed tomography  assessed lobe-based lung parameters and the clinical outcomes of patients with chronic  obstructive pulmonary disease (COPD), including the frequency of exacerbation and annual  change in forced expiratory volume in 1 second (FEV1).",Non-OADS,/arxiv_data1/oa_pdf/ff/0c/copd-10-1027.PMC4459613.pdf
lg.jpJournal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Kurashima et al Running head recto: CT images and clinical outcomes of COPD DOI: http://dx.doi.org/10.2147/COPD.S81748,Non-OADS,/arxiv_data1/oa_pdf/ff/0c/copd-10-1027.PMC4459613.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ff/0c/copd-10-1027.PMC4459613.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/0c/copd-10-1027.PMC4459613.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ff/6b/dddt-9-2819.PMC4459614.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2819–2829Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2819Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8306 7neuroprotective and antioxidant effects of ghrelin  in an experimental glaucoma model nagehan can1 Onur catak2 Burak T urgut2 Tamer Demir2 nevin ilhan3 T uncay Kuloglu4 ibrahim hanifi Ozercan5 1Department of Ophthalmology,   Elazıg ˘ Training and Research Hospital,   2Department of Ophthalmology,   3Department of Biochemistry,   4Department of histology and  embryology, 5Department of  Pathology, School of Medicine, Fırat  University, Elazıg ˘, T urkeyAbstract:  Damage to retinal ganglion cells due to elevation of intraocular pressure (IOP) is  responsible for vision loss in glaucoma.",Non-OADS,/arxiv_data1/oa_pdf/ff/6b/dddt-9-2819.PMC4459614.pdf
"Studies in rat eyes correspondence: Onur catak Department of Ophthalmology, school  of Medicine, Fırat University, 23119  Elazıg ˘, Turkey Tel +90 42 4233 3555 Fax +90 42 4238 8096 email dronurcatak@gmail.co mJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Can et al Running head recto: Neuroprotective and antioxidant effects of ghrelin in glaucoma DOI: http://dx.doi.org/10.2147/DDDT.S83067",Non-OADS,/arxiv_data1/oa_pdf/ff/6b/dddt-9-2819.PMC4459614.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ff/6b/dddt-9-2819.PMC4459614.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/6b/dddt-9-2819.PMC4459614.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/93/67/copd-10-985.PMC4459615.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 985–993International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  985OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8092 6Prognostic factors for clinical failure of  exacerbations in elderly outpatients with  moderate-to-severe COPD robert Wilson1 antonio anzueto2 Marc Miravitlles3 Pierre arvis4 Daniel haverstock5 Mila Trajanovic6 sanjay sethi7 1host Defence Unit, royal Brompton  hospital, london, UK; 2University of  Texas health science Center, south  T exas Veterans health Care system,   san antonio, TX, Usa; 3Pneumology  Department, hospital Universitari Vall  d’hebron, CIB er de enfermedades  respiratorias (CIBeres), Barcelona,   spain; 4Bayer healthCare  Pharmaceuticals, loos, France;   5Bayer healthCare Pharmaceuticals,   Whippany, nJ, Usa; 6Bayer healthCare  Pharmaceuticals, T oronto, On ,   Canada; 7University at Buffalo, Buffalo,   nY, UsaBackground:  Acute exacerbations represent a significant burden for patients with moderate-to- severe chronic obstructive pulmonary disease.",Non-OADS,/arxiv_data1/oa_pdf/93/67/copd-10-985.PMC4459615.pdf
"Keywords:  AECOPD, clinical failure, prognostic factor, long-term outcome, poor outcome Introduction Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are the most  common causes of hospitalization and death among severe COPD (chronic obstruc - tive pulmonary disease) patients, with frequent exacerbations leading to a more rapid  decline in lung function and prolonged time to recovery to previous health status as  well as reducing 5-year survival.1–5 To improve survival and reduce costs, clinicians  must be able to identify individuals at the highest risk for poor outcomes so that effec - tive interventions can be implemented.Correspondence: robert Wilson host Defence Unit, royal Brompton  hospital, sydney street, london  sW3 6nP, UK Tel +44 20 7351 8337 Fax +44 20 7351 8338 email r.wilson@rbht.nhs.u k Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Wilson et al Running head recto: Prognostic factors for clinical failure in AECOPD DOI: http://dx.doi.org/10.2147/COPD.S80926",Non-OADS,/arxiv_data1/oa_pdf/93/67/copd-10-985.PMC4459615.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/93/67/copd-10-985.PMC4459615.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/67/copd-10-985.PMC4459615.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6d/b4/ijwh-7-565.PMC4459616.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 565–580International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  565RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S7324 4Sclerostin inhibition: a novel therapeutic approach  in the treatment of osteoporosis Arti D Shah1 Dolores Shoback1,2 e Michael Lewiecki3,4 1Division of endocrinology and  Metabolism, Department of Medicine,  University of California, San Francisco,  CA, USA; 2endocrine Research Unit,  Department of Medicine, veterans  Affairs Medical Center, San Francisco,  CA, USA; 3University of New Mexico  School of Medicine, Albuquerque, NM,  USA; 4New Mexico Clinical Research &  Osteoporosis Center, Albuquerque,  NM, USAAbstract:  Osteoporosis and osteoporosis-related fractures are growing problems with the  aging population and are associated with significant morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/6d/b4/ijwh-7-565.PMC4459616.pdf
"The most common cause of osteoporosis is estrogen deficiency in postmenopausal  women, who typically have a high rate of bone remodeling with an imbalance of bone Correspondence: e Michael Lewiecki New Mexico Clinical Research &  Osteoporosis Center, 300 Oak Street,  Ne Albuquerque, NM 87106, USA Tel +1 505 938 2117 Fax +1 505 884 4006 email mlewiecki@gmail.co m Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2015 Volume: 7 Running head verso: Shah et al Running head recto: Sclerostin inhibition for the treatment of osteoporosis DOI: http://dx.doi.org/10.2147/IJWH.S73244",Non-OADS,/arxiv_data1/oa_pdf/6d/b4/ijwh-7-565.PMC4459616.pdf
"Available from: http://www.iofbonehealth.org/ facts-statistic s. Accessed February 11, 2015.",OADS,/arxiv_data1/oa_pdf/6d/b4/ijwh-7-565.PMC4459616.pdf
"Available from:  http://www.shef.ac.uk/FRAX/pdfs/WHO_Technical_Report.pd f.  Accessed February 11, 2015.",OADS,/arxiv_data1/oa_pdf/6d/b4/ijwh-7-565.PMC4459616.pdf
Available from: http://nof.org/articles/23 5.,Non-OADS,/arxiv_data1/oa_pdf/6d/b4/ijwh-7-565.PMC4459616.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/6d/b4/ijwh-7-565.PMC4459616.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/b4/ijwh-7-565.PMC4459616.pdf
"Avail - able from: http://clinicaltrials.gov/ct2/results?term =romosozumab&   Search=Searc h. Accessed February 11, 2015.",OADS,/arxiv_data1/oa_pdf/6d/b4/ijwh-7-565.PMC4459616.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/89/29/ijn-10-3815.PMC4459617.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 3815–3827International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3815OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8254 3Mesoporous bioactive glass surface modified  poly(lactic-co-glycolic acid) electrospun fibrous  scaffold for bone regeneration Abstract:  A mesoporous bioactive glass (MBG) surface modified with poly(lactic-co-glycolic  acid) (PLGA) electrospun fibrous scaffold for bone regeneration was prepared by dip-coating a  PLGA electrospun fibrous scaffold into MBG precursor solution.,Non-OADS,/arxiv_data1/oa_pdf/89/29/ijn-10-3815.PMC4459617.pdf
"There are many approaches to building bone scaffolds, but electrospinning is very  simple and produces highly porous (90%) products that offer interconnected pores Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Chen et al Running head recto: Bioactive glass surface electrospun scaffold for bone regeneration DOI: http://dx.doi.org/10.2147/IJN.S82543 shijie chen,1,* Zhiyuan Jian,2,*  linsheng huang,2,* Wei Xu,3,*  shaohua liu,4 Dajiang song,3  Zongmiao Wan,3 amanda  Vaughn,5 ruisen Zhan,1  chaoyue Zhang,1 song Wu,1  Minghua hu,6 Jinsong li1 1Department of Orthopaedics, The  Third Xiangya hospital of central south  University, changsha, hunan, People’s  republic of china; 2The First general  surgery Department of shiyan Taihe  hospital affiliated to hubei University  of Medicine, shiyan, People’s republic  of china; 3Department of Orthopedic  Oncology, changzheng hospital, The  second Military Medical University,   shanghai, People’s republic of china;   4Department of spine surgery, Xiangya  hospital of central south University,   changsha, hunan, People’s republic  of china; 5Department of Molecular  Biosciences, Institute of cellular and  Molecular Biology, The University  of T exas at austin, austin, TX, Usa;   6Department of anthropotomy,   changsha Medical college, changsha,   hunan, People’s  republic of china *These authors contributed equally  to this work correspondence: Jinsong li  Department of Orthopaedics, The Third  Xiangya hospital of central south  University, changsha, hunan, 410013,  People’s republic of china Tel +86 731 8861 8026 email jinsongli.1982@gmail.co m Minghua hu Department of anthropotomy,  changsha Medical college, changsha,  hunan, 410219, People’s republic of china Tel +86 731 8880 8731 email 111tiger@sina.co m",Non-OADS,/arxiv_data1/oa_pdf/89/29/ijn-10-3815.PMC4459617.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/89/29/ijn-10-3815.PMC4459617.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/89/29/ijn-10-3815.PMC4459617.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bf/bb/idr-8-163.PMC4459619.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2015:8 163–172Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  163RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S6959 6Efinaconazole in the treatment of onychomycosis Shari R Lipner Richard K Scher Department of Dermatology, Weill  Cornell Medical College, New York,  NY, USA Correspondence: Shari R Lipner   Department of Dermatology, Weill  Cornell Medical College,  1305 York  Avenue, New York, NY  10021, USA   Tel +1 646 962 3376  email shl9032@med.cornell.ed uAbstract:  Efinaconazole  10% topical solution is a new triazole recently approved for the   treatment of onychomycosis.",Non-OADS,/arxiv_data1/oa_pdf/bf/bb/idr-8-163.PMC4459619.pdf
Available from: http://www.ama-assn.,Non-OADS,/arxiv_data1/oa_pdf/bf/bb/idr-8-163.PMC4459619.pdf
Available from: http://www.accessdata.fda.gov/drug - satfda_docs/label/2014/203567s000lbl.pd f.  24.,Non-OADS,/arxiv_data1/oa_pdf/bf/bb/idr-8-163.PMC4459619.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/bf/bb/idr-8-163.PMC4459619.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/bb/idr-8-163.PMC4459619.pdf
Available from:  http://www.kaken.co.jp/english/rd_pipeline.htm l.  58.,Non-OADS,/arxiv_data1/oa_pdf/bf/bb/idr-8-163.PMC4459619.pdf
Available from: http://ir.valeant.com/investor-relations/ news-releases/news-release-details /2013/Valeant-Pharmaceuticals- Announces-Receipt-Of-US-FDA-Complete-Response-Letter-For- Efinaconazole.,Non-OADS,/arxiv_data1/oa_pdf/bf/bb/idr-8-163.PMC4459619.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6c/85/jpr-8-257.PMC4459620.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 257–268Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  257ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S7830 3Predictors of placebo response in peripheral  neuropathic pain: insights from pregabalin   clinical trials Roy Freeman1 Birol emir2 Bruce Parsons2 1autonomic and Peripheral nerve  laboratory, Department of  neurology, Beth israel Deaconess  Medical center, Boston, M a, Usa;   2Pfizer inc, new York, nY, Usa correspondence: Roy Freeman   autonomic and Peripheral nerve  laboratory, Department of neurology,  Beth israel Deaconess Medical center, 1  Deaconess Road, Boston, Ma 02215 Usa    Tel +1 617 632 8454  Fax +1 617 632 0852  email rfreeman@bidmc.harvard.ed uBackground:  Greater understanding of factors associated with the high placebo-response rates  noted in recent neuropathic pain trials may improve trial design.",Non-OADS,/arxiv_data1/oa_pdf/6c/85/jpr-8-257.PMC4459620.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/6c/85/jpr-8-257.PMC4459620.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/85/jpr-8-257.PMC4459620.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5e/c0/ijn-10-3803.PMC4459621.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nanomedicine 2015:10 3803–3814International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3803OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7738 3gold nanoparticles allow detection of early-stage  edema in mice via computed tomography imaging Jenny Domey Ulf T eichgräber Ingrid hilger Institute of Diagnostic and  Interventional radiology, University  hospital Jena, Jena, germanyAbstract:  Due to their high X-ray attenuation, gold nanoparticles (GNPs) emerged as  preclinical contrast agents by giving high vasculature contrast.",Non-OADS,/arxiv_data1/oa_pdf/5e/c0/ijn-10-3803.PMC4459621.pdf
"In this context, they have been particularly considered for photothermal therapy of tumors,  by which heat is generated due to intense surface-plasmon resonance absorption of gold  nano-spheres, -stars, and -rods.1–3 In addition, GNPs are promising as contrast media in  several computed tomography (CT) imaging approaches due to the high attenuation coeffi - cient of gold providing a greater contrast than commonly used iodine contrast agents.4–6 Gold has mainly been considered for tumor imaging7,8 frequently by taking  advantage of the progressive permeation through transendothelial pores on tumor  blood vessels (the enhanced permeability and retention effect) after intravenous (iv)  application.9 Some studies also achieved good CT imaging contrast after intratumoral  injection of GNPs in xenograft tumor mouse models.10–12 GNPs have never been considered for the detection of inflammation, although  the incidence of severe chronic inflammable diseases, such as ulcerative colitis and  Crohn’s disease, has increased during the 20th century in North America and Western correspondence: Jenny Domey;   Ingrid hilger Institute of Diagnostic and Interventional  radiology, University hospital Jena,  Forschungszentrum lobeda, erlanger  allee 101, D-07747 Jena, germany Tel +49 3641 932 5921 Fax +49 3641 932 5922 email jenny.domey@med.uni-jena.d e;  ingrid.hilger@med.uni-jena.d e Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Domey et al Running head recto: Gold nanoparticles for CT imaging of edema DOI: http://dx.doi.org/10.2147/IJN.S77383",Non-OADS,/arxiv_data1/oa_pdf/5e/c0/ijn-10-3803.PMC4459621.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/5e/c0/ijn-10-3803.PMC4459621.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/c0/ijn-10-3803.PMC4459621.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5a/8d/ijnrd-8-053.PMC4459622.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nephrology and Renovascular Disease 2015:8 53–57International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  53ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S6171 8Ramadan fasting and chronic kidney disease: does  estimated glomerular filtration rate change after and  before Ramadan?,Non-OADS,/arxiv_data1/oa_pdf/5a/8d/ijnrd-8-053.PMC4459622.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/5a/8d/ijnrd-8-053.PMC4459622.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/8d/ijnrd-8-053.PMC4459622.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5a/e7/dddt-9-2847.PMC4459623.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2847–2854Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2847Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8209 8Efficacy of fimasartan/hydrochlorothiazide  combination in hypertensive patients inadequately  controlled by fimasartan monotherapy Moo-Y ong rhee,1 sang hong  Baek,2 Weon Kim,3 chang gyu  Park,4 seung Woo Park,5 Byung- hee Oh,6 sang-hyun Kim,7  Jae-Joong Kim,8 Joon-han shin,9  Byung-su Y oo,10 se-Joong rim,11  Jong-Won ha,12 Joon hyung  Doh,13Y oungkeun ahn,14 Jei  Keon chae,15 Jeong Bae Park,16  soon-Kil Kim,17 cheol ho Kim18 1cardiovascular center, Dongguk University  ilsan hospital, goyang, 2catholic University  of Korea, seoul st Mary’s hospital, seoul,   3cardiovascular Department of internal  Medicine, Kyung hee University Medical  center, seoul, 4Division of cardiology,   guro hospital, Korea University college  of Medicine, seoul, 5Division of cardiology,   samsung Medical center, seoul, 6Department  of internal Medicine, seoul national University  hospital, seoul, 7Division of cardiology, seoul  Metropolitan government seoul national  University Boramae Medical center, seoul,   8Division of cardiology, asan Medical center,   seoul, 9Division of cardiology, ajou University  hospital, suwon, 10Division of cardiology,   Wonju severance christian hospital, Wonju,   11Division of cardiology, gang nam severance  hospital, seoul, 12Division of cardiology,   severance hospital, seoul, 13Division of  cardiology, inje University ilsan hospital,   goyang, 14Department of cardiology,   chonnam national University hospital,   gwangju, 15chonbuk national University  hospital, Jeonju, 16Department of cardiology,   cheil general hospital, Dankook University  college of Medicine, seoul, 17Department of  cardiology, hanyang University guri hospital,   guri, 18Department of internal Medicine,   seoul national University Bundang hospital,   seongnam, republic of KoreaBackground:  The study reported here compared the blood pressure (BP)-lowering efficacy  of fimasartan alone with that of fimasartan/hydrochlorothiazide (HCTZ) combination in  patients whose BP goal was not achieved after 4 weeks of treatment with once-daily fimasartan  60 mg. Methods:  Patients with sitting diastolic blood pressure (siDBP) 90 mmHg with 4 weeks of  once-daily fimasartan 60 mg were randomly assigned to receive either once-daily fimasartan  60 mg/HCTZ 12.5 mg or fimasartan 60 mg for 4 weeks.",Non-OADS,/arxiv_data1/oa_pdf/5a/e7/dddt-9-2847.PMC4459623.pdf
"Fimasartan is a new antihypertensive drug that lowers BP  by blocking the angiotensin II type 1 receptor.2 The efficacy of fimasartan in reduc - ing office-measured BP was shown to be greater than that of losartan.3 Maintenance  of 24-hour BP reduction by fimasartan was comparable to or slightly better than by correspondence: cheol ho Kim Department of internal Medicine, seoul national  University college of Medicine, seoul national  University Bundang hospital, gumi-ro 173,  Bundang-gu, seongnam-si, gyeonggi-do 463-707,  republic of Korea Tel +82 31 787 7001 Fax +82 31 787 4052 email cheolkim@snu.ac.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Rhee et al Running head recto: Combination fimasartan/hydrochlorothiazide treatment in hypertension DOI: http://dx.doi.org/10.2147/DDDT.S82098",Non-OADS,/arxiv_data1/oa_pdf/5a/e7/dddt-9-2847.PMC4459623.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/5a/e7/dddt-9-2847.PMC4459623.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/e7/dddt-9-2847.PMC4459623.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f7/27/copd-10-995.PMC4459624.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 995–1013International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  995RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S8251 8Novel aspects of pathogenesis and regeneration  mechanisms in COPD edvardas Bagdonas Jovile Raudoniute Ieva Bruzauskaite Ruta Aldonyte State Research Institute Center for  Innovative Medicine, vilnius, LithuaniaAbstract:  Chronic obstructive pulmonary disease (COPD), a major cause of death and mor - bidity worldwide, is characterized by expiratory airflow limitation that is not fully reversible,  deregulated chronic inflammation, and emphysematous destruction of the lungs.",Non-OADS,/arxiv_data1/oa_pdf/f7/27/copd-10-995.PMC4459624.pdf
"This may be among the reasons Correspondence: Ruta Aldonyte State Research Institute Center for  Innovative Medicine, Zygimantu 9,  vilnius LT 01102, Lithuania Tel +370 5 262 8636 Fax +370 5 212 3073 email r.aldonyte@imcentras.l t Journal name: International Journal of COPD Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Bagdonas et al Running head recto: COPD pathogenetic mechanisms revisited DOI: http://dx.doi.org/10.2147/COPD.S82518",Non-OADS,/arxiv_data1/oa_pdf/f7/27/copd-10-995.PMC4459624.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/f7/27/copd-10-995.PMC4459624.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/27/copd-10-995.PMC4459624.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6e/41/mder-8-251.PMC4459625.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2015:8 251–254Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  251ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S8336 0Randomized trial comparing episiotomies   with Braun-stadler episiotomy scissors   and EPiscissORs-60® ganpat sawant Divya Kumar Dr DY Patil Medical college and  hospital, nerul, navi Mumbai, india correspondence: ganpat sawant   Dr DY Patil Medical college and hospital,  nerul, navi Mumbai, india   Email dypatilrcog@yahoo.co mIntroduction:  Episiotomy angle is a crucial factor in causation of obstetric anal sphincter  injuries (OASIS), which are the major cause of female bowel incontinence.",Non-OADS,/arxiv_data1/oa_pdf/6e/41/mder-8-251.PMC4459625.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/6e/41/mder-8-251.PMC4459625.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/75/08/ott-8-1271.PMC4459626.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 1271–1276OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1271Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8001 2Combination of icotinib, surgery, and internal- radiotherapy of a patient with lung cancer  severely metastasized to the vertebrae bones  with EGFR mutation: a case report Li-Li Qu Hai-Feng Qin Hong-Jun Gao Xiao-Qing Liu Department of Lung Cancer, affiliated  Hospital of academy of Military  Medical science, Beijing, people’s  republic of ChinaAbstract:  A 48-year-old Chinese female was referred to us regarding EGFR -mutated advanced  non-small cell lung cancer, and metastasis to left scapula and vertebrae bones which caused  pathological fracture at T8 and T10 thoracic vertebrae.",Non-OADS,/arxiv_data1/oa_pdf/75/08/ott-8-1271.PMC4459626.pdf
"Computed tomography (CT) scan revealed an osteolytic lesion 11 cm  in size in the left scapula, magnetic resonance imaging (MRI) revealed pathological Correspondence: Xiao-Qing Liu Department of Lung Cancer, Affiliated  Hospital of academy of Military Medical  science, No 8 east road, Fengtai District,  Beijing 100071, people’s republic of  China Tel +86 10 6694 7163 Fax +86 10 5112 8605 email liuxq@medmail.com.c n Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2015 Volume: 8 Running head verso: Qu et al Running head recto: Long PFS with aggressive combination therapy DOI: http://dx.doi.org/10.2147/OTT.S80012",Non-OADS,/arxiv_data1/oa_pdf/75/08/ott-8-1271.PMC4459626.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/75/08/ott-8-1271.PMC4459626.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/08/ott-8-1271.PMC4459626.pdf
http://www.nccn.org/professionals/physician_ gls/ pdf/nscl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/75/08/ott-8-1271.PMC4459626.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/61/fc/ott-8-1277.PMC4459627.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1277–1284OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1277Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S6576 2Clinical utility and patient consideration in the use  of lenalidomide for multiple myeloma in Chinese  patients Jing wang Hongfeng Guo Xin Zhou Department of Hematology, wuxi  People’s Hospital, Nanjing Medical  University, wuxi, People’s Republic  of ChinaAbstract:  Multiple myeloma (MM) is an incurable hematologic malignancy caused by the  autonomous growth of malignant plasma cells.",Non-OADS,/arxiv_data1/oa_pdf/61/fc/ott-8-1277.PMC4459627.pdf
"Many patients with advanced relapsed/refractory MM (RRMM) in People’s Republic  of China have already failed on thalidomide and/or bortezomib treatments and are in  need of additional effective regimens to prevent further disease progression.Correspondence: Xin Zhou Department of Hematology, wuxi  People’s Hospital, Nanjing Medical  University, 299 Qingyang Road, wuxi  214023, People’s Republic of China Tel +86 510 8535 0201 email zx89232@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2015 Volume: 8 Running head verso: Wang et al Running head recto: Lenalidomide in Chinese MM patients DOI: http://dx.doi.org/10.2147/OTT.S65762",Non-OADS,/arxiv_data1/oa_pdf/61/fc/ott-8-1277.PMC4459627.pdf
"Available from: http://globocan.iarc.fr/ Pages/fact_sheets_population.asp x. Accessed March 31, 2015.",OADS,/arxiv_data1/oa_pdf/61/fc/ott-8-1277.PMC4459627.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/61/fc/ott-8-1277.PMC4459627.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/61/fc/ott-8-1277.PMC4459627.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/61/fc/ott-8-1277.PMC4459627.pdf
"Available from: http://data.stats.gov.cn/workspace/ index?a =q&type =global&dbcode =hgnd&m =hgnd&dimension =zb&co de=A020108&region =000000&time =2013,201 3.",OADS,/arxiv_data1/oa_pdf/61/fc/ott-8-1277.PMC4459627.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c6/fa/dddt-9-2831.PMC4459628.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2831–2838Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2831Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8321 3Applications of calixarenes in cancer chemotherapy:  facts and perspectives Ali Y ousaf1 Shafida Abd Hamid1 Noraslinda M Bunnori1 AA ishola2 1Kulliyyah of Science, 2Kulliyyah  of Medicine, international islamic  University Malaysia, Bandar indera  Mahkota, MalaysiaAbstract:  Research on the therapeutic applications of calixarene derivatives is an emerging  area of interest.",Non-OADS,/arxiv_data1/oa_pdf/c6/fa/dddt-9-2831.PMC4459628.pdf
"In addition to their unique physicochemical properties, they also  serve as hosts that can encapsulate many types of guests.8Correspondence: Shafida Abd Hamid Kulliyyah of Science, international  islamic University Malaysia, Bandar  indera Mahkota, 25200 Kuantan,  Pahang, Malaysia Tel +60 9 570 5120 Fax +60 9 571 6783 email shafida@iium.edu.m y Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Y ousaf et al Running head recto: Anticancer activity of calixarenes DOI: http://dx.doi.org/10.2147/DDDT.S83213",Non-OADS,/arxiv_data1/oa_pdf/c6/fa/dddt-9-2831.PMC4459628.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c6/fa/dddt-9-2831.PMC4459628.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/fa/dddt-9-2831.PMC4459628.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/31/5b/ppa-9-695.PMC4459629.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Preference and Adherence 2015:9 695–706Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  695Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6394 8Profile of paliperidone palmitate once-monthly  long-acting injectable in the management  of schizophrenia: long-term safety, efficacy,  and patient acceptability – a review Alexandre González- Rodríguez1 Rosa Catalán1–4 Rafael Penadés1–4 Clemente Garcia-Rizo1,3,4 Miquel Bioque1,4 eduard Parellada1,3–5 Miquel Bernardo1–4 1Barcelona Clinic Schizophrenia  Unit (BCSU), Neuroscience Institute,   Hospital Clinic of Barcelona,   2Department of Psychiatry and  Clinical Psychobiology, University  of Barcelona, 3institut d’ investigacions  Biomèdiques August Pi I Sunyer  (IDIBAPS), Barcelona, Spain; 4Centro  de investigación Biomédica en Red  de Salud Mental (CIBERSAM), Madrid,   Spain; 5Department of Pharmacology,   University of Barcelona, Barcelona,   SpainBackground and objectives:  Short-term studies focused on once-monthly paliperidone  palmitate (PP) at doses of 25 mg eq, 50 mg eq, 75 mg eq, 100 mg eq, or 150 mg eq have shown  its efficacy and tolerability in the treatment of schizophrenia patients.",Non-OADS,/arxiv_data1/oa_pdf/31/5b/ppa-9-695.PMC4459629.pdf
"Although the first formulations were for oral administration, the specific characteristics  of the disease allowed the development of the concept of long-acting injectables (LAIs)  in order to ensure treatment adherence and management of these populations.2Correspondence: Rosa Catalán Barcelona Clínic Schizophrenia Unit  (BCSU), Neurosciences Institute, Hospital  Clínic of Barcelona, 170, Villarroel Street,  08036 Barcelona, Spain Tel +34 93 227 5400 email rcatalan @clinic.ub.e s Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: González-Rodríguez et al Running head recto: Paliperidone palmitate once-monthly LAI DOI: http://dx.doi.org/10.2147/PPA.S63948",Non-OADS,/arxiv_data1/oa_pdf/31/5b/ppa-9-695.PMC4459629.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/31/5b/ppa-9-695.PMC4459629.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7e/da/tacg-8-133.PMC4459630.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pThe Application of Clinical Genetics 2015:8 133–136The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  133Shor T repor Topen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S7430 0hardy–Weinberg equilibrium analysis of the 48 bp  VNTr in the III exon of the DrD4 gene   in a sample of parents of ADhD cases Salvador Trejo José J T oscano-Flores esmeralda Matute María de Lourdes ramírez- Dueñas Laboratorio de Neuropsicología  y Neurolingüística, Instituto de  Neurociencias CUCBA, Guadalajara,   Jalisco, Mexico Correspondence: María de Lourdes   ramírez-Dueñas   Laboratorio de Neuropsicología  y Neurolingüística, Instituto de  Neurociencias CUCBA.",Non-OADS,/arxiv_data1/oa_pdf/7e/da/tacg-8-133.PMC4459630.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/7e/da/tacg-8-133.PMC4459630.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7e/da/tacg-8-133.PMC4459630.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a2/a8/copd-10-1035.PMC4459631.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1035–1042International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1035OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8230 3a comparative study of COPD burden between  urban vs rural communities in northern Thailand Chaicharn Pothirat Warawut Chaiwong nittaya Phetsuk sangnual Pisalthanapuna nonglak Chetsadaphan Juthamas Inchai Division of Pulmonary, Critical Care  and allergy, Department of Internal  Medicine, Faculty of Medicine, Chiang  Mai University, Chiang Mai, ThailandBackground:  COPD prevalence and consequent burden are expected to rapidly increase  worldwide.",Non-OADS,/arxiv_data1/oa_pdf/a2/a8/copd-10-1035.PMC4459631.pdf
"The objectives of this study were to compare the prevalence, clinical  characteristics, disease severity, previous physician diagnosis, and management of  COPD between urban and rural communities in Chiang Mai Province, Thailand.Correspondence: Chaicharn Pothirat Division of Pulmonary, Critical Care  and allergy, Department of Internal  Medicine, Faculty of Medicine, Chiang Mai  University, 110 Inthavaroros road,   sri Phum, Muang Chiang Mai District,  Chiang Mai 50200, Thailand Tel +66 53 946 228 Fax +66 53 895 117 email cpothira@med.cmu.ac.t h Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Pothirat et al Running head recto: COPD burden in northern Thailand DOI: http://dx.doi.org/10.2147/COPD.S82303",Non-OADS,/arxiv_data1/oa_pdf/a2/a8/copd-10-1035.PMC4459631.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a2/a8/copd-10-1035.PMC4459631.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/a8/copd-10-1035.PMC4459631.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b9/be/ppa-9-725.PMC4459632.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 725–731Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  725Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7545 9Patient considerations in the treatment of cervical  dystonia: focus on botulinum toxin type A Reversa R Mills Fernando L Pagan Department of Neurology, Movement  Disorders and Neurorestoration  Division, Georgetown University  Hospital, washington, DC,  USAAbstract:  Cervical dystonia is the most common form of focal dystonia characterized by  involuntary muscle contractions causing abnormal movements and posturing of the head and  neck and is associated with significant pain.",Non-OADS,/arxiv_data1/oa_pdf/b9/be/ppa-9-725.PMC4459632.pdf
"The  prevalence of CD in the United States is estimated to be around 400 per 100,000,4 and  it is estimated that approximately 89 per million people worldwide are living with CD.5  CD is slightly more common in females, with a male-to-female ratio of 1 to 1.2.6 CD  can occur in patients of all ages; however, the peak age of onset is around 41.8 years.6  Most cases of CD are idiopathic and there is a family history in about 12% of cases.7  CD can also be secondary to trauma or musculoskeletal, spinal cord, intracranial, ocular,  and vestibular disorders.8 CD is characterized by abnormal posturing of the head and neck in the form of tilt - ing, flexion, or extension movements of the head combined with elevation or anterior Correspondence: Fernando L Pagan Department of Neurology, Movement  Disorders and Neurorestoration  Division, Georgetown University  Hospital, 3900 Reservoir Rd, Nw, 7  PHC, washington,   DC 20007, USA Tel +1 202 444 8525 Fax +1 202 444 4115 email FPOGAN01@gunet.georgetown.ed uJournal name: Patient Preference and Adherence Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Mills and Pagan Running head recto: Treatment of cervical dystonia with BoNT A DOI: http://dx.doi.org/10.2147/PPA.S75459",Non-OADS,/arxiv_data1/oa_pdf/b9/be/ppa-9-725.PMC4459632.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/b9/be/ppa-9-725.PMC4459632.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/2d/hiv-7-175.PMC4459633.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pHIV/AIDS – Research and Palliative Care 2015:7 175–182HIV/AIDS – Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  175ORIg InAl ReSeARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S8148 1Magnitude of HIV and syphilis seroprevalence  among pregnant women in gondar, northwest  ethiopia: a cross-sectional study Mulugeta Melku1 Asmarie Kebede2 Zelalem Addis3 1Department of Hematology and  Immuohematology, School of  Biomedical and laboratory Sciences,   2Department of nursing, University  of gondar Teaching Hospital,   3Department of Medical Microbiology,  School of Biomedical and laboratory  Sciences, College of Medicine and  Health Sciences, University of  gondar, gondar, ethiopia Correspondence: Mulugeta Melku   Department of Hematology and  Immuohematology, School of Biomedical  and laboratory Sciences, College   of Medicine and Health Sciences,  University of gondar, PO Box  196,   gondar 6200, ethiopia   Tel +251 9 1008 4521  email mulugeta.melku@gmail.co mBackground:  Human immunodeficiency virus (HIV) and syphilis are major public health  problems in sub-Saharan Africa, causing numerous adverse pregnancy outcomes.",Non-OADS,/arxiv_data1/oa_pdf/71/2d/hiv-7-175.PMC4459633.pdf
Available from: http://documents.worldbank.,Non-OADS,/arxiv_data1/oa_pdf/71/2d/hiv-7-175.PMC4459633.pdf
"Available from: http://apps.who.int/ iris/bitstream/10665/82207/1/WHO_RHR_13.02_eng.pd f. Accessed   August 20, 2014.",OADS,/arxiv_data1/oa_pdf/71/2d/hiv-7-175.PMC4459633.pdf
Available from: http://apps.who.,Non-OADS,/arxiv_data1/oa_pdf/71/2d/hiv-7-175.PMC4459633.pdf
Available from: http://apps.who.int/iris/bit - stream/10665/85376/1/9789241505895_eng.pdf .,OADS,/arxiv_data1/oa_pdf/71/2d/hiv-7-175.PMC4459633.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/71/2d/hiv-7-175.PMC4459633.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/2d/hiv-7-175.PMC4459633.pdf
Available from: http://www.unaids.org/sites/default/ files/en/media/unaids/contentassets/documents/epidemiology/2012/ gr2012/2012_FS_regional_ssa_en.pd f.  25.,OADS,/arxiv_data1/oa_pdf/71/2d/hiv-7-175.PMC4459633.pdf
Available from: http://www.mhtf.org/wp-content/ uploads/sites/17/2014/01/WorkingPaper_MaternalHealth-HIV1.pd f.  26.,Non-OADS,/arxiv_data1/oa_pdf/71/2d/hiv-7-175.PMC4459633.pdf
"Available from: http://dhsprogram.com/pubs/ pdf/FR255/FR255.pd f. Accessed September 12, 2014.",OADS,/arxiv_data1/oa_pdf/71/2d/hiv-7-175.PMC4459633.pdf
Available from: http://www.who.int/diagnostics_  laboratory/publications/en/hiv_assays_rep_14.pdf.,OADS,/arxiv_data1/oa_pdf/71/2d/hiv-7-175.PMC4459633.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2d/04/jbm-6-157.PMC4459634.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Blood Medicine 2015:6 157–175Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  157Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JBM.S7882 6Prognostic significance of ASXL1 , JAK2V617F   mutations and JAK2V617F  allele burden in  Philadelphia-negative myeloproliferative  neoplasms ipek Y onal-hindilerden aynur Daglar-aday Basak akadam-T eker ceylan Yilmaz Meliha nalcaci akif selim Yavuz Deniz sargin Division of hematology, Department  of internal Medicine, istanbul Medical  Faculty, istanbul University, Fatih- istanbul, T urkey correspondence: ipek Yonal-hindilerden   stanbul Üniversitesi stanbul Tıp  Fakültesi, ç Hastalıkları ABD, Hematoloji  BD, Fatih/Çapa, istanbul, 34093, Türkiye   Tel +90 212 414 2000   Fax +90 212 315 3640   email ipekyonal@yahoo.com.t rBackground:  Despite insights into the genetic basis of Philadelphia-negative myeloprolifera - tive neoplasms (Ph-negative MPNs), a significant proportion of essential thrombocythemia  (ET) and primary myelofibrosis (PMF) patients present with no known MPN disease alleles.",Non-OADS,/arxiv_data1/oa_pdf/2d/04/jbm-6-157.PMC4459634.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/2d/04/jbm-6-157.PMC4459634.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2d/04/jbm-6-157.PMC4459634.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5c/a1/dddt-9-2811.PMC4459635.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2811–2817Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2811Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8282 0Bioequivalence evaluation of two amlodipine  salts, besylate and orotate, each in a fixed-dose  combination with olmesartan in healthy subjects Soo-Yun Lee1 Jung-Ryul Kim2,3 Jin ah Jung4 Wooseong huh2,5 Mi Y oung Bahng6 Jae-Wook Ko1,2 1Department of health sciences and  T echnology, SAIHST, Sungkyunkwan  University, seoul, republic of  Korea; 2Department of clinical  Pharmacology and Therapeutics,   samsung Medical center, seoul,   Republic of Korea; 3Department  of clinical research Design and  Evaluation, SAIHST, Sungkyunkwan  University, seoul, republic of  Korea; 4Department of clinical  Pharmacology, inje University, Busan  Paik Hospital, Busan, Republic of  Korea; 5Department of internal  Medicine, samsung Medical center,   Sungkyunkwan University School  of Medicine, seoul, republic of  Korea; 6Dong-A ST Co., Ltd., Seoul,   Republic of KoreaAbstract:  A fixed-dose combination of amlodipine and olmesartan is used to treat high blood  pressure in patients whose hypertension is not sufficiently controlled with either drug alone.",Non-OADS,/arxiv_data1/oa_pdf/5c/a1/dddt-9-2811.PMC4459635.pdf
"This drug inhibits the vasoconstrictive and aldosterone-secreting effects  by blocking the binding of angiotensin II to its receptors, and results in a decrease in  blood pressure.1,3 With oral administration of olmesartan medoxomil, conversion to the  active compound, olmesartan, occurs rapidly and completely during gastrointestinal  absorption, and the drug is eliminated mainly in the urine (35%–50%) and feces.4 The 2013 European Society of Hypertension and European Society of Cardiology  guidelines underline that regardless of which drug is employed, monotherapy effec - tively reduces blood pressure in only a limited number of hypertensive patients and  that most patients require a combination of at least two drugs to achieve blood pressure  control.5 For this reason, fixed-dose combination formulations of two or more classes Correspondence: Jae-Wook Ko Department of clinical Pharmacology  and Therapeutics, 9th Floor,  Main Building, samsung Medical center,   81 Irwon-ro, Gangnam-gu, Seoul,  Republic of Korea 135-710 Tel +82 2 3410 3690 Fax +82 2 3410 0915 email jw0701.ko@samsung.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Lee et al Running head recto: Bioequivalence of two amlodipine salts in combination with olmesartan DOI: http://dx.doi.org/10.2147/DDDT.S82820",Non-OADS,/arxiv_data1/oa_pdf/5c/a1/dddt-9-2811.PMC4459635.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/5c/a1/dddt-9-2811.PMC4459635.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/a1/dddt-9-2811.PMC4459635.pdf
"Available from: http://www.ich.org/fileadmin/Public_Web_Site/ ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pd f. Accessed  May 4, 2015.",Non-OADS,/arxiv_data1/oa_pdf/5c/a1/dddt-9-2811.PMC4459635.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/24/cb/tcrm-11-889.PMC4459636.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pTherapeutics and Clinical Risk Management 2015:11 889–899Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  889Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S5511 6Fluticasone-formoterol: a systematic review of its  potential role in the treatment of asthma  Correspondence: Suzanne G Bollmeier St Louis College of Pharmacy, 4588  Parkview Place, St Louis, MO 63110, USA Tel +1 314 446 8525 Fax +1 314 446 8500  email sbollmeier@stlcop.ed u Theresa R Prosser Suzanne G Bollmeier St Louis College of Pharmacy,   St Louis, MO, USABackground:  The purpose of this systematic review is to summarize and evaluate the available  published data regarding the efficacy and safety of a combination product containing fluticasone propi - onate/formoterol (FP-F) in order to establish its potential role compared with other inhaled combination  corticosteroid/long-acting beta2 receptor agonists for the maintenance treatment of asthma.",Non-OADS,/arxiv_data1/oa_pdf/24/cb/tcrm-11-889.PMC4459636.pdf
Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Prosser and Bollmeier Running head recto: Fluticasone-formoterol in asthma DOI: http://dx.doi.org/10.2147/TCRM.S55116,Non-OADS,/arxiv_data1/oa_pdf/24/cb/tcrm-11-889.PMC4459636.pdf
Available from: http://www.ginas - thma.org/local/uploads/content/files/GINA_Appendix_2014_Jun11.,OADS,/arxiv_data1/oa_pdf/24/cb/tcrm-11-889.PMC4459636.pdf
"Available from: http://www.cdc.gov/media/ releases/2012/p0515_asthma_impact.htm l. Accessed December 10,  2014.",Non-OADS,/arxiv_data1/oa_pdf/24/cb/tcrm-11-889.PMC4459636.pdf
Available from: http://www.ginasthma.org /.,Non-OADS,/arxiv_data1/oa_pdf/24/cb/tcrm-11-889.PMC4459636.pdf
"Available from: http://www.nhlbi.nih.gov/guidelines/asthma/ asthgdln.pd f. Accessed December 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/24/cb/tcrm-11-889.PMC4459636.pdf
"Avail - able from: http://www.pharmatimes.com/Article/12-07-04/SkyePharma_s_ Flutiform_finally_gets_EU_yes.asp x. Accessed December 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/24/cb/tcrm-11-889.PMC4459636.pdf
Available from: http://www.pmlive.com/pharma_news/suc cessfu l_ partnerships_in_pharma_skyepharma_and_mundipharma_60675 1.,Non-OADS,/arxiv_data1/oa_pdf/24/cb/tcrm-11-889.PMC4459636.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/24/cb/tcrm-11-889.PMC4459636.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/cb/tcrm-11-889.PMC4459636.pdf
Available from: http://www.nice.org.uk/advice/esnm 3.,Non-OADS,/arxiv_data1/oa_pdf/24/cb/tcrm-11-889.PMC4459636.pdf
"Available from:  https://www.medicines.org.uk/emc/PIL.26957.latest.pd f. Accessed  December 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/24/cb/tcrm-11-889.PMC4459636.pdf
"Available from:  http://www.skyepharma.com/Doc/02_PDF/01_FINANCIAL%20 INFORMATION/2013%20Annual%20Report.pd f. Accessed   December 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/24/cb/tcrm-11-889.PMC4459636.pdf
"Available at http://www.plosbiology.org/article/ info:doi/10.1371/image.pbio.v08.i05 Roeder AH, Tarr PT, Tobin C, Zhang X, Chickarmane V, Cunha A, Meyerowitz EM (2011) Computational morphodynamics of plants: integrating development over space and time.",OADS,/arxiv_data1/oa_pdf/a4/f6/344_2011_Article_9241.PMC4459658.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.04.004,Non-OADS,/arxiv_data1/oa_pdf/be/8d/main.PMC4459864.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,6,3 0 –32 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/be/8d/main.PMC4459864.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,6,3 0 –32 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/be/8d/main.PMC4459864.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.04.005,Non-OADS,/arxiv_data1/oa_pdf/80/6e/main.PMC4459865.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,6,3 3–34 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/80/6e/main.PMC4459865.pdf
"Nutrition Research and Practice 2015;9(3):219-226 ⓒ2015 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Anti-inflammatory effect of enzymatic hydrolysates from Styela  clava  flesh tissue in lipopolysaccharide-stimulated RAW 264.7  macrophages and in vivo  zebrafish model Seok-Chun Ko1 and You-Jin Jeon2§ 1Institute of Marine Biotechnology, Pukyong National University, Busan 608-737, Korea 2D e p a r t m e n t  o f  M a r i n e  L i f e  S c i e n c e ,  J e j u  N a t i o n a l  U n i v ersity, 102 Jejudaehak-ro, Jeju-si, Jeju 690-756, Korea BACKGROUND/OBJECTIVES:  In this study, potential anti-inflammatory effect of enzymatic hydrolysates from Styela clava  flesh  tissue was assessed via nitric oxide (NO) production in lipopolysaccahride (LPS) induced RAW 264.7 macrophages and in vivo   zebrafish model.",Non-OADS,/arxiv_data1/oa_pdf/c5/b1/nrp-9-219.PMC4460052.pdf
"Nutrition Research and Practice 2015;9(3):227-234 ⓒ2015 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Dual effects of a mixture of grape pomace (Campbell Early) and  Omija fruit ethanol extracts on lipid metabolism and the  antioxidant defense system in diet-induced obese mice Hye Jin Han1,2, Un Ju Jung1, Hye-Jin Kim3, Byoung Seok Moon3, Su-Jung Cho1,2, Yong Bok Park4, Dong Gun Lee4 and Myung-Sook Choi1,2§ 1Department of Food Science and Nutrition, Kyungpook Nati onal University, 80 Daehakro, Bukgu, Daegu 702-701, Korea 2Center for Food and Nutritional Genomics Research, Kyungpook National University, Daegu 702-701, Korea 3Food R&D, CJ Cheiljedang Corp., Seoul 152-051, Korea 4School of Life Science & Biotechnology, Kyungp ook National University, Daegu 702-701, Korea BACKGROUND/OBJECTIVES: We investigated the effects of a combination of grape pomace ( Vitis labrusca , Campbell Early) and  Omija fruit ( Schizandra chinensis , Baillon) ethanol extracts on lipid metabolism and antioxidant defense system in diet-induced  obese mice.",Non-OADS,/arxiv_data1/oa_pdf/bc/cb/nrp-9-227.PMC4460053.pdf
"Nutrition Research and Practice 2015;9(3):235-241 ⓒ2015 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Inhibitory effects of Doenjang , Korean traditional fermented  soybean paste, on oxidative stress and inflammation in adipose  tissue of mice fed a high-fat diet Ye Rim Nam1, Sae Bom Won1, Young-Shin Chung3, Chung Shil Kwak4 and Young Hye Kwon1,2§ 1Department of Food and Nutrition, Seoul National University, Seoul 151-742, Korea 2Research Institute of Human Ecology, Seoul National Un iversity, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea 3Department of Biotechnology, Hoseo University, Asan 336-795, Korea 4Institute on Aging, Seoul National University, Seoul 110-799, Korea BACKGROUND/OBJECTIVES:  Doenjang , Korean traditional fermented soybean paste has been reported to have an anti-obesity  effect.",Non-OADS,/arxiv_data1/oa_pdf/ed/41/nrp-9-235.PMC4460054.pdf
"Nutrition Research and Practice 2015;9(3):242-248 ⓒ2015 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Comparison of the gut microbiota profile in breast-fed and  formula-fed Korean infants using pyrosequencing Sang A Lee1, Ji Ye Lim2, Bong-Soo Kim3,4, Su Jin Cho5, Nak Yon Kim6, Ok Bin Kim7§ and Yuri Kim1,2§ 1The Graduate School of Clinical Health Sciences, Ewha Womans University, Seoul 120-750, Korea  2Department of Nutritional Science and Food Management, Ewha Womans University, 52, Ewhayeodae-gil, Seodaemun-gu, Seoul 120-750,  Korea 3ChunLab, Inc. Seoul 151-742, Korea 4Department of Life Science, Hallym University, Gangwon 200-702, Korea 5Department of Pediatrics, School of Medicine, Ewha Womans University, Seoul 158-710, Korea 6Arante Women, Hospital, Seoul 150-836, Korea 7Department of Life Science, Global Top 5 Research Program, Ewha Womans University, Seoul 120-750, Korea BACKGROUND/OBJECTIVES:  Feeding in infancy is the most significant determinant of the intestinal microbiota in early life.",Non-OADS,/arxiv_data1/oa_pdf/f2/b1/nrp-9-242.PMC4460055.pdf
The pyrosequences obtained  in this study are available in the EMBL SRA database under the  study PRJEB6615 (http://www.ebi.ac.uk/ena/data/view/PRJEB6615).,OADS,/arxiv_data1/oa_pdf/f2/b1/nrp-9-242.PMC4460055.pdf
"Nutrition Research and Practice 2015;9(3):249-255 ⓒ2015 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   The supplementation effects of peanut sprout on reduction of  abdominal fat and health indices in overweight and obese women Ae Wha Ha1, Woo Kyoung Kim1, Jung Hwan Kim2 and Nam E Kang3§ 1Department of Food Science and Nutrition, Dankook University, Gyunggi-Do, 448-701, Korea  2Department of Nursing, Eulji University, Gyeonggi-Do 461-632, Korea 3Department of Food and Nutrition, Eulji University, 553  Sanseong-Daero,Seongnam-Si, Gyeonggi-Do 461-632, Korea BACKGROUD/OBJECTIVES:  This study was conducted in order to investigate the effect of peanut sprout extracts (PSE) on health  indices in overweight and obese women (BMI ≧23 kg/m2).",Non-OADS,/arxiv_data1/oa_pdf/3f/11/nrp-9-249.PMC4460056.pdf
"Nutrition Research and Practice 2015;9(3):256-261 ⓒ2015 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   The effect of yacon ( Samallanthus sonchifolius ) ethanol extract on  cell proliferation and migration of C6 glioma cells stimulated with  fetal bovine serum Kang Pa Lee1, Nan Hee Choi2, Jin Teak Kim2 and In-Sik Park2§ 1Department of Medical Science, School of Medicine, Konkuk University, Seoul 143-701, Korea 2Department of Anatomy, college of Korean Medicine, Dongguk University Gyeongju Campus 123, Dongdae-ro, Gyeongju-si, Gyengbuk, 7 80-714, Korea BACKGROUND/OBJECTIVES:  Yacon ( Samallanthus sonchifolius ), a common edible plant grown throughout the world, is well  known for its antidiabetic properties.",Non-OADS,/arxiv_data1/oa_pdf/3f/4f/nrp-9-256.PMC4460057.pdf
"Nutrition Research and Practice 2015;9(3):262-267 ⓒ2015 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Hypoglycemic and antioxidant effects of Daraesoon ( Actinidia  arguta shoot) in animal models of diabetes mellitus Ah-Yeon Lee1, Min-Jung Kang2, Eunok Choe3 and Jung-In Kim1§ 1Department of Smart Food and Drugs, School of Food and Life Science, Inje University, 197 Inje-ro, Gimhae, 621-749, Korea 2Food and Nutrition Research Team, Division of Research and Development, Hurom Co., Ltd., 158 Golden root-ro, Gimhae, Gyungnam, 621-844, Korea  3Department of Food and Nutrition, Inha University, 100 Inha-ro, Incheon, 402-823, Korea  BACKGROUND/OBJECTIVES:  The primary objective of the treatment of diabetes mellitus is the attainment of glycemic control.",Non-OADS,/arxiv_data1/oa_pdf/91/58/nrp-9-262.PMC4460058.pdf
Available from: http://www.foodnara.go.kr/hfoodi/.,Non-OADS,/arxiv_data1/oa_pdf/91/58/nrp-9-262.PMC4460058.pdf
"Nutrition Research and Practice 2015;9(3):268-277 ⓒ2015 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Efficacy of mid-upper arm circumference in identification,  follow-up and discharge of malnourished children during nutrition  rehabilitation Joseph Birundu Mogendi1,3§, Hans De Steur1, Xavier Gellynck1, Hibbah Araba Saeed2 and Anselimo Makokha4 1Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, B-9000 Ghent, Belgium  2S c h o o l  o f  H e a l t h  a n d  R e l a t e d  R e s e a r c h ,  U n i v e r s i t y  o f  S h e f f i e l d ,  ( S c H A R R ) ;  R e g e n t  C o u r t ,  3 0  R e g e n t  S t r e e t ,  S h e f f i e l d  S 1  4 D A ,  U K 3Department of Nutrition and Dietetics, School of Health Sciences, Mount Kenya University 342-01000, Thika, Kenya 4Department of Food Science, Technology and Nutrition, Faculty of  Agriculture, Jomo Kenyatta University of Agriculture and Techn ology, 62000-00200, Nairobi, Kenya  BACKGROUND/OBJECTIVES:  Although it is crucial to identify those children likely to be treated in an appropriate nutrition  rehabilitation programme and discharge them at the appropriate time, there is no golden standard for such identification.",Non-OADS,/arxiv_data1/oa_pdf/a3/12/nrp-9-268.PMC4460059.pdf
Available from: http://www.unicef.org/  publications/files/Community_Based_Management_of_Sever_Acut e__Malnutirtion.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a3/12/nrp-9-268.PMC4460059.pdf
"Nutrition Research and Practice 2015;9(3):278-287 ⓒ2015 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   The relationship between household income and dietary intakes o f  1-10 year old urban Malaysian Zalilah Mohd Shariff1§, Khor Geok Lin2, Sarina Sariman3, Huang Soo Lee1, Chin Yit Siew1, Barakatun Nisak Mohd Yusof1, Chan  Yoke Mun1 and Maznorila Mohamad2 1Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selan gor, Malaysia 2Department of Nutrition and Dietetics, Faculty of Medicine and Health, International Medical University, 57000 Kuala Lumpur, Ma laysia 3Nutrition Programme, Faculty of Health and Life Sciences, Manage ment and Science University, 40100 Shah Alam, Selangor, Malaysi a BACKGROUND/OBJECTIVES:  Diet plays an important role in growth and development of children.",Non-OADS,/arxiv_data1/oa_pdf/49/37/nrp-9-278.PMC4460060.pdf
"Nutrition Research and Practice 2015;9(3):288-295 ⓒ2015 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Breakfast skipping and breakfast type are associated with daily  nutrient intakes and metabolic syndrome in Korean adults Sang-Jin Chung1, Yoonna Lee2, Seokhwa Lee3 and Kyungran Choi3§ 1Department of Foods and Nutrition, Kookmin University, Seoul 136-702, Korea 2Department of Food and Nutrition, Shingu College, Gyunggi 462-743, Korea 3Department of Interior Design, Graduate School of Techno Design, Oriental Culture and Design Center, Kookmin University, 77 Jeo ngneung-ro, Seongbuk-gu,  Seoul 136-702, Korea  BACKGROUND/OBJECTIVES: Emerging evidence shows that eating breakfast and breakfast types may be associated with health  outcomes and dietary intakes in various populations.",Non-OADS,/arxiv_data1/oa_pdf/db/50/nrp-9-288.PMC4460061.pdf
"Nutrition Research and Practice 2015;9(3):296-303 ⓒ2015 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Importance-satisfaction analysis of street food sanitation and  choice factor in Korea and Taiwan Nami Joo1, Sanghyun Park1, Bohee Lee2 and Jiyoung Yoon3§ 1Department of Food and Nutrition, Sookmyung Women’s University, Seoul 140-742, Korea 2Graduate School of Education, Sookmyun g Women’s University, Seoul 140-742, Korea 3Department of LCB Hospitality Management, Sookmyung Women’s University, 52 Hyochangwon-gil, Youngsan-gu, Seoul 140-742, Korea BACKGROUND/OBJECTIVES:  The present study investigated Korean and Taiwan adults on the importance of and the satisfaction  with street food sanitation and street food choice factor, in order to present management and improvement measures for street foods.SUBJECTS/METHODS:  The present study conducted a survey on 400 randomly chosen adults (200 Korean, 200 Taiwanese).",Non-OADS,/arxiv_data1/oa_pdf/b5/3f/nrp-9-296.PMC4460062.pdf
Available from: http://www.fda.gov/Food/Guidance  Regulation/GuidanceDocumentsRegulatoryInformation/ProducePla ntProducts/ucm118891.htm.,Non-OADS,/arxiv_data1/oa_pdf/b5/3f/nrp-9-296.PMC4460062.pdf
"Nutrition Research and Practice 2015;9(3):304-312 ⓒ2015 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Acculturation and changes in dietary behavior and anthropometric  measures among Chinese international students in South Korea Jounghee Lee1, Ran-Ran Gao2 and Jung-Hee Kim2§ 1Department of Nutrition Education, Graduate School of Education, Kyonggi University, Gyeonggi 443-760, Korea 2Department of Food and Nutrition, Seoul Women's Univ ersity, 621 Hwarangro, Nowon-gu, Seoul 139-774, Korea BACKGROUND/OBJECTIVES:  International students face dissimilar food environments, which could lead to changes in dietary  behaviors and anthropometric characteristics between before and after migration.",Non-OADS,/arxiv_data1/oa_pdf/f9/50/nrp-9-304.PMC4460063.pdf
Available from: http://kosis.kr/.,Non-OADS,/arxiv_data1/oa_pdf/f9/50/nrp-9-304.PMC4460063.pdf
"Nutrition Research and Practice 2015;9(3):313-318 ⓒ2015 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Dietary patterns and cardio-cerebrovascular disease in a Chinese  population Honglin Wang, Meng Qu, Peirong Yang, Biao Yang and Feng Deng§ Baoji Center for Disease Control and Prevention , XiBao Road No.",Non-OADS,/arxiv_data1/oa_pdf/20/37/nrp-9-313.PMC4460064.pdf
"Nutrition Research and Practice 2015;9(3):319-327 ⓒ2015 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Validity of self-reported height and weight in elderly Poles Ewa Nied źwiedzka§, Anna D ługosz and Lidia W ądołowska Department of Human Nutrition, University of Warmia and Mazuryul.",Non-OADS,/arxiv_data1/oa_pdf/f9/0d/nrp-9-319.PMC4460065.pdf
"Nutrition Research and Practice 2015;9(3):328-335 ⓒ2015 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   The cross-sectional relationship between dietary calcium intake  and metabolic syndrome among men and women aged 40 or older  in rural areas of Korea Song Kyoung Shin1,2, Mi Kyung Kim1,2§, Young-Hoon Lee3, Dong Hoon Shin4, Min-Ho Shin5, Byung-Yeol Chun6 a n d  B o  Y o u l  C h o i1,2 1Department of Preventive Medicine, College of Medicine, Hanyang Unviersity, 222 Wangsimni-ro, Seoul 133-791, Korea 2Institute for Health and Society, Hanyang University, Seoul 133-791, Korea 3Department of Preventive Medicine, Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Jeonbu k 570-794, Korea  4Department of Preventive Medicine, Keimyung University Dongsan Medical Center, Daegu 705-701, Korea 5Department of Preventive Medicine, Chonnam National University Medical School, Gwangju 501-757, Korea 6Department of Preventive Medicine, School of Medicine, and Health Promotion Research Center, Kyungpook National University, Dae gu 702-701, Korea BACKGROUND/OBJECTIVES: Studies conducted in Western populations have suggested that dietary calcium may protect against  metabolic abnormalities, but there is little evidence of this e ffect in Asians, who have relatively low calcium intake.",Non-OADS,/arxiv_data1/oa_pdf/b8/c0/nrp-9-328.PMC4460066.pdf
"Nutrition Research and Practice 2015;9(3):336 ⓒ2015 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Erratum: A comparative study on dietary behavior, nutritional knowledge  and life stress between Korean and Chinese female high school  students Sohwan Son1, Yoona Ro2, Hwajin Hyun3, Hongmie Lee4 and Kyunghee Song1§ 1Department of Food and Nutrition, Myongji University, 1 16, Myongji-ro, Cheoin-gu, Yo ngin, Gyeonggi 449-728, Korea 2Columbia University, 116th Street and Broadway, New York, NY 10027, USA 3Department of Food and Nutrition, Joon gbu University, Chungnam 312-702, Korea 4Department of Food Science and Nutrition, Daejin University, Gyeonggi 487-711, Korea Nutrition Research and Practice 2014;8(2):205-212; doi:10.4162/nrp.2014.8.2.205; pISSN 1976-1457 eISSN 2005-6168 Nutrition Research and Practice 2015;9(3):336; doi:10.4162/nrp.2015.9.3.336; pISSN 1976-1457 eISSN 2005-6168 Before correction On page 207, Paragraph 1: As for mothers' academic background, the percentage of Korean girls’ mothers whose highest level of education was high school (60.2%), was higher than the percentage of Korean girls’ mothers whose highest level of education was high school (38.8%), and  the percentage of Chinese girls' mothers whose highest level of education was middle school (21.6%) was higher than he percenta ge  of Korean girls' mothers whose highest level of education was middle school (3.2%).",Non-OADS,/arxiv_data1/oa_pdf/82/c1/nrp-9-336.PMC4460067.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Claudio Rivera: claudio.rivera@helsinki.fi; or Anastasia Lud - wig: anastasia.ludwig@helsinki.fi Abbreviations used in this paper: ANOVA, analysis of variance; co-IP, coimmu - noprecipitation; CTD, C-terminal domain; DIV, day in vitro; FRET, Förster reso - nance energy transfer; GEF, guanine nucleotide exchange factor; KO, knockout;  mEPSC, miniature excitatory postsynaptic current; PAK, p21-activated kinase;  VGLUT1, vesicular glutamate transporter-1; WT, wild type.THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201411008/DC1.,Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1007/s00424-  014-1547-6 Bokoch, G.M.",Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1146/annurev.biochem.72 .121801.161742 Bolte, S., and F.P.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1111/j.1365-2818.2006.01706.x Bonhoeffer, T., and R. Yuste.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1016/S0896-6273(02)00906-6 Calabrese, B., M.S.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1152/physiol.00042.2005 Chamma, I., Q. Chevy, J.C. Poncer, and S. Lévi.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"6:5. http://dx.doi.org/10.3389/fncel.2012.00005 Dopie, J., K.P.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1016/j.pneurobio.2005.02.003 Feng, G., R.H. Mellor, M. Bernstein, C. Keller-Peck, Q.T.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)00084-2 Fiumelli, H., A. Briner, M. Puskarjov, P. Blaesse, B.J.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1093/cercor/ bhs027 Gauvain, G., I. Chamma, Q. Chevy, C. Cabezas, T. Irinopoulou, N. Bodrug, M.  Carnaud, S. Lévi, and J.C. Poncer.",Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1016/j.neuron.2008.01.013 Horn, Z., T. Ringstedt, P. Blaesse, K. Kaila, and E. Herlenius.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"31:2142– 2155. http://dx.doi.org/10.1111/j.1460-9568.2010.07258.x Hotulainen, P., and C.C.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1083/jcb.201003008 Hotulainen, P., E. Paunola, M.K.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1091/mbc.E04-07-0555 Hotulainen, P., O. Llano, S. Smirnov, K. Tanhuanpää, J. Faix, C. Rivera, and  P. Lappalainen.",Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1083/jcb.200809046 Hübner, C.A., V .",Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1016/S0896-6273(01)00297-5 Ikeda, K., H. Onimaru, J. Yamada, K. Inoue, S. Ueno, T. Onaka, H. Toyoda, A.  Arata, T.O.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.2909-04.2004 Inoue, K., S. Ueno, and A. Fukuda.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1016/S0014-5793(04)00328-X Itoh, R.E., K. Kurokawa, Y .",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1128/ MCB.22.18.6582-6591.2002 Ivakine, E.A., B.A.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1006/bbrc.2000.2845 Koskinen, M., E. Bertling, and P. Hotulainen.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1016/B978-0-12-388448-0.00011-5 Li, H., S. Khirug, C. Cai, A. Ludwig, P. Blaesse, J. Kolikova, R. Afzalov, S.K.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1016/j.neuron.2007.10.039 Ludwig, A., H. Li, M. Saarma, K. Kaila, and C. Rivera.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1016/j.celrep.2014.05.022 Manser, E., T.H.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1016/S1097-2765(00)80019-2 Markkanen, M., T. Karhunen, O. Llano, A. Ludwig, C. Rivera, P. Uvarov, and  M.S.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1002/cne.23510 Matus, A., M. Ackermann, G. Pehling, H.R.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1016/S0896-6273(02)00758-4 Miller, J.H.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1074/jbc.M301052200 Payne, J.A., C. Rivera, J. V oipio, and K. Kaila.",Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
http://dx.doi.org/10.1016/S0166-  2236(03)00068-7,OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1113/jphysiol.2010.203703 Penzes, P., and M.E.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1002/cm.21015 Pertz, O.",Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1242/jcs.064345 Reynolds, A., E. Brustein, M. Liao, A. Mercado, E. Babilonia, D.B.",Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.3791-07.2008 Rivera, C., J. V oipio, J.A.",Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1038/16697 Rodriguez, A., D.B.",Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1371/journal.pone.0001997 Salin-Cantegrel, A., M. Shekarabi, S. Rasheed, F.M.",Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1371/journal.pone.0065294 Saneyoshi, T., and Y .",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1002/ cm.21037 Saneyoshi, T., G. Wayman, D. Fortin, M. Davare, N. Hoshi, N. Nozaki, T.  Natsume, and T.R.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1016/j.neuron.2007.11.016 Sarmiere, P.D., and J.R. Bamburg.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4681-08.2009Star, E.N., D.J.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1038/nn811 Strange, K., T.D.",Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1083/jcb.200509096 Tolias, K.F., J.G.",Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"94:133– 148. http://dx.doi.org/10.1016/j.pneurobio.2011.04.011 Tornberg, J., V .",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1111/j.1460-9568.2005 .03959.x van Rheenen, J., M. Langeslag, and K. Jalink.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1016/j.neuroscience.2005.05.053 Wei, W.C., C.J.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
"http://dx.doi.org/10.1083/jcb.200211002 Zhang, H., D.J.",OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
http://dx.doi.org/10.1523/JNEUROSCI.3553-04.2005,Non-OADS,/arxiv_data1/oa_pdf/3a/79/JCB_201411008.PMC4460141.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).*C.-M.",Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
Online supplemental material is available at http://www.jcb.org/cgi/ content/full/jcb.201411104/DC1.,Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
Additional data are available in the JCB DataViewer at http://dx.doi.org/10.1083/jcb.201411104.dv.,OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1089/ ars.2008.2270 Balmain, A., and I.B.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1038/303072a0 Borg, J.P., S. Marchetto, A.",Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1038/35017038 Caulin, C., T. Nguyen, M.A.",Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
http://dx.doi.org/10.1158/0008- 5472.CAN-04-1488,Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1038/onc.2012.388 Dai, P., W.C. Xiong, and L. Mei.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1038/nature10189 Deshaies, R.J., and C.A.",Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1002/1098-2744(200101)30:1<37::AID-MC1011>3.0.CO;2-7 Einspahr, J.G., G.T.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1128/ MCB.25.1.162-171.2005 Gu, Q., G.T.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"29:858– 865. http://dx.doi.org/10.1093/carcin/bgn021 Hingorani, S.R., E.F. Petricoin, A. Maitra, V .",Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1016/ S1535-6108(03)00309-X Huang, Y .Z., M. Zang, W.C. Xiong, Z. Luo, and L. Mei.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1593/neo.11420 Kamura, T., K. Maenaka, S. Kotoshiba, M. Matsumoto, D. Kohda, R.C.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1146/annurev.pharmtox.46.120604.141046 Kitagawa, M., S. Hatakeyama, M. Shirane, M. Matsumoto, N. Ishida, K.  Hattori, I. Nakamichi, A. Kikuchi, K. Nakayama, and K. Nakayama.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1093/ emboj/18.9.2401 Kolch, W. 2003.",Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"4:246. http://dx.doi.org/10.3389/fphys.2013.00246 Lapouge, G., K.K.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1074/jbc.274.12.7936 Li, H., M. Tan, L. Jia, D. Wei, Y .",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1172/JCI70297 Lichti, U., J. Anders, and S.H.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1158/0008- 5472.CAN-07-0515 Mazur, P.K., B.M.",Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1371/journal.pone.0013578 Moon, E.J., P. Sonveaux, P.E.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1038/ nrc1881 Peterson, T.R., M. Laplante, C.C.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1016/j.cell.2009.03.046 Qi, M., H. Zhou, S. Fan, Z. Li, G. Yao, S. Tashiro, S. Onodera, M. Xia, and T.  Ikejima.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1016/j.ejphar.2013.05.051 Rada, P., A.I.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1128/MCB.01204-10 Rada, P., A.I.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1128/MCB.00180-12 Rehman, I., D.T.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1002/ (SICI)1098-2744(200004)27:4<298::AID-MC8>3.0.CO;2-4 Rodier, F., and J. Campisi.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1083/jcb.201009094 Satoh, H., T. Moriguchi, J. Takai, M. Ebina, and M. Yamamoto.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-12-4499,Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1038/nature07884 Spencer, J.M., S.M.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1001/archderm.1995.01690190048009 Sun, Y ., and H. Li.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1007/s13238-012-2105-7 Sun, Y ., M. Tan, H. Duan, and M. Swaroop.",Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1038/ sj.onc.1203635 Tan, M., J.R. Gallegos, Q. Gu, Y .",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1593/neo.06568 Tan, M., Q. Gu, H. He, D. Pamarthy, G.L.",Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1038/ sj.onc.1210780 Tan, M., S.W.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1016/j.devcel.2011.09.014 Tan, M., H. Li, and Y .",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1038/onc.2013.473Tao, Y ., P. Dai, Y .",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1177/1947601910382776 Xie, C.M., W.Y .",Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1016/j.freeradbiomed.2011.06.016 Xie, C.M., X.Y .",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1093/carcin/bgt136 Xie, C.M., W. Wei, and Y .",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"40:97– 106. http://dx.doi.org/10.1016/j.jgg.2013.02.001 Xie, C.M., X.Y .",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.4161/auto.29164 Yang, J., D. McEachern, W. Li, M.A.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1158/1535-7163.MCT-10-0643 Ye, Y ., and M. Rape.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1038/nrm2780 Young, A.R., and M. Narita.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.1101/gad.519709 Zamkova, M., N. Khromova, B.P.",OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"http://dx.doi.org/10.4161/cc.23723 Zhao, Y ., X. Xiong, L. Jia, and Y .",Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/78/JCB_201411104.PMC4460146.pdf
"In studying this basic problem, we  are continually bombarded by nature’s surprises and  challenges.Cell biology: More than skin deep Elaine Fuchs Howard Hughes Medical Institute, Robin Cheumers Neustein Laboratory of Mammalian Cell Biology and Genetics, The Rockefeller University,  New York, NY 10065 © 2015 Fuchs This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/0a/d8/JCB_201503129.PMC4460147.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/0a/d8/JCB_201503129.PMC4460147.pdf
"http://dx.doi.org/10.1038/nature14289 Beronja, S., G. Livshits, S. Williams, and E. Fuchs.",Non-OADS,/arxiv_data1/oa_pdf/0a/d8/JCB_201503129.PMC4460147.pdf
"http://dx.doi.org/10.1038/nm.2167 Blanpain, C., and E. Fuchs.",OADS,/arxiv_data1/oa_pdf/0a/d8/JCB_201503129.PMC4460147.pdf
"344:1242281. http://dx.doi.org/10.1126/science.1242281 Buczacki, S.J., H.I.",OADS,/arxiv_data1/oa_pdf/0a/d8/JCB_201503129.PMC4460147.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/d8/JCB_201503129.PMC4460147.pdf
"http://dx.doi.org/10.1016/0092-8674(80)90094-X Greco, V ., T. Chen, M. Rendl, M. Schober, H.A.",OADS,/arxiv_data1/oa_pdf/0a/d8/JCB_201503129.PMC4460147.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/d8/JCB_201503129.PMC4460147.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/d8/JCB_201503129.PMC4460147.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/d8/JCB_201503129.PMC4460147.pdf
"http://dx.doi.org/10.1038/nature05766 Jones, P.H., S. Harper, and F.M.",OADS,/arxiv_data1/oa_pdf/0a/d8/JCB_201503129.PMC4460147.pdf
"http://dx.doi.org/10.1016/0092- 8674(95)90453-0 Jones, P.H., B.D.",OADS,/arxiv_data1/oa_pdf/0a/d8/JCB_201503129.PMC4460147.pdf
"http://dx.doi.org/10.1016/j.stem.2007.09.014 Lim, X., S.H.",OADS,/arxiv_data1/oa_pdf/0a/d8/JCB_201503129.PMC4460147.pdf
"http://dx.doi.org/10.1016/j.cell.2012.04.045 Mascré, G., S. Dekoninck, B. Drogat, K.K.",OADS,/arxiv_data1/oa_pdf/0a/d8/JCB_201503129.PMC4460147.pdf
"http://dx.doi.org/10.1387/ ijdb.15005570 Page, M.E., P. Lombard, F. Ng, B. Göttgens, and K.B.",OADS,/arxiv_data1/oa_pdf/0a/d8/JCB_201503129.PMC4460147.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0a/d8/JCB_201503129.PMC4460147.pdf
"http://dx.doi.org/10.1038/nature12602 Snippert, H.J., L.G.",OADS,/arxiv_data1/oa_pdf/0a/d8/JCB_201503129.PMC4460147.pdf
"http://dx.doi.org/10.1016/j.cell.2010.09.016 Tumbar, T., G. Guasch, V .",OADS,/arxiv_data1/oa_pdf/0a/d8/JCB_201503129.PMC4460147.pdf
http://dx.doi.org/10.1126/science.1092436,Non-OADS,/arxiv_data1/oa_pdf/0a/d8/JCB_201503129.PMC4460147.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Chan Young Park: cypark@unist.ac.kr; Ricardo E. Dolmetsch:  ricardo.dolmetsch@novartis.com; or Richard S. Lewis: rslewis@stanford.edu Abbreviations used in this paper: CAD, CRAC activation domain; CRAC, Ca2+  release-activated Ca2+; DVF, divalent-free; FRET, Förster resonance energy  transfer; NFAT, nuclear factor of activated T cells; PDBu, phorbol 12,13-dibu - tyrate; PM, plasma membrane; ROI, region of interest; SOCE, store-operated  calcium entry; STIM, stromal interaction molecule; Tg, thapsigargin.THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
Structural modeling De novo secondary structure predictions for the CAD regions of STIM2α and STIM2β were made using COILS (http://embnet.vital-it.ch/software/COILS_form.html).,OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
Homology modeling of the 3D struc- ture of STIM2α/β CAD domains was performed using the Phyre2  server (http://www.sbg.bio.ic.ac.uk/phyre2).,OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
Statistics All statistical analysis was performed in Prism 6 (GraphPad Soft- ware) or the GraphPad QuickCalcs website (http://www.graphpad.com/quickcalcs/).,OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201412060/DC1.,Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1126/ scisignal.2003649 Bennett-Lovsey, R.M., A.D. Herbert, M.J. Sternberg, and L.A. Kelley.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1002/prot.21688Bird, G.S., S.Y .",Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1016/j.cub.2009.08.022 Blanchetot, C., L.G.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1093/emboj/21.4.493 Brandman, O., J. Liou, W.S.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1016/j.cell.2007.11.039 Brandt, P., and T.C.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1038/ncb0609-669 Calloway, N., M. Vig, J.P. Kinet, D. Holowka, and B. Baird.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1021/ bi901936q Covington, E.D., M.M.",Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1091/mbc.E10-02-0145 Darbellay, B., S. Arnaudeau, D. Ceroni, C.R.",Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1083/ jcb.201012157 Dolmetsch, R.E., R.S.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1038/386855a0 Dolmetsch, R.E., K. Xu, and R.S.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1038/31960 Dong, H., G. Fiorin, V .",Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1111/j.1600-0854.2009.00995.x Feske, S. 2010.",Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1038/nature04702 Feske, S., C. Picard, and A. Fischer.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1074/jbc.M109.018408 Gudlur, A., A. Quintana, Y .",Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"5:5164. http://dx.doi.org/10.1038/ncomms6164 Hall, M.P., R.J. Nagel, W.S.",Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1261/rna.038422.113 Hawkins, B.J., K.M.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1083/jcb.201004152 Hogan, P.G., R.S.",Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1146/annurev.immunol.021908.132550 Hoover, P.J., and R.S.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1016/j.bbrc.2012.10.034 Kawasaki, T., I. Lange, and S. Feske.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1126/scisignal.2001122 Lewis, R.S.",Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1101/cshperspect.a003970 Li, Z., L. Liu, Y .",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1038/ cr.2010.131 Li, Q., S. Zheng, A. Han, C.H.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1038/ nature07065 Lupas, A., M. Van Dyke, and J.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1126/ science.252.5009.1162 McNally, B.A., A. Somasundaram, M. Yamashita, and M. Prakriya.",Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1113/jphysiol.2012.250456 Miao, Y ., C. Miner, L. Zhang, P.I.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.7554/eLife.00802 Muik, M., M. Fahrner, R. Schindl, P. Stathopulos, I. Frischauf, I. Derler, P.  Plenk, B. Lackner, K. Groschner, M. Ikura, and C. Romanin.",Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1038/ emboj.2011.79 Nesin, V ., G. Wiley, M. Kousi, E.C.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1016/j.cell.2012.01.055 Parekh, A.B., and J.W.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1152/physrev.00057.2003Park, C.Y ., P.J.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1016/j.cell.2009.02.014 Parvez, S., A. Beck, C. Peinelt, J. Soboloff, A. Lis, M. Monteilh-Zoller, D.L.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1096/fj.07-9449com Pozo-Guisado, E., D.G.",Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1242/ jcs.067215 Rao, A., C. Luo, and P.G.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1083/jcb.200502019 Sadaghiani, A.M., S.M.",Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1038/ncb1995 Soboloff, J., M.A.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.0263-14.2014 Srikanth, S., H.J.",Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1074/ jbc.M608247200 Stathopulos, P.B., R. Schindl, M. Fahrner, L. Zheng, G.M.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"4:2963. http://dx.doi.org/10.1038/ncomms3963 Stiber, J., A. Hawkins, Z.S.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1128/MCB.00608-09 Vandenberghe, M., M. Raphaël, V .",Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1016/j.ceca.2011.04.002 Vig, M., C. Peinelt, A. Beck, D.L.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1126/science.1127883 Wang, X., Y .",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"4:2805. http://dx.doi.org/10.1038/ ncomms3805 Williams, R.T., S.S. Manji, N.J. Parker, M.S.",Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1042/0264-6021:3570673 Wu, M.M., J. Buchanan, R.M.",Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1083/ jcb.200604014 Wu, M.M., E.D.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1091/mbc.E14-06-1107Yang, X., H. Jin, X. Cai, S. Li, and Y .",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1073/ pnas.1118947109 Yuan, J.P., W. Zeng, M.R.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1038/ncb1842 Zal, T., and N.R.",OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
"http://dx.doi.org/10.1038/nature04147 Zheng, L., P.B.",Non-OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
http://dx.doi.org/10.1016/j.bbrc.2007.12.129,OADS,/arxiv_data1/oa_pdf/93/11/JCB_201412060.PMC4460148.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Jan Ellenberg: jan.ellenberg@embl.de Abbreviations used in this paper: CMPK, chicken muscle pyruvate kinase; HCV,  hepatitis C virus; INM, inner nuclear membrane; KD, knockdown; LBR, Lamin  B receptor; NE, nuclear envelope; NPC, nuclear pore complex; ONM, outer  nuclear membrane.THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"The resulting 2.5-h movies of Target-INM- LBR translocation after gene KD were analyzed using CellCog- nition (http://www.cellcognition.org) to segment and track cells  based on the nuclear marker H2B-mCherry (Held et al., 2010;  Walter et al., 2010), selecting cell trajectories that remained in in- terphase for the entire movie (Fig.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
Online supplemental material is available at http://www.jcb.org/ cgi/content/full/jcb.201409133/DC1.,Non-OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.4161/nucl.2.2.14637 Beaudouin, J., D. Gerlich, N. Daigle, R. Eils, and J. Ellenberg.",Non-OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1016/S0092-8674(01)00627-4 Beck, M., F. Förster, M. Ecke, J.M.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"306:1387– 1390. http://dx.doi.org/10.1126/science.1104808 Braunagel, S.C., S.T.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
http://dx.doi.org/10.1073/ pnas.0703186104,Non-OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1128/ JVI.01661-08 Burke, B., and C.L.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1146/annurev.genom.7.080505.115732 Collinet, C., M. Stöter, C.R.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1038/nature08779 Ellenberg, J., E.D.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1177/1087057108320133 Galy, V ., I.W.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1091/ mbc.E03-04-0237 Gardner, J.M., C.J.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1083/jcb.201011017 Gomez-Cavazos, J.S., and M.W.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1016/j.ceb.2012.08.008 Held, M., M.H.A.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1038/nmeth.1486 Hirano, Y ., K. Hizume, H. Kimura, K. Takeyasu, T. Haraguchi, and Y .",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1074/jbc.M112.397950 Kaiser, C., E.Y .",Non-OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1038/nature05075 Krull, S., J. Thyberg, B. Björkroth, H.R.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1091/mbc.E04-03-0165 Lamarre, D., P.C.",Non-OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1038/nature02099 Lénárt, P., and J. Ellenberg.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1016/j.ymeth.2005.07.010 Lin, M.Z., J.S.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1073/ pnas.0803060105 Lusk, C.P., G. Blobel, and M.C.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1038/nrm2165 Maimon, T., N. Elad, I. Dahan, and O. Medalia.",Non-OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"20:998– 1006. http://dx.doi.org/10.1016/j.str.2012.03.025 Meinema, A.C., J.K. Laba, R.A. Hapsari, R. Otten, F.A.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1126/science.1205741 Mohr, D., S. Frey, T. Fischer, T. Güttler, and D. Görlich.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1038/emboj.2009.200Neumann, B., T. Walter, J.K. Hériché, J. Bulkescher, H. Erfle, C. Conrad, P.  Rogers, I. Poser, M. Held, U. Liebel, et al.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1083/jcb.200409149 Powell, L., and B. Burke.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1083/jcb.110.4.883 Ribbeck, K., and D. Görlich.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1093/emboj/20.6.1320 Sachdev, R., C. Sieverding, M. Flötenmeyer, and W. Antonin.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1073/ pnas.0404934101 Saksena, S., M.D.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1038/nsmb1098 Schindelin, J., I. Arganda-Carreras, E. Frise, V .",Non-OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1038/nmeth.2019 Simpson, J.C., B. Joggerst, V .",Non-OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1083/jcb.120.3.631 Soullam, B., and H.J.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1083/jcb.130.1.15 Szymborska, A., A. de Marco, N. Daigle, V .C.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1083/ jcb.200912045 Turgay, Y ., R. Ungricht, A. Rothballer, A.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1038/emboj.2010.119 Walter, T., M. Held, B. Neumann, J.K. Hériché, C. Conrad, R. Pepperkok, and J.  Ellenberg.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1016/j.jsb.2009.10.004 Walther, T.C., A. Alves, H. Pickersgill, I. Loïodice, M. Hetzer, V .",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1016/S0092-8674(03)00235-6 Yang, L., T. Guan, and L. Gerace.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
"http://dx.doi.org/10.1083/ jcb.137.6.1199 Ye, Q., and H.J.",OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
http://dx.doi.org/10.1083/jcb.201009068,Non-OADS,/arxiv_data1/oa_pdf/04/0f/JCB_201409133.PMC4460149.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Ulrike Kutay: ulrike.kutay@bc.biol.ethz.ch P. Horvath’s present address is Synthetic and Systems Biology Unit, Biological  Research Center, Szeged, Hungary; and Institute for Molecular Medicine Fin - land (FIMM), University of Helsinki, Helsinki, Finland.",Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201409127/DC1.,Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
Additional data are available in the JCB DataViewer at http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1083/jcb.111.3.807 Banaszynski, L.A., C.W.",Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"127:4715– 4721. http://dx.doi.org/10.1021/ja043277y Beck, M., V .",Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1038/nature06170 Burke, B., and C.L.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1038/nrm3488 Burke, B., and C.L.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"Rep. 3:2854. http://dx.doi.org/10.1038/srep02854 Chen, J., X.F.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1093/embo-reports/kvd092 de Planque, M.R., and J.A.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1083/jcb.138.6.1193 Erkmann, J.A., E.J.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1091/mbc.E04-11-1023 Finlay, D.R., D.D.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1083/jcb.104.2.189 Friedman, J.R., and G.K. V oeltz.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1016/j.tcb.2011.07.004 Gardner, J.M., C.J.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1083/jcb.201011017 Görlich, D., S. Prehn, R.A. Laskey, and E. Hartmann.",Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"79:767– 778. http://dx.doi.org/10.1016/0092-8674(94)90067-1 Grossman, E., O. Medalia, and M. Zwerger.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1038/nrm2641 Herzfeld, A., M. Federman, and O. Greengard.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1083/jcb.57.2.475 Ho, S.N., S.R.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1038/382822a0 Izaurralde, E., U. Kutay, C. von Kobbe, I.W.",Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1111/tra.12008 Katta, S.S., C.J.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1021/bi9519258 King, M.C., C.P.",Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1021/ bi00002a031 Kutay, U., E. Izaurralde, F.R.",Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1093/emboj/16.6.1153 LaCasse, E.C., and Y .A.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1093/nar/23.10.1647 Laurell, E., K. Beck, K. Krupina, G. Theerthagiri, B. Bodenmiller, P. Horvath, R.  Aebersold, W. Antonin, and U. Kutay.",Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1016/j.cell.2011.01.012 Liu, T.Y ., X. Bian, S. Sun, X. Hu, R.W.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1038/nrm2165 Ma, Y ., S. Cai, Q. Lv, Q. Jiang, Q. Zhang, Z. Sodmergen, Z. Zhai, and C. Zhang.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1242/jcs.03355 Maeshima, K., H. Iino, S. Hihara, T. Funakoshi, A. Watanabe, M. Nishimura,  R. Nakatomi, K. Yahata, F. Imamoto, T. Hashikawa, et al.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1038/nsmb.1878 Maimon, T., N. Elad, I. Dahan, and O. Medalia.",Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"20:998– 1006. http://dx.doi.org/10.1016/j.str.2012.03.025 Mansfeld, J., S. Güttinger, L.A. Hawryluk-Gara, N. Panté, M. Mall, V .",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1016/j.molcel.2006.02.015 Meinema, A.C., J.K. Laba, R.A. Hapsari, R. Otten, F.A.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1126/science.1205741 Mitchell, J.M., J. Mansfeld, J. Capitanio, U. Kutay, and R.W.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1083/jcb.201007098 Ohba, T., E.C.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1083/jcb.200409149 Olins, A.L., G. Rhodes, D.B.",Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.4161/nucl.1.1.10515 Ori, A., N. Banterle, M. Iskar, A. Andrés-Pons, C. Escher, H. Khanh Bui, L.  Sparks, V .",Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"9:648. http://dx.doi.org/10.1038/ msb.2013.4 Orso, G., D. Pendin, S. Liu, J. Tosetto, T.J. Moss, J.E.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1038/nature08280 Östlund, C., T. Sullivan, C.L.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1021/ bi052156n Powell, L., and B. Burke.",Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1038/ncb1184 Rapsomaniki, M.A., P. Kotsantis, I.E.",Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1093/bioinformatics/bts241 Ribbeck, K., and D. Görlich.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1093/ emboj/20.6.1320 Ribbeck, K., and D. Görlich.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1093/emboj/21.11.2664Rismanchi, N., C. Soderblom, J. Stadler, P.P.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1093/hmg/ ddn046 Rothballer, A., and U. Kutay.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1016/j.cell.2012.07.024 Rothballer, A., T.U.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1073/ pnas.0404934101 Saksena, S., M.D.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1038/nsmb1098 Schwoebel, E.D., T.H.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1083/jcb.200111077 Smith, S., and G. Blobel.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1083/jcb.120.3.631 Sosa, B.A., A. Rothballer, U. Kutay, and T.U.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"120:1093– 1100. http://dx.doi.org/10.1083/jcb.120.5.1093 Soullam, B., and H.J.",Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1083/jcb.130.1.15 Sprague, B.L., and J.G.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1083/jcb.200601001 Tapley, E.C., N. Ly, and D.A.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1091/mbc.E10-08-0733 Terry, L.J., and S.R.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1128/EC.00225-09 Theerthagiri, G., N. Eisenhardt, H. Schwarz, and W. Antonin.",Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1083/ jcb.200912045 Turgay, Y ., R. Ungricht, A. Rothballer, A.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1038/emboj.2010.119 Ulbert, S., M. Platani, S. Boue, and I.W.",Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
"http://dx.doi.org/10.1083/jcb.200512078 Zemp, I., T. Wild, M.F.",OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
http://dx.doi.org/10.1083/ jcb.201009068,Non-OADS,/arxiv_data1/oa_pdf/4b/15/JCB_201409127.PMC4460150.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Heinrich Leonhardt: h.leonhardt@lmu.de Abbreviations used in this paper: DARPin, designed ankyrin repeat protein;  ERK, extracellular signal–regulated kinase; F3H, fluorescent-3-hybrid; FP, fluor - escent protein; GBP, GFP-binding protein; hcAb, heavy chain antibody; PPI,  protein–protein interaction; PTM, posttranslational modification.THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1021/ja407527p Adams, J.J., and S.S. Sidhu.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1016/j.sbi.2013.11.003 Al-Khodor, S., C.T.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"18:132– 139. http://dx.doi.org/10.1016/j.tim.2009.11.004 Bandeiras, T.M., R.C.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1016/S0022-2836(03)00896-9 Blank, K., P. Lindner, B. Diefenbach, and A. Plückthun.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1006/prep.2001.1575 Bowley, D.R., A.F.",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/518027a Brauchle, M., S. Hansen, E. Caussinus, A. Lenard, A. Ochoa-Espinosa, O.  Scholz, S.G. Sprecher, A. Plückthun, and M. Affolter.",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1242/bio.201410041 Burgess, A., T. Lorca, and A. Castro.",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1371/journal.pone.0045726 Carlsson, A., O. Persson, J. Ingvarsson, B. Widegren, L. Salford, C.A.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1002/prca.200900173 Carlsson, A., D.M.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1093/nar/gks784 Caussinus, E., O. Kanca, and M. Affolter.",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/nsmb.2180 Chaikuad, A., T. Keates, C. Vincke, M. Kaufholz, M. Zenn, B. Zimmermann,  C. Gutiérrez, R.G.",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1016/0022-2836(85)90137-8 Colwill, K., Renewable Protein Binder Working Group, and S. Gräslund.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/nmeth.1607 Cristea, I.M., R. Williams, B.T.",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1074/mcp.M500227-MCP200 Cui, J., M. Zhang, Y .Q.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1107/S090744491000644X Domanska, K., S. Vanderhaegen, V .",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1016/j.jmb.2007.06.045 Eggenstein, E., A. Eichinger, H.J.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1016/j.jsb.2013.03.009 Ekstrand, M.I., A.R.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1016/j.cell.2014.03.059 Forrer, P., M.T.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1016/S0014-5793(03)00177-7 Frauer, C., and H. Leonhardt.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1093/nar/gkn1029 Fridy, P.C., Y .",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/nmeth.3170 Gautier, A., A. Juillerat, C. Heinis, I.R.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1016/j.chembiol.2008.01.007 Gebauer, M., A. Schiefner, G. Matschiner, and A. Skerra.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1126/science.1198701 Grabulovski, D., M. Kaspar, and D. Neri.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1074/jbc.M609211200 Grallert, A., A. Patel, V .A.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.org/10.1016/j.cell.2011.08.046,OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1016/j.neuron.2013.04.017 Gu, G.J., M. Friedman, C. Jost, K. Johnsson, M. Kamali-Moghaddam, A.  Plückthun, U. Landegren, and O. Söderberg.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/nature13761 Guizetti, J., L. Schermelleh, J. Mäntler, S. Maar, I. Poser, H. Leonhardt, T.  Müller-Reichert, and D.W. Gerlich.",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1126/science.1201847 Gulyani, A., E. Vitriol, R. Allen, J. Wu, D. Gremyachinskiy, S. Lewis, B.  Dewar, L.M.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/ nchembio.585 Hamers-Casterman, C., T. Atarhouch, S. Muyldermans, G. Robinson, C.  Hamers, E.B.",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/363446a0 Harmsen, M.M., R.C.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"37:579– 590. http://dx.doi.org/10.1016/S0161-5890(00)00081-X Helma, J., K. Schmidthals, V .",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1371/journal.pone.0050026 Herce, H.D., W. Deng, J. Helma, H. Leonhardt, and M.C.",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"4:2660. http://dx.doi.org/10.1038/ncomms3660 Hoet, R.M., E.H. Cohen, R.B.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/nbt1067 Hosein, R.E., S.A. Williams, K. Haye, and R.H. Gavin.",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1021/bc200304k Ingvarsson, J., C. Wingren, A. Carlsson, P. Ellmark, B. Wahren, G. Engström,  U. Harmenberg, M. Krogh, C. Peterson, and C.A.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1002/ pmic.200701167 Irannejad, R., J.C. Tomshine, J.R. Tomshine, M. Chevalier, J.P. Mahoney, J.  Steyaert, S.G. Rasmussen, R.K. Sunahara, H. El-Samad, B. Huang, and M. von Zastrow.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/ nature12000 Jobling, S.A., C. Jarman, M.M.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/nbt772 Jones, C.T., M.T.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1021/bc9000257 Keppler, A., S. Gendreizig, T. Gronemeyer, H. Pick, H. V ogel, and K. Johnsson.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/nbt765 Kidder, B.L., G. Hu, and K. Zhao.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/ni.2117 Kim, J., R.M.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/nsmb.1727 Kochenderfer, J.N., W.H.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1182/ blood-2010-04-281931 Kohl, A., H.K.",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"284:1141– 1151. http://dx.doi.org/10.1006/jmbi.1998.2238 Koide, A., S. Abbatiello, L. Rothgery, and S. Koide.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1016/S0969-2126(01)00266-0 Krishnamurthy, H., and E. Gouaux.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/nature10737 Kruse, A.C., A.M. Ring, A. Manglik, J. Hu, K. Hu, K. Eitel, H. Hübner, E.  Pardon, C. Valant, P.M. Sexton, et al.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/nature12735 Kummer, L., P. Parizek, P. Rube, B. Millgramm, A. Prinz, P.R.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1073/ pnas.1205399109 Kummer, L., C.W.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.org/10.1038/nrm3738,Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1074/jbc.M302336200 Los, G.V ., L.P. Encell, M.G.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1021/ cb800025k Mouratou, B., F. Schaeffer, I. Guilvout, D. Tello-Manigne, A.P.",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1073/ pnas.0702963104 Muyldermans, S. 2013.",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1146/ annurev-biochem-063011-092449 Muyldermans, S., T. Atarhouch, J. Saldanha, J.A.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"7:1129– 1135. http://dx.doi.org/10.1093/protein/7.9.1129 Nalbant, P., L. Hodgson, V .",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1126/science.1100367 Nguyen, V .K., R. Hamers, L. Wyns, and S. Muyldermans.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1093/emboj/19.5.921 Nord, K., E. Gunneriusson, J. Ringdahl, S. Ståhl, M. Uhlén, and P.A.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/nbt0897-772 Ostermeier, C., S. Iwata, B. Ludwig, and H. Michel.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/nsb1095-842 Paduch, M., A. Koide, S. Uysal, S.S. Rizk, S. Koide, and A.A. Kossiakoff.",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/nprot.2014.039 Parizek, P., L. Kummer, P. Rube, A. Prinz, F.W.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1021/cb3001167 Parmeggiani, F., R. Pellarin, A.P.",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"376:1282– 1304. http://dx.doi.org/10.1016/j.jmb.2007.12.014 Pecqueur, L., C. Duellberg, B. Dreier, Q. Jiang, C. Wang, A. Plückthun, T.  Surrey, B. Gigant, and M. Knossow.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1146/annurev-pharmtox-010611-134654 Pollithy, A., T. Romer, C. Lang, F.D.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/nature09648 Rasmussen, S.G., B.T.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/nature10361Riedl, J., A.H. Crevenna, K. Kessenbrock, J.H.",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/nmeth.1991 Rothbauer, U., K. Zolghadr, S. Tillib, D. Nowak, L. Schermelleh, A. Gahl,  N. Backmann, K. Conrath, S. Muyldermans, M.C.",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/nmeth953 Rothbauer, U., K. Zolghadr, S. Muyldermans, A. Schepers, M.C.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"7:282– 289. http://dx.doi.org/10.1074/mcp.M700342-MCP200 Sato, Y ., M. Mukai, J. Ueda, M. Muraki, T.J. Stasevich, N. Horikoshi, T. Kujirai,  H. Kita, T. Kimura, S. Hira, et al.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"Sci Rep. 3:2436. http://dx.doi.org/10.1038/srep02436 Schermelleh, L., R. Heintzmann, and H. Leonhardt.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1002/pro.2312 Sennhauser, G., P. Amstutz, C. Briand, O. Storchenegger, and M.G.",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1016/j.jmb.2010.10.033 Sha, F., E.B.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1073/ pnas.1303640110 Silverman, J., Q. Liu, A. Bakker, W. To, A. Duguay, B.M.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/nbt1166 Sims, J.J., F. Scavone, E.M. Cooper, L.A. Kane, R.J. Youle, J.D.",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/nmeth.1888 Skrabana, R., R. Dvorsky, J. Sevcik, and M. Novak.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1016/j.jsb.2010.02.016 Smith, G.P., S.U.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/ nsmb1029 Stijlemans, B., K. Conrath, V .",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1074/jbc.M307341200 Sundberg, E.J., and R.A. Mariuzza.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1016/j.cell.2013.07.021 Tanha, J., T.D.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1093/protein/gzl037 Taussig, M.J., O. Stoevesandt, C.A.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1110/ps.034892.108 Tiede, C., A.A. Tang, S.E.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1021/ja0290882 Trinkle-Mulcahy, L., S. Boulon, Y .W.",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1083/jcb.200805092 Uysal, S., V .",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1016/S0161-5890(97)00146-6 Walther, T.C., and M. Mann.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1083/ jcb.201004052 Willuda, J., A. Honegger, R. Waibel, P.A.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1002/pmic.200700025 Wojcik, J., O. Hantschel, F. Grebien, I. Kaupe, K.L.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1038/nsmb.1793 Wörn, A., and A. Plückthun.",Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
"http://dx.doi.org/10.1006/jmbi.2000.4265 Zhou, Y ., J.H.",OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/42/JCB_201409074.PMC4460151.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Mu-ming Poo: mpoo@ion.ac.cn Z.-h. Zhang’s present address is Dept.",Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
Online  supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201410068/DC1.,Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
Additional data are available in the JCB Dat-aViewer at http://dx.doi.org/10.1083/jcb.201410068.dv.,OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1083/jcb.200601060 Brugués, A., E. Anon, V .",Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1152/ajpcell.00270.2001 Carlier, M.F., A. Ducruix, and D. Pantaloni.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1126/science.1163595 Cheng, P.L., H. Lu, M. Shelly, H. Gao, and M.M.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1016/j.neuron.2010.12.021 Courtemanche, N., J.Y .",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1073/ pnas.1308257110 De, R., A. Zemel, and S.A. Safran.",Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1038/nphys680 Dogterom, M., J.W.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"17:67– 74. http://dx.doi.org/10.1016/j.ceb.2004.12.011 du Roure, O., A. Saez, A. Buguin, R.H. Austin, P. Chavrier, P. Silberzan, and  B. Ladoux.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"102:14122) http://dx.doi.org/10.1073/ pnas.0408482102 Even-Ram, S., A.D. Doyle, M.A.",Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1038/ncb1540 Falnikar, A., S. Tole, and P.W.",Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1091/mbc.E10-11-0905 Feng, Y ., and C.A.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1016/j.devcel.2009.09.003 Frady, E.P., C.R.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1093/carcin/bgs120 Gomes, E.R., S. Jani, and G.G.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1016/j.cell.2005.02.022 Grashoff, C., B.D.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1038/nature09198 Guan, C.B., H.T.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1091/mbc.E11-06-0556 Hatten, M.E.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1146/annurev.neuro.22.1.511 He, M., Z.H.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.0240-10.2010 Hiramatsu, R., T. Matsuoka, C. Kimura-Yoshida, S.W.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1083/jcb.142.1.181 Keren, K. 2011.",Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1146/annurev-cellbio-100109-104104 Kimura, K., M. Ito, M. Amano, K. Chihara, Y .",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1126/science.273.5272.245 Kuo, J.C., X. Han, C.T.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1038/ncb2216 Lieber, A.D., S. Yehudai-Resheff, E.L. Barnhart, J.A.",Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1083/jcb.201004104 Macnab, R.M., and D.E.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1038/nature07522 Martini, F.J., and M. Valdeolmillos.",Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.1962-10.2010 Matsuda, S., T. Fujita, M. Kajiya, K. Takeda, H. Shiba, H. Kawaguchi, and H.  Kurihara.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1002/jcp.22942 Mitra, S.K., D.A.",Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1038/nrm1549 Moore, S.W., and M.P.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1002/dneu.20947 Munevar, S., Y .",Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1016/S0006-3495(01)76145-0 Myers, J.P., and T.M.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.2381-11.2011 Myers, J.P., E. Robles, A. Ducharme-Smith, and T.M.",Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1038/nrm2957 Patla, I., T. V olberg, N. Elad, V .",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1038/ncb2095 Plotnikov, S.V ., A.M. Pasapera, B. Sabass, and C.M.",Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1242/jcs.090563 Roca-Cusachs, P., A. del Rio, E. Puklin-Faucher, N.C. Gauthier, N. Biais,  and M.P.",Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1073/ pnas.1220723110 Salbreux, G., G. Charras, and E. Paluch.",Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1038/ nphys2355 Shattil, S.J., C. Kim, and M.H.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1126/ science.1179735 Sieg, D.J., C.R.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1016/j.bpj.2012.08.005 Theveneau, E., L. Marchant, S. Kuriyama, M. Gull, B. Moepps, M. Parsons,  and R. Mayor.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1038/nphys1269 Tsai, J.W., K.H.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1038/nn1934 Vicente-Manzanares, M., X. Ma, R.S.",Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1038/nrm2786 Wang, Y .-L., and R.J. Pelham Jr. 1998.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1016/S0076-6879(98)98041-7 Waterman-Storer, C.M., and E. Salmon.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1016/S0955-0674(99)80008-8 Webb, D.J., K. Donais, L.A. Whitmore, S.M.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1038/ncb1230 Woo, S., and T.M.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.4209-05.2006 Wu, W., K. Wong, J. Chen, Z. Jiang, S. Dupuis, J.Y .",Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1038/22477 Xiao, H., P. Verdier-Pinard, N. Fernandez-Fuentes, B. Burd, R. Angeletti, A.  Fiser, S.B.",Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1039/c0ib00156b Yim, E.K., and M.P.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"3:41. http://dx.doi.org/10.1186/ scrt132 Yuan, X.B., M. Jin, X. Xu, Y .Q.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
"http://dx.doi.org/10.1038/ncb895 Zheng, J.Q., Z. Zheng, and M. Poo.",OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
http://dx.doi.org/10.1083/jcb.127.6.1693,Non-OADS,/arxiv_data1/oa_pdf/fd/84/JCB_201410068.PMC4460152.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e6/39/JCB_201502092.PMC4460153.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Paul S. Maddox: pmaddox@unc.edu J.F.",Non-OADS,/arxiv_data1/oa_pdf/e6/39/JCB_201502092.PMC4460153.pdf
Online supplemental material is available  at http://www.jcb.org/cgi/content/full/jcb.201502092/DC1.,Non-OADS,/arxiv_data1/oa_pdf/e6/39/JCB_201502092.PMC4460153.pdf
"http://dx.doi.org/10.1091/mbc.E02-06-0346 Conklin, E.G.",Non-OADS,/arxiv_data1/oa_pdf/e6/39/JCB_201502092.PMC4460153.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/39/JCB_201502092.PMC4460153.pdf
"http://dx.doi.org/10.1016/j.cub.2012.03.046 Greenan, G., C.P.",OADS,/arxiv_data1/oa_pdf/e6/39/JCB_201502092.PMC4460153.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/39/JCB_201502092.PMC4460153.pdf
"http://dx.doi.org/10.1091/mbc.E13-01-0043 Jevtić, P., and D.L.",OADS,/arxiv_data1/oa_pdf/e6/39/JCB_201502092.PMC4460153.pdf
"http://dx.doi.org/10.1016/j.cub.2014.10.051 Kieserman, E.K., and R. Heald.",OADS,/arxiv_data1/oa_pdf/e6/39/JCB_201502092.PMC4460153.pdf
"http://dx.doi.org/10.4161/cc.10.22.17975 Levy, D.L., and R. Heald.",OADS,/arxiv_data1/oa_pdf/e6/39/JCB_201502092.PMC4460153.pdf
"http://dx.doi.org/10.1016/j.cell.2010.09.012 Levy, D.L., and R. Heald.",OADS,/arxiv_data1/oa_pdf/e6/39/JCB_201502092.PMC4460153.pdf
"http://dx.doi.org/10.1146/annurev-cellbio-092910-154158 Loughlin, R., J.D.",OADS,/arxiv_data1/oa_pdf/e6/39/JCB_201502092.PMC4460153.pdf
"http://dx.doi.org/10.1016/j.cell.2011.11.014 Maddox, P.S., N. Portier, A. Desai, and K. Oegema.",OADS,/arxiv_data1/oa_pdf/e6/39/JCB_201502092.PMC4460153.pdf
"http://dx.doi.org/10.1038/nature09321 Neurohr, G., A. Naegeli, I. Titos, D. Theler, B. Greber, J. Díez, T. Gabaldón,  M. Mendoza, and Y .",OADS,/arxiv_data1/oa_pdf/e6/39/JCB_201502092.PMC4460153.pdf
"http://dx.doi.org/10.1126/science.1201578 Reese, K.J., M.A.",Non-OADS,/arxiv_data1/oa_pdf/e6/39/JCB_201502092.PMC4460153.pdf
"http://dx.doi.org/10.1016/S1097-2765(00)00043-5 Ribbeck, K., G. Lipowsky, H.M. Kent, M. Stewart, and D. Görlich.",OADS,/arxiv_data1/oa_pdf/e6/39/JCB_201502092.PMC4460153.pdf
"http://dx.doi.org/10.1093/emboj/17.22.6587 Schubert, I., and J.L.",OADS,/arxiv_data1/oa_pdf/e6/39/JCB_201502092.PMC4460153.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/39/JCB_201502092.PMC4460153.pdf
http://dx.doi.org/10.1016/j.cub.2008.07.092,OADS,/arxiv_data1/oa_pdf/e6/39/JCB_201502092.PMC4460153.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Benjamin L. Allen: benallen@umich.edu Abbreviations used in this paper: β-Gal, β-galactosidase; BM, basement mem - brane; BMP, bone morphogenetic protein; CRD, cysteine-rich domain; GAG,  glycosaminoglycan; GPI, glycosyl-PI; HH, Hedgehog; HHIP1, HH-interacting  protein-1; hpe, hours postelectroporation; HS, heparan sulfate; HSPG2, HS  proteoglycan 2; NSHH, N-terminal SHH; PI, phosphatidylinositol; PTCH1,  Patched-1; SHH, Sonic HH; SPR, surface plasmon resonance.THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1038/jid.2014.63 Ågren, M., P. Kogerman, M.I.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/j.gene.2004.01.010 Alexandre, C., A. Jacinto, and P.W.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1101/gad.10.16.2003 Alfaro, A.C., B. Roberts, L. Kwong, M.F.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1242/dev.110056 Allen, B.L., and A.C. Rapraeger.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1083/jcb.200307053 Allen, B.L., T. Tenzen, and A.P.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1101/gad.1543607 Allen, B.L., J.Y .",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/j.devcel.2011.04.018 Al Oustah, A., C. Danesin, N. Khouri-Farah, M.-A.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1107/S0907444906029799 Ayers, K.L., A. Gallet, L. Staccini-Lavenant, and P.P.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/j.devcel.2010.02.015 Ayers, K.L., R. Mteirek, A. Cervantes, L. Lavenant-Staccini, P.P.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1242/dev.078402 Baker, N.A., D. Sept, S. Joseph, M.J. Holst, and J.A.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1101/ gad.1951710 Bellaiche, Y ., I.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1038/27932 Bellusci, S., J. Grindley, H. Emoto, N. Itoh, and B.L.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1038/nsmb.1607 Bitgood, M.J., and A.P.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1006/dbio.1995.0010 Bosanac, I., H.R.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1038/nsmb.1632 Bouwmeester, T., S. Kim, Y .",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/S1097-2765(01)00271-4 Carpenter, D., D.M.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1164/ rccm.201403-0569OC Cayuso, J., F. Ulloa, B. Cox, J. Briscoe, and E. Martí.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"133:517– 528. http://dx.doi.org/10.1242/dev.02228 Chamberlain, C.E., J. Jeong, C. Guo, B.L.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1242/dev.013086 Chan, J.A., S. Balasubramanian, R.M.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1038/nn.2287 Chang, V .T., M. Crispin, A.R.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/j.str.2007.01.011Charrier, J.B., F. Lapointe, N.M.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81374-4 Chen, C.H., D.P.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1038/17611 Chuang, P.T., T. Kawcak, and A.P.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1101/gad.1026303 Cornesse, Y ., T. Pieler, and T. Hollemann.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80334-7 Danesin, C., E. Agius, N. Escalas, X. Ai, C. Emerson, P. Cochard, and C.  Soula.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.0715-06.2006 Desbordes, S.C., and B. Sanson.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1242/dev.00874 Dessaud, E., L.L.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"450:717– 720. http://dx.doi.org/10.1038/nature06347 Dierker, T., R. Dreier, A. Petersen, C. Bordych, and K. Grobe.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/0092-8674(95)90536-7 Ericson, J., P. Rashbass, A. Schedl, S. Brenner-Morton, A. Kawakami, V .",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80323-2 Esko, J.D., and U. Lindahl.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1172/JCI200113530 Forbes, A.J., Y .",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/S1534-5807(03)00031-5 Goodrich, L.V ., R.L.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1101/gad.10.3.301 Gritli-Linde, A., P. Lewis, A.P.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
http://dx.doi.org/10.1006/dbio.2001.0336,Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1038/nrm1681 Han, C., T.Y .",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1242/ dev.00958 Holtz, A.M., K.A.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"140:3423– 3434. http://dx.doi.org/10.1242/dev.095083 Hsieh, J.C., L. Kodjabachian, M.L.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1038/18899 Ishibashi, M., and A.P.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1242/dev.01566 Karlsson, M., and S. Björnsson.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
8:15. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"5:4849. http://dx.doi.org/10.1038/ncomms5849 Leyns, L., T. Bouwmeester, S.H.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81921-2 Li, X., T.D.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/j.jaci.2011.01.056 Liem, K.F., Jr., T.M.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1242/ dev.01522 Litingtung, Y ., L. Lei, H. Westphal, and C. Chiang.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1038/1717 Lum, L., S. Yao, B. Mozer, A. Rovescalli, D. V on Kessler, M. Nirenberg, and  P.A.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/S0092-8674(85)80105-7 Malinauskas, T., A.R.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1038/nsmb.2081 Marigo, V ., R.A. Davey, Y .",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1038/384176a0 Martí, E., D.A.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1038/375322a0 McMahon, J.A., S. Takada, L.B.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1101/gad.12.10.1438 McMahon, A.P., P.W.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"53:1– 114. http://dx.doi.org/10.1016/S0070-2153(03)53002-2 Meno, C., Y .",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1038/ng0298-104 Nieuwenhuis, E., J. Motoyama, P.C.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1128/MCB.00295-06 Nybakken, K., S.A. V okes, T.-Y .",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"37:1323– 1332. http://dx.doi.org/10.1038/ng1682 Ohlig, S., U. Pickhinke, S. Sirko, S. Bandari, D. Hoffmann, R. Dreier, P. Farshi,  M. Götz, and K. Grobe.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1074/jbc.M112.356667 Park, Y ., C. Rangel, M.M.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/S0012-1606(02)00019-2 Pathi, S., S. Pagan-Westphal, D.P.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/S0925-4773(01)00427-0 Pepicelli, C.V ., P.M. Lewis, and A.P.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/S0960-9822(98)70446-4 Perrimon, N., and M. Bernfield.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1038/35008000 Piccolo, S., Y .",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80132-4 Piccolo, S., E. Agius, L. Leyns, S. Bhattacharyya, H. Grunz, T. Bouwmeester,  and E.M. De Robertis.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1038/17820 Pillai, S.G., D. Ge, G. Zhu, X. Kong, K.V .",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1371/journal.pgen.1000421 Raman, S., R. Vernon, J. Thompson, M. Tyka, R. Sadreyev, J. Pei, D. Kim,  E. Kellogg, F. DiMaio, O. Lange, et al.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1002/prot.22540 Roessler, E., Y .-Z.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/j.celrep.2013.06.038 Sekine, K., H. Ohuchi, M. Fujiwara, M. Yamasaki, T. Yoshizawa, T. Sato, N.  Yagishita, D. Matsui, Y .",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/0092-8674(92)90316-5 Smith, W.C., A.K.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1038/361547a0 Stone, D.M., M. Hynes, M. Armanini, T.A.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1038/384129a0 Szabó, N.-E., T. Zhao, M. Cankaya, T. Theil, X. Zhou, and G. Álvarez- Bolado.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.1089-09.2009 Tenzen, T., B.L.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/S1097-2765(00)80214-2 Thibert, C., M.-A.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1126/ science.1085405 Touahri, Y ., N. Escalas, B. Benazeraf, P. Cochard, C. Danesin, and C. Soula.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1006/bbrc.1996.1147 Van Durme, Y .M.T.A., M. Eijgelsheim, G.F. Joos, A. Hofman, A.G. Uitterlinden,  G.G.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1183/09031936.00129509V okes, S.A., H. Ji, S. McCuine, T. Tenzen, S. Giles, S. Zhong, W.J.R.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1242/dev.001966 Wang, S., M. Krinks, K. Lin, F.P.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81922-4 Whalen, D.M., T. Malinauskas, R.J.C.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1038/34201 Yan, D., and X. Lin.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1101/cshperspect.a002493 Young, R.P., C.F.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/j.jsb.2011.04.017 Zhao, L., S.E.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1016/j.devcel.2011.12.023 Zhou, X., R.M.",OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://dx.doi.org/10.1093/hmg/ ddr569 Zimmerman, L.B., J.M.",Non-OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
http://dx.doi.org/10.1016/S0092-8674(00)80133-6,OADS,/arxiv_data1/oa_pdf/87/cc/JCB_201411024.PMC4460154.pdf
"http://www.cdc.gov/ nchs/about/major/hdasd/listpubs.h tm (assessed on May 11, 2008).",OADS,/arxiv_data1/oa_pdf/be/48/jgc-12-03-257.PMC4460169.pdf
http://www.ons.gov.uk/ons/index.,Non-OADS,/arxiv_data1/oa_pdf/dd/dd/jgc-12-03-263.PMC4460170.pdf
This i sa no p e na c c e s sa r t i c l eu n der the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/d3/main.PMC4460194.pdf
"6Pitavastatin ’s effects on lipid param- eters have been reported to be signi ﬁcant, and the safety pro ﬁle comparable with those of other statins such as atorvastatin, simvastatin, and pravastatin.7–9Pitavastatin calcium has been available for clinical use in Japan since 2003 and also has approvalContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/cuthreCurrent Therapeutic Research http://dx.doi.org/10.1016/j.curtheres.2015.02.001 0011-393X/ &2015.",Non-OADS,/arxiv_data1/oa_pdf/87/d3/main.PMC4460194.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/d3/main.PMC4460194.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/a1/TOORTHJ-9-191.PMC4460211.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/27/TOOPHTJ-9-56.PMC4460212.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/66/TOORTHJ-9-194.PMC4460213.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/TOORTHJ-9-185.PMC4460214.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/e8/TOORTHJ-9-188.PMC4460215.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/97/TOOPHTJ-9-89.PMC4460216.pdf
STRATUSOCT: Establishment of Normative Reference Values for Retinal Nerve Fiber Layer Thickness Measurements2003: Available from: http://www.zeiss.co.nz/C1256 C4F002FF302/EmbedTitelIntern/StratusOCT/$File/OCT+Normative+Database+Paper.pdf.,OADS,/arxiv_data1/oa_pdf/81/f3/TOOPHTJ-9-58.PMC4460217.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/81/f3/TOOPHTJ-9-58.PMC4460217.pdf
"Now a senior lecturer, Dr de Magalhaes leads the Integrative Genomics of Ageing Group (http://pcwww.liv.ac.uk/~aging/) which focuses on understanding the genetic, cellular, and mo-lecular mechanisms of ageing.",Non-OADS,/arxiv_data1/oa_pdf/58/71/CG-16-139.PMC4460218.pdf
"Visit his Lab web-page for further information about research work: https://sites.google.com/site/gkplab/home;  http://www.dpmb.ac.in/index.php?page=girdhar-pandey SELECTED PUBLICATION   [1] Kanwar P, Sanyal SK, Tokas I, Yadav AK, Pandey A, Kapoor S, Pandey GK.",Non-OADS,/arxiv_data1/oa_pdf/58/71/CG-16-139.PMC4460218.pdf
http://www.genome.,Non-OADS,/arxiv_data1/oa_pdf/f0/35/CG-16-159.PMC4460220.pdf
http://www.genome.,Non-OADS,/arxiv_data1/oa_pdf/f0/35/CG-16-159.PMC4460220.pdf
"http://www.lifetec hnologies.com/us/en/home /life-science/ se- quencing/next-generation-sequencing/solid-next-generation- sequencing/solid-next-generation-sequencing-systems-reagents- accessories/solid-next-generation-sequencing-chemistry.html#  (Accessed October 2,  2014 )/g1 [18] Huang, Y. F.; Chen, S. C.; Chiang, Y. S.; Chen, T. H.; Chiu, K. P.  Palindromic sequence impedes sequencing-by-ligation mechanism.",Non-OADS,/arxiv_data1/oa_pdf/f0/35/CG-16-159.PMC4460220.pdf
"http://www.life  technologies.com/us/en/home /life-science/sequencing/next- generation-sequencing/ion-torrent-next-generation-sequencing- workflow/ion-torrent-next-generation-sequencing-run-sequence/  ion-pgm-ion-proton-system-chips.html (Accessed October 6, 2014 ) [20] Quail, M. A.; Smith, M.; Coupland, P.; Otto, T. D.; Harris, S. R.;  Connor, T. R.; Bertoni, A.; Swerdlow, H. P.; Gu, Y.",Non-OADS,/arxiv_data1/oa_pdf/f0/35/CG-16-159.PMC4460220.pdf
"http://www.extremetech.com/extreme/190409-minion-usb- stick-gene-sequencer-finally-comes-to-market (Accessed October  6, 2014 )/g1 [29] Lohmann, K.; Klein, C. Next Generation Sequencing and the Fu- ture of Genetic Diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/f0/35/CG-16-159.PMC4460220.pdf
"http://www.insightpharmareports.com/reports_ re- port.aspx?id=124496&r=11285 (Accessed September 22,  2014 )/g1 [39] National Human Genome Research Institute.",OADS,/arxiv_data1/oa_pdf/f0/35/CG-16-159.PMC4460220.pdf
"http://raregenomics.org  (Accessed October 15,  2014 )/g1 [41] Cohen Jr, M.M.",Non-OADS,/arxiv_data1/oa_pdf/f0/35/CG-16-159.PMC4460220.pdf
"http://www.acog.org/Resources-And-Publications/  Committee-Opinions/Committee-on-Genetics/Noninvasive- Prenatal-Testing-for-Fetal-Aneuploidy (Accessed December 22,  2014 )/g1 [88] Chervenak, F. A.; McCullough, L. B. Perinatal ethics: a practical  method of analysis of obligations to mother and fetus.",Non-OADS,/arxiv_data1/oa_pdf/f0/35/CG-16-159.PMC4460220.pdf
"http://www.aap.org/en-us/a bout-the- aap/aap-press-room/Pages/AAP-Issues-New-Guidance-on-Genetic-Testing-of-Children.aspx (Accessed December 8, 2014 )/g1 [91] Boycott, K. M.; Vanstone, M. R.; Bulman, D. E.; MacKenzie, A. E.  Rare-disease genetics in the era of next-generation sequencing: dis- covery to translation.",Non-OADS,/arxiv_data1/oa_pdf/f0/35/CG-16-159.PMC4460220.pdf
http://www.mhlw.go.jp/t oukei/saikin/hw/titeki/ index.html  (Nov 18; 2014).,Non-OADS,/arxiv_data1/oa_pdf/c6/9a/CG-16-175.PMC4460221.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/54/TOOPHTJ-9-78.PMC4460225.pdf
"Available from: http://www.who.int/ageing/en/ [37] Guedes G, Tsai JC, Loewen NA.",Non-OADS,/arxiv_data1/oa_pdf/1b/f8/TOOPHTJ-9-101.PMC4460226.pdf
"Available from: http://www.prb.org/Publications/ Articles/2011/ agingpopulationclocks.aspx   Received: March 28, 2015 Revised: March 30, 2015 Accepted: March 30, 2015  © Spaeth et al.",Non-OADS,/arxiv_data1/oa_pdf/1b/f8/TOOPHTJ-9-101.PMC4460226.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/f8/TOOPHTJ-9-101.PMC4460226.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/a3/TOVJ-9-1.PMC4460227.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/93/TOOPHTJ-9-68.PMC4460228.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/39/TOOPHTJ-9-104.PMC4460229.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/6d/83/atr-04-01-22203.PMC4460257.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non- Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.Dear Editor, We read with interest the Editorial published recently ,  entitled “The transforming face of fracture epidemiol - ogy” (1).",Non-OADS,/arxiv_data1/oa_pdf/ab/00/atr-04-01-24732.PMC4460258.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/cb/10/atr-04-01-21738.PMC4460259.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non- Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/d5/e8/atr-04-01-22831.PMC4460260.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/62/d6/atr-04-01-18357.PMC4460261.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non- Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/68/ad/atr-04-01-22925.PMC4460262.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/4c/rjv061.PMC4460270.pdf
"The atom types that are involved in the  intera ction were taken from the coordinate section in the PDB files (http://www.wwpdb.org/docs.html) and classified co r- responding to their type of interaction (HB, hydrogen bond; HYD, hydrophobic interaction; and ION, ionic interaction).",OADS,/arxiv_data1/oa_pdf/94/e7/CMC-22-799.PMC4460280.pdf
"[21] Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected  Adults and Adolescents http://aidsinfo.nih.gov/guidelines on  8/6/2014  [22] European AIDS Clinical Society GuidlinesVersion 7.02 June 2014  http://eacsociety.org/Guidelines.aspx  [23] Wilkins E, Nelson M, Agarwal K, et al.",Non-OADS,/arxiv_data1/oa_pdf/c0/f5/CHIVR-13-250.PMC4460281.pdf
"ETHICAL STATEMENT  Work was the reported experiments in accordance with  the ethical standards of the committee responsible for human  experimentation (institutional and national), and with the  Helsinki Declaration of 1975, as revised in 2008 (http://www.wma.net/en/20activities/10ethics/10helsinki/).",Non-OADS,/arxiv_data1/oa_pdf/03/63/CNR-12-47.PMC4460282.pdf
Available from: http://www.cdc.gov/globalaids/What-CDC- is-Doing/implementation-science.html.,OADS,/arxiv_data1/oa_pdf/57/7a/CHIVR-13-244.PMC4460284.pdf
Available from:  http://www.usaid.gov/news-infor mation/fact-sheets/usaids- implementation-science-investment.,Non-OADS,/arxiv_data1/oa_pdf/57/7a/CHIVR-13-244.PMC4460284.pdf
Available from:  http://www.popcouncil.org/pdfs/horizons/orhivaidshndb k.pdf.,Non-OADS,/arxiv_data1/oa_pdf/57/7a/CHIVR-13-244.PMC4460284.pdf
Available from: http://www.who.int/allian  ce-hpsr/resources/9789241563895/en/index.html.,OADS,/arxiv_data1/oa_pdf/57/7a/CHIVR-13-244.PMC4460284.pdf
Available from: http://www.unaids.org/en/media/unaids/  contentassets/dataimport/publications/irc-pub03/costtu_en.pdf.,OADS,/arxiv_data1/oa_pdf/57/7a/CHIVR-13-244.PMC4460284.pdf
Thecorporate and individual sponsors of this study are listed on the CSPOR website ( http://www.csp.or.jp/cspor/kyousan_e.html ).,Non-OADS,/arxiv_data1/oa_pdf/1e/da/535_2014_Article_996.PMC4460291.pdf
"Copyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/79/jos-17-101.PMC4460329.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  101Prognostic Impact of Cerebral Small Vessel Disease  on Stroke Outcome Beom Joon Kim,a Seung-Hoon Leeb aDepartment of Neurology and Cerebrovascular Center, Seoul National University Bundang Hospital, Seongnam, Korea bDepartment of Neurology, Seoul National University Hospital, Seoul, Korea Correspondence:  Seung-Hoon Lee Department of Neurology, Seoul National  University Hospital, 101 Daehak-ro,  Jongno-gu, Seoul 110-744, Korea E-mail: sb0516@snu.ac.kr Received: November 19, 2014 Revised: January 7, 2015 Accepted: January 20, 2015 The authors have no financial conflicts of  interest.Cerebral small vessel disease (SVD), which includes white matter hyperintensities (WMHs),  silent brain infarction (SBI), and cerebral microbleeds (CMBs), develops in a conjunction of  cumulated injuries to cerebral microvascular beds, increased permeability of blood-brain  barriers, and chronic oligemia.",Non-OADS,/arxiv_data1/oa_pdf/a1/79/jos-17-101.PMC4460329.pdf
"Keywords Small vessel disease; White matter hyperintensity; Silent brain infarction; Cere - bral microbleed; Prognosis; OutcomeJournal of Stroke  201 5;17(2):101- 110 http://dx.doi.org/10.5853/jos.2015.17.2.101 Introduction Stroke is a major cause of substantial disability and the fourth- leading cause of mortality in United States.1 In Korea, the inci - dence of stroke is estimated to be 216 per 100,000 person-year,  and it will steeply increase as the geriatric proportion of the pop - ulation increases.2 Recanalization of occluded cerebral arteries  and reconstitution of brain perfusion before irreversible infarc - tion occurs is the paramount therapeutic strategy for acute isch - emic stroke.",Non-OADS,/arxiv_data1/oa_pdf/a1/79/jos-17-101.PMC4460329.pdf
"Prognostic Impact of Cerebral SVDs http://dx.doi.org/10.5853/jos.2015.17.2.101 102 http://j-stroke.orgIn this review, we examine how these neuroimaging markers  modify the prognosis after ischemic or hemorrhagic stroke and  what mechanisms exist behind such modifications.",Non-OADS,/arxiv_data1/oa_pdf/a1/79/jos-17-101.PMC4460329.pdf
"2 / May 2015 http://dx.doi.org/10.5853/jos.2015.17.2.101 http://j-stroke.org  103es the incidence of hemorrhagic stroke in patients who regularly  took aspirin or warfarin.11,12 In acute stroke, a series of case re - ports also raised a hemorrhagic suspicion from the presence of  CMB.13,14 However, a subanalysis of the DEFUSE study and a  retrospective analysis based on 279 cases contradicted these  findings.15,16 In a pooled analysis of 570 intravenously treated  acute stroke cases from 13 centers worldwide, the incidence of  symptomatic hemorrhage slightly increased by 3% in cases with  coexisting CMB, but this increase was not statistically signifi - cant.17 However, the ongoing argument over this is not over yet.",Non-OADS,/arxiv_data1/oa_pdf/a1/79/jos-17-101.PMC4460329.pdf
"Prognostic Impact of Cerebral SVDs http://dx.doi.org/10.5853/jos.2015.17.2.101 104 http://j-stroke.orgthe progression of WMH as well as cross-sectional status corre - lated with development of a new lacunar infarction.31 However,  a new lacunar infarction does not imply a symptomatic one.",Non-OADS,/arxiv_data1/oa_pdf/a1/79/jos-17-101.PMC4460329.pdf
"2 / May 2015 http://dx.doi.org/10.5853/jos.2015.17.2.101 http://j-stroke.org  105Neurocognitive outcomes It is not hard to imagine that the long-term trajectory of cogni - tive functions in patients with cerebral SVDs will deteriorate, as  SVD markers are neuroimaging phenomena indicating cumula - tive cerebral injuries (T able 4).",Non-OADS,/arxiv_data1/oa_pdf/a1/79/jos-17-101.PMC4460329.pdf
"Prognostic Impact of Cerebral SVDs http://dx.doi.org/10.5853/jos.2015.17.2.101 106 http://j-stroke.orgextent of leukoaraiosis (a proxy of cerebral WMH visualized on  computed tomography scans), worsening of the Glasgow Coma  Scale score immediately after hemorrhagic stroke, and long-term  mortality.57 Likewise, coexisting leukoaraiosis detected on com - puted tomography scans was associated with an increased risk of  extension of hematoma into ventricles.58 Such WMHs were also  inversely related to poor functional recovery after spontaneous  intracerebral hemorrhage.",Non-OADS,/arxiv_data1/oa_pdf/a1/79/jos-17-101.PMC4460329.pdf
2 / May 2015 http://dx.doi.org/10.5853/jos.2015.17.2.101 http://j-stroke.org  107 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/a1/79/jos-17-101.PMC4460329.pdf
"Prognostic Impact of Cerebral SVDs http://dx.doi.org/10.5853/jos.2015.17.2.101 108 http://j-stroke.orgemic and hemorrhagic stroke survivors in terms of immediate  response to recanalization treatment, functional recovery, recur - rent vascular events, and neurocognitive trajectories.",Non-OADS,/arxiv_data1/oa_pdf/a1/79/jos-17-101.PMC4460329.pdf
2 / May 2015 http://dx.doi.org/10.5853/jos.2015.17.2.101 http://j-stroke.org  109sel disease affects clinical outcome in patients with acute stria - tocapsular stroke.,Non-OADS,/arxiv_data1/oa_pdf/a1/79/jos-17-101.PMC4460329.pdf
Prognostic Impact of Cerebral SVDs http://dx.doi.org/10.5853/jos.2015.17.2.101 110 http://j-stroke.orgtion-based study.,Non-OADS,/arxiv_data1/oa_pdf/a1/79/jos-17-101.PMC4460329.pdf
"Copyright © 2015  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/c1/jos-17-111.PMC4460330.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  111Prevention and Management of Cerebral Small  Vessel Disease Vincent Mok,a Jong S. Kimb aDivision of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Special     Administrative Region, China bStroke Center and Department of Neurology, University of Ulsan, Asan Medical Center, Seoul, Korea Correspondence:  Jong S. Kim Department of Neurology, Asan Medical  Center, University of Ulsan College of  Medicine, 88 Olympic-ro 43-gil,   Songpa-gu, Seoul 138-736, Korea Tel: +82-2-3010-3440 Fax: +82-2-474-4691 E-mail: jongskim@amc.seoul.kr Received: February 22, 2015 Revised: April 7, 2015 Accepted: April 7, 2015 Supported by a grant from Ministry for  Health, Welfare and Family Affairs,  Republic of Korea (HI14C1985).",Non-OADS,/arxiv_data1/oa_pdf/65/c1/jos-17-111.PMC4460330.pdf
"Keywords  Prevention; Treatment; Small vessel disease Special Review Small Vessel Disease IIJournal of Stroke  201 5;17(2):111- 122 http://dx.doi.org/10.5853/jos.2015.17.2.111 Introduction  Lacunar infarcts (lacunes), white matter hyperintensities  (WMH), and cerebral microbleeds (CMBs) are considered vari - ous manifestations of cerebral small vessel disease (SVD).",Non-OADS,/arxiv_data1/oa_pdf/65/c1/jos-17-111.PMC4460330.pdf
"Treatment of Small Vessel Disease  http://dx.doi.org/10.5853/jos.2015.17.2.111 112 http://j-stroke.orgrating arteriole that is associated with acute neurological symp - toms (i.e., lacunar stroke).",Non-OADS,/arxiv_data1/oa_pdf/65/c1/jos-17-111.PMC4460330.pdf
"2 / May 2015 http://dx.doi.org/10.5853/jos.2015.17.2.111 http://j-stroke.org  113tous disease (presumably related to a large-vessel atheromatous  plaque blocking the mouth of the penetrating artery) had the  highest prevalence of atheromatous indicators (i.e., coronary ar - tery disease, asymptomatic cerebral atherosclerotic disease) and  the lowest prevalence of SVD indicators (i.e., WMH, CMBs);  distal lacunar infarcts without parent atheromatous disease  (presumably related to fibrinoid necrosis) had the lowest preva - lence of atheromatous indicators and the highest prevalence of  SVD indicators; and proximal lacunar infarcts without parent  atheromatous disease (presumably related to microatheroma at  the proximal portion of the penetrating artery) showed inter - mediate features (Figure 1).",Non-OADS,/arxiv_data1/oa_pdf/65/c1/jos-17-111.PMC4460330.pdf
Treatment of Small Vessel Disease  http://dx.doi.org/10.5853/jos.2015.17.2.111 114 http://j-stroke.orgBP)26 were associated with WMH.,Non-OADS,/arxiv_data1/oa_pdf/65/c1/jos-17-111.PMC4460330.pdf
"2 / May 2015 http://dx.doi.org/10.5853/jos.2015.17.2.111 http://j-stroke.org  115ciation was found between peripheral markers of coagulation ac - tivation (e.g., D-dimer, prothrombin fragments 1 and 2) and  WMH progression.",OADS,/arxiv_data1/oa_pdf/65/c1/jos-17-111.PMC4460330.pdf
Treatment of Small Vessel Disease  http://dx.doi.org/10.5853/jos.2015.17.2.111 116 http://j-stroke.orgwith non-lacunar stroke.,Non-OADS,/arxiv_data1/oa_pdf/65/c1/jos-17-111.PMC4460330.pdf
"2 / May 2015 http://dx.doi.org/10.5853/jos.2015.17.2.111 http://j-stroke.org  117Dyslipidemia  Dyslipidemia, especially elevated LDL cholesterol levels, plays  an important role in the development of atherosclerosis.",Non-OADS,/arxiv_data1/oa_pdf/65/c1/jos-17-111.PMC4460330.pdf
Treatment of Small Vessel Disease  http://dx.doi.org/10.5853/jos.2015.17.2.111 118 http://j-stroke.orgmain.,Non-OADS,/arxiv_data1/oa_pdf/65/c1/jos-17-111.PMC4460330.pdf
"2 / May 2015 http://dx.doi.org/10.5853/jos.2015.17.2.111 http://j-stroke.org  119D’ Agostino RB, et al.",OADS,/arxiv_data1/oa_pdf/65/c1/jos-17-111.PMC4460330.pdf
